id	sid	tid	token	lemma	pos
ghmj-1231	1	1	indonesian	indonesian	ADJ
ghmj-1231	1	2	scholars	scholars	PROPN
ghmj-1231	1	3	’	'	PUNCT
ghmj-1231	1	4	alliance	alliance	NOUN
ghmj-1231	1	5	ghmj	ghmj	NOUN
ghmj-1231	1	6	(	(	PUNCT
ghmj-1231	1	7	global	global	ADJ
ghmj-1231	1	8	health	health	PROPN
ghmj-1231	1	9	management	management	NOUN
ghmj-1231	1	10	journal	journal	PROPN
ghmj-1231	1	11	)	)	PUNCT
ghmj-1231	1	12	2025	2025	NUM
ghmj-1231	1	13	,	,	PUNCT
ghmj-1231	1	14	vol	vol	NOUN
ghmj-1231	1	15	.	.	NOUN
ghmj-1231	1	16	8	8	NUM
ghmj-1231	1	17	,	,	PUNCT
ghmj-1231	1	18	no	no	INTJ
ghmj-1231	1	19	.	.	PUNCT
ghmj-1231	2	1	2s	2s	NUM
ghmj-1231	2	2	x	x	SYM
ghmj-1231	2	3	open	open	ADJ
ghmj-1231	2	4	access	access	NOUN
ghmj-1231	2	5	research	research	NOUN
ghmj-1231	2	6	article	article	NOUN
ghmj-1231	2	7	the	the	DET
ghmj-1231	2	8	1st	1st	ADJ
ghmj-1231	2	9	cirebon	cirebon	PROPN
ghmj-1231	2	10	international	international	PROPN
ghmj-1231	2	11	health	health	NOUN
ghmj-1231	2	12	symposium	symposium	NOUN
ghmj-1231	2	13	:	:	PUNCT
ghmj-1231	2	14	faculty	faculty	NOUN
ghmj-1231	2	15	of	of	ADP
ghmj-1231	2	16	medicine	medicine	NOUN
ghmj-1231	2	17	,	,	PUNCT
ghmj-1231	2	18	universitas	universita	NOUN
ghmj-1231	2	19	swadaya	swadaya	NOUN
ghmj-1231	2	20	gunung	gunung	NOUN
ghmj-1231	2	21	jati	jati	PROPN
ghmj-1231	2	22	update	update	NOUN
ghmj-1231	2	23	on	on	ADP
ghmj-1231	2	24	non	non	ADJ
ghmj-1231	2	25	-	-	ADJ
ghmj-1231	2	26	communicable	communicable	ADJ
ghmj-1231	2	27	diseases	disease	NOUN
ghmj-1231	2	28	:	:	PUNCT
ghmj-1231	2	29	global	global	ADJ
ghmj-1231	2	30	perspective	perspective	NOUN
ghmj-1231	2	31	on	on	ADP
ghmj-1231	2	32	health	health	NOUN
ghmj-1231	2	33	challenges	challenge	NOUN
ghmj-1231	2	34	and	and	CCONJ
ghmj-1231	2	35	innovation	innovation	NOUN
ghmj-1231	2	36	angiotensin	angiotensin	NOUN
ghmj-1231	2	37	converting	convert	VERB
ghmj-1231	2	38	enzyme	enzyme	NOUN
ghmj-1231	2	39	2	2	NUM
ghmj-1231	2	40	(	(	PUNCT
ghmj-1231	2	41	ace2	ace2	PROPN
ghmj-1231	2	42	)	)	PUNCT
ghmj-1231	3	1	g8790a	g8790a	PROPN
ghmj-1231	3	2	gene	gene	NOUN
ghmj-1231	3	3	polymorphism	polymorphism	NOUN
ghmj-1231	3	4	as	as	ADP
ghmj-1231	3	5	a	a	DET
ghmj-1231	3	6	risk	risk	NOUN
ghmj-1231	3	7	factor	factor	NOUN
ghmj-1231	3	8	for	for	ADP
ghmj-1231	3	9	essential	essential	ADJ
ghmj-1231	3	10	hypertension	hypertension	NOUN
ghmj-1231	3	11	nazaul	nazaul	NOUN
ghmj-1231	3	12	husna1	husna1	PROPN
ghmj-1231	3	13	*	*	PROPN
ghmj-1231	3	14	,	,	PUNCT
ghmj-1231	3	15	donny	donny	PROPN
ghmj-1231	3	16	nauphar2	nauphar2	PROPN
ghmj-1231	3	17	,	,	PUNCT
ghmj-1231	3	18	tiar	tiar	VERB
ghmj-1231	3	19	masykuroh	masykuroh	NOUN
ghmj-1231	3	20	pratamawati2	pratamawati2	ADP
ghmj-1231	3	21	*	*	PROPN
ghmj-1231	3	22	1	1	X
ghmj-1231	3	23	.	.	X
ghmj-1231	3	24	faculty	faculty	NOUN
ghmj-1231	3	25	of	of	ADP
ghmj-1231	3	26	medicine	medicine	NOUN
ghmj-1231	3	27	,	,	PUNCT
ghmj-1231	3	28	universitas	universita	NOUN
ghmj-1231	3	29	swadaya	swadaya	NOUN
ghmj-1231	3	30	gunung	gunung	PROPN
ghmj-1231	3	31	jati	jati	PROPN
ghmj-1231	3	32	,	,	PUNCT
ghmj-1231	3	33	cirebon	cirebon	NOUN
ghmj-1231	3	34	,	,	PUNCT
ghmj-1231	3	35	indonesia	indonesia	PROPN
ghmj-1231	3	36	(	(	PUNCT
ghmj-1231	3	37	45132	45132	NUM
ghmj-1231	3	38	)	)	PUNCT
ghmj-1231	3	39	;	;	PUNCT
ghmj-1231	3	40	2	2	X
ghmj-1231	3	41	.	.	X
ghmj-1231	3	42	department	department	NOUN
ghmj-1231	3	43	of	of	ADP
ghmj-1231	3	44	genetics	genetic	NOUN
ghmj-1231	3	45	,	,	PUNCT
ghmj-1231	3	46	faculty	faculty	NOUN
ghmj-1231	3	47	of	of	ADP
ghmj-1231	3	48	medicine	medicine	NOUN
ghmj-1231	3	49	,	,	PUNCT
ghmj-1231	3	50	universitas	universita	NOUN
ghmj-1231	3	51	swadaya	swadaya	NOUN
ghmj-1231	3	52	gunung	gunung	PROPN
ghmj-1231	3	53	jati	jati	PROPN
ghmj-1231	3	54	,	,	PUNCT
ghmj-1231	3	55	cirebon	cirebon	NOUN
ghmj-1231	3	56	,	,	PUNCT
ghmj-1231	3	57	indonesia	indonesia	PROPN
ghmj-1231	3	58	(	(	PUNCT
ghmj-1231	3	59	45132	45132	NUM
ghmj-1231	3	60	)	)	PUNCT
ghmj-1231	3	61	.	.	PUNCT
ghmj-1231	4	1	*	*	PUNCT
ghmj-1231	4	2	corresponding	correspond	VERB
ghmj-1231	4	3	author	author	NOUN
ghmj-1231	4	4	’s	’s	PART
ghmj-1231	4	5	e	e	NOUN
ghmj-1231	4	6	-	-	NOUN
ghmj-1231	4	7	mail	mail	NOUN
ghmj-1231	4	8	:	:	PUNCT
ghmj-1231	4	9	drtyarladala@gmail.com	drtyarladala@gmail.com	NOUN
ghmj-1231	4	10	;	;	PUNCT
ghmj-1231	4	11	nazaulh12@gmail.com	nazaulh12@gmail.com	X
ghmj-1231	4	12	doi	doi	NOUN
ghmj-1231	4	13	:	:	PUNCT
ghmj-1231	4	14	10.35898	10.35898	NUM
ghmj-1231	4	15	/	/	SYM
ghmj-1231	4	16	ghmj-82s1231	ghmj-82s1231	PROPN
ghmj-1231	4	17	abstract	abstract	ADJ
ghmj-1231	4	18	background	background	NOUN
ghmj-1231	4	19	:	:	PUNCT
ghmj-1231	4	20	globally	globally	ADV
ghmj-1231	4	21	,	,	PUNCT
ghmj-1231	4	22	the	the	DET
ghmj-1231	4	23	number	number	NOUN
ghmj-1231	4	24	of	of	ADP
ghmj-1231	4	25	people	people	NOUN
ghmj-1231	4	26	with	with	ADP
ghmj-1231	4	27	hypertension	hypertension	NOUN
ghmj-1231	4	28	has	have	AUX
ghmj-1231	4	29	doubled	double	VERB
ghmj-1231	4	30	,	,	PUNCT
ghmj-1231	4	31	from	from	ADP
ghmj-1231	4	32	650	650	NUM
ghmj-1231	4	33	million	million	NUM
ghmj-1231	4	34	to	to	PART
ghmj-1231	4	35	1.3	1.3	NUM
ghmj-1231	4	36	billion	billion	NUM
ghmj-1231	4	37	.	.	PUNCT
ghmj-1231	5	1	the	the	DET
ghmj-1231	5	2	world	world	PROPN
ghmj-1231	5	3	health	health	PROPN
ghmj-1231	5	4	organization	organization	NOUN
ghmj-1231	5	5	reported	report	VERB
ghmj-1231	5	6	that	that	SCONJ
ghmj-1231	5	7	hypertension	hypertension	NOUN
ghmj-1231	5	8	is	be	AUX
ghmj-1231	5	9	responsible	responsible	ADJ
ghmj-1231	5	10	for	for	ADP
ghmj-1231	5	11	more	more	ADJ
ghmj-1231	5	12	than	than	ADP
ghmj-1231	5	13	10	10	NUM
ghmj-1231	5	14	million	million	NUM
ghmj-1231	5	15	deaths	death	NOUN
ghmj-1231	5	16	every	every	DET
ghmj-1231	5	17	year	year	NOUN
ghmj-1231	5	18	.	.	PUNCT
ghmj-1231	6	1	essential	essential	ADJ
ghmj-1231	6	2	hypertension	hypertension	NOUN
ghmj-1231	6	3	is	be	AUX
ghmj-1231	6	4	a	a	DET
ghmj-1231	6	5	multifactorial	multifactorial	ADJ
ghmj-1231	6	6	condition	condition	NOUN
ghmj-1231	6	7	with	with	ADP
ghmj-1231	6	8	genetics	genetic	NOUN
ghmj-1231	6	9	as	as	ADP
ghmj-1231	6	10	one	one	NUM
ghmj-1231	6	11	of	of	ADP
ghmj-1231	6	12	the	the	DET
ghmj-1231	6	13	factors	factor	NOUN
ghmj-1231	6	14	.	.	PUNCT
ghmj-1231	7	1	genome	genome	NOUN
ghmj-1231	7	2	-	-	PUNCT
ghmj-1231	7	3	wide	wide	ADJ
ghmj-1231	7	4	association	association	NOUN
ghmj-1231	7	5	study	study	NOUN
ghmj-1231	7	6	has	have	AUX
ghmj-1231	7	7	identified	identify	VERB
ghmj-1231	7	8	several	several	ADJ
ghmj-1231	7	9	genes	gene	NOUN
ghmj-1231	7	10	associated	associate	VERB
ghmj-1231	7	11	with	with	ADP
ghmj-1231	7	12	hypertension	hypertension	NOUN
ghmj-1231	7	13	,	,	PUNCT
ghmj-1231	7	14	one	one	NUM
ghmj-1231	7	15	of	of	ADP
ghmj-1231	7	16	which	which	PRON
ghmj-1231	7	17	is	be	AUX
ghmj-1231	7	18	the	the	DET
ghmj-1231	7	19	angiotensin	angiotensin	NOUN
ghmj-1231	7	20	converting	convert	VERB
ghmj-1231	7	21	enzyme	enzyme	NOUN
ghmj-1231	7	22	2	2	NUM
ghmj-1231	7	23	(	(	PUNCT
ghmj-1231	7	24	ace2	ace2	NOUN
ghmj-1231	7	25	)	)	PUNCT
ghmj-1231	7	26	gene	gene	NOUN
ghmj-1231	7	27	.	.	PUNCT
ghmj-1231	8	1	essential	essential	ADJ
ghmj-1231	8	2	hypertension	hypertension	NOUN
ghmj-1231	8	3	may	may	AUX
ghmj-1231	8	4	be	be	AUX
ghmj-1231	8	5	predisposed	predispose	VERB
ghmj-1231	8	6	to	to	ADP
ghmj-1231	8	7	by	by	ADP
ghmj-1231	8	8	the	the	DET
ghmj-1231	8	9	g8790a	g8790a	PROPN
ghmj-1231	8	10	polymorphism	polymorphism	NOUN
ghmj-1231	8	11	of	of	ADP
ghmj-1231	8	12	the	the	DET
ghmj-1231	8	13	ace2	ace2	PROPN
ghmj-1231	8	14	gene	gene	NOUN
ghmj-1231	8	15	,	,	PUNCT
ghmj-1231	8	16	which	which	PRON
ghmj-1231	8	17	is	be	AUX
ghmj-1231	8	18	hypothesized	hypothesize	VERB
ghmj-1231	8	19	to	to	PART
ghmj-1231	8	20	interfere	interfere	VERB
ghmj-1231	8	21	with	with	ADP
ghmj-1231	8	22	the	the	DET
ghmj-1231	8	23	normal	normal	ADJ
ghmj-1231	8	24	function	function	NOUN
ghmj-1231	8	25	of	of	ADP
ghmj-1231	8	26	the	the	DET
ghmj-1231	8	27	renin	renin	ADJ
ghmj-1231	8	28	angiotensin	angiotensin	NOUN
ghmj-1231	8	29	system	system	NOUN
ghmj-1231	8	30	(	(	PUNCT
ghmj-1231	8	31	ras	ras	NOUN
ghmj-1231	8	32	)	)	PUNCT
ghmj-1231	8	33	.	.	PUNCT
ghmj-1231	9	1	aims	aim	VERB
ghmj-1231	9	2	:	:	PUNCT
ghmj-1231	9	3	the	the	DET
ghmj-1231	9	4	purpose	purpose	NOUN
ghmj-1231	9	5	of	of	ADP
ghmj-1231	9	6	this	this	DET
ghmj-1231	9	7	study	study	NOUN
ghmj-1231	9	8	is	be	AUX
ghmj-1231	9	9	to	to	PART
ghmj-1231	9	10	determine	determine	VERB
ghmj-1231	9	11	whether	whether	SCONJ
ghmj-1231	9	12	the	the	DET
ghmj-1231	9	13	ace2	ace2	PROPN
ghmj-1231	9	14	g8790a	g8790a	PROPN
ghmj-1231	9	15	gene	gene	NOUN
ghmj-1231	9	16	polymorphism	polymorphism	NOUN
ghmj-1231	9	17	in	in	ADP
ghmj-1231	9	18	cirebon	cirebon	NOUN
ghmj-1231	9	19	,	,	PUNCT
ghmj-1231	9	20	west	west	PROPN
ghmj-1231	9	21	java	java	PROPN
ghmj-1231	9	22	,	,	PUNCT
ghmj-1231	9	23	indonesia	indonesia	PROPN
ghmj-1231	9	24	,	,	PUNCT
ghmj-1231	9	25	is	be	AUX
ghmj-1231	9	26	associated	associate	VERB
ghmj-1231	9	27	with	with	ADP
ghmj-1231	9	28	an	an	DET
ghmj-1231	9	29	increased	increase	VERB
ghmj-1231	9	30	risk	risk	NOUN
ghmj-1231	9	31	of	of	ADP
ghmj-1231	9	32	essential	essential	ADJ
ghmj-1231	9	33	hypertension	hypertension	NOUN
ghmj-1231	9	34	.	.	PUNCT
ghmj-1231	10	1	methods	method	NOUN
ghmj-1231	10	2	:	:	PUNCT
ghmj-1231	10	3	this	this	PRON
ghmj-1231	10	4	is	be	AUX
ghmj-1231	10	5	a	a	DET
ghmj-1231	10	6	case	case	NOUN
ghmj-1231	10	7	-	-	PUNCT
ghmj-1231	10	8	control	control	NOUN
ghmj-1231	10	9	study	study	NOUN
ghmj-1231	10	10	conducted	conduct	VERB
ghmj-1231	10	11	at	at	ADP
ghmj-1231	10	12	the	the	DET
ghmj-1231	10	13	talun	talun	ADJ
ghmj-1231	10	14	health	health	NOUN
ghmj-1231	10	15	center	center	NOUN
ghmj-1231	10	16	,	,	PUNCT
ghmj-1231	10	17	cirebon	cirebon	PROPN
ghmj-1231	10	18	regency	regency	PROPN
ghmj-1231	10	19	,	,	PUNCT
ghmj-1231	10	20	aprilaugust	aprilaugust	NOUN
ghmj-1231	10	21	2024	2024	NUM
ghmj-1231	10	22	,	,	PUNCT
ghmj-1231	10	23	involving	involve	VERB
ghmj-1231	10	24	30	30	NUM
ghmj-1231	10	25	essential	essential	ADJ
ghmj-1231	10	26	hypertensive	hypertensive	ADJ
ghmj-1231	10	27	patients	patient	NOUN
ghmj-1231	10	28	and	and	CCONJ
ghmj-1231	10	29	30	30	NUM
ghmj-1231	10	30	healthy	healthy	ADJ
ghmj-1231	10	31	controls	control	NOUN
ghmj-1231	10	32	.	.	PUNCT
ghmj-1231	11	1	the	the	DET
ghmj-1231	11	2	study	study	NOUN
ghmj-1231	11	3	population	population	NOUN
ghmj-1231	11	4	comprised	comprise	VERB
ghmj-1231	11	5	adults	adult	NOUN
ghmj-1231	11	6	aged	age	VERB
ghmj-1231	11	7	30	30	NUM
ghmj-1231	11	8	to	to	PART
ghmj-1231	11	9	72	72	NUM
ghmj-1231	11	10	years	year	NOUN
ghmj-1231	11	11	.	.	PUNCT
ghmj-1231	12	1	data	datum	NOUN
ghmj-1231	12	2	was	be	AUX
ghmj-1231	12	3	obtained	obtain	VERB
ghmj-1231	12	4	through	through	ADP
ghmj-1231	12	5	the	the	DET
ghmj-1231	12	6	examination	examination	NOUN
ghmj-1231	12	7	of	of	ADP
ghmj-1231	12	8	blood	blood	NOUN
ghmj-1231	12	9	pressure	pressure	NOUN
ghmj-1231	12	10	,	,	PUNCT
ghmj-1231	12	11	dna	dna	PROPN
ghmj-1231	12	12	extraction	extraction	NOUN
ghmj-1231	12	13	,	,	PUNCT
ghmj-1231	12	14	pcr	pcr	NOUN
ghmj-1231	12	15	-	-	PUNCT
ghmj-1231	12	16	rflp	rflp	PROPN
ghmj-1231	12	17	with	with	ADP
ghmj-1231	12	18	alui	alui	NOUN
ghmj-1231	12	19	restriction	restriction	NOUN
ghmj-1231	12	20	enzyme	enzyme	NOUN
ghmj-1231	12	21	,	,	PUNCT
ghmj-1231	12	22	and	and	CCONJ
ghmj-1231	12	23	then	then	ADV
ghmj-1231	12	24	visualization	visualization	NOUN
ghmj-1231	12	25	of	of	ADP
ghmj-1231	12	26	the	the	DET
ghmj-1231	12	27	results	result	NOUN
ghmj-1231	12	28	with	with	ADP
ghmj-1231	12	29	gel	gel	NOUN
ghmj-1231	12	30	electrophoresis	electrophoresis	NOUN
ghmj-1231	12	31	.	.	PUNCT
ghmj-1231	13	1	the	the	DET
ghmj-1231	13	2	chi	chi	ADJ
ghmj-1231	13	3	-	-	PUNCT
ghmj-1231	13	4	square	square	ADJ
ghmj-1231	13	5	test	test	NOUN
ghmj-1231	13	6	technique	technique	NOUN
ghmj-1231	13	7	and	and	CCONJ
ghmj-1231	13	8	the	the	DET
ghmj-1231	13	9	odds	odd	NOUN
ghmj-1231	13	10	ratio	ratio	NOUN
ghmj-1231	13	11	(	(	PUNCT
ghmj-1231	13	12	or	or	CCONJ
ghmj-1231	13	13	)	)	PUNCT
ghmj-1231	13	14	computation	computation	NOUN
ghmj-1231	13	15	were	be	AUX
ghmj-1231	13	16	used	use	VERB
ghmj-1231	13	17	to	to	PART
ghmj-1231	13	18	analyze	analyze	VERB
ghmj-1231	13	19	the	the	DET
ghmj-1231	13	20	data	datum	NOUN
ghmj-1231	13	21	.	.	PUNCT
ghmj-1231	14	1	results	result	NOUN
ghmj-1231	14	2	:	:	PUNCT
ghmj-1231	14	3	the	the	DET
ghmj-1231	14	4	g	g	PROPN
ghmj-1231	14	5	allele	allele	NOUN
ghmj-1231	14	6	was	be	AUX
ghmj-1231	14	7	higher	high	ADJ
ghmj-1231	14	8	in	in	ADP
ghmj-1231	14	9	the	the	DET
ghmj-1231	14	10	case	case	NOUN
ghmj-1231	14	11	group	group	NOUN
ghmj-1231	14	12	33	33	NUM
ghmj-1231	14	13	(	(	PUNCT
ghmj-1231	14	14	55	55	NUM
ghmj-1231	14	15	%	%	NOUN
ghmj-1231	14	16	)	)	PUNCT
ghmj-1231	14	17	,	,	PUNCT
ghmj-1231	14	18	while	while	SCONJ
ghmj-1231	14	19	the	the	DET
ghmj-1231	14	20	a	a	DET
ghmj-1231	14	21	allele	allele	NOUN
ghmj-1231	14	22	was	be	AUX
ghmj-1231	14	23	higher	high	ADJ
ghmj-1231	14	24	in	in	ADP
ghmj-1231	14	25	the	the	DET
ghmj-1231	14	26	control	control	NOUN
ghmj-1231	14	27	group	group	NOUN
ghmj-1231	14	28	34	34	NUM
ghmj-1231	14	29	(	(	PUNCT
ghmj-1231	14	30	56.7	56.7	NUM
ghmj-1231	14	31	%	%	NOUN
ghmj-1231	14	32	)	)	PUNCT
ghmj-1231	14	33	.	.	PUNCT
ghmj-1231	15	1	the	the	DET
ghmj-1231	15	2	statistical	statistical	ADJ
ghmj-1231	15	3	analysis	analysis	NOUN
ghmj-1231	15	4	showed	show	VERB
ghmj-1231	15	5	that	that	SCONJ
ghmj-1231	15	6	there	there	PRON
ghmj-1231	15	7	was	be	VERB
ghmj-1231	15	8	no	no	DET
ghmj-1231	15	9	significant	significant	ADJ
ghmj-1231	15	10	link	link	NOUN
ghmj-1231	15	11	between	between	ADP
ghmj-1231	15	12	the	the	DET
ghmj-1231	15	13	ace2	ace2	PROPN
ghmj-1231	15	14	g8790a	g8790a	PROPN
ghmj-1231	15	15	gene	gene	NOUN
ghmj-1231	15	16	variation	variation	NOUN
ghmj-1231	15	17	and	and	CCONJ
ghmj-1231	15	18	essential	essential	ADJ
ghmj-1231	15	19	hypertension	hypertension	NOUN
ghmj-1231	15	20	,	,	PUNCT
ghmj-1231	15	21	with	with	ADP
ghmj-1231	15	22	a	a	DET
ghmj-1231	15	23	p	p	NOUN
ghmj-1231	15	24	-	-	PUNCT
ghmj-1231	15	25	value	value	NOUN
ghmj-1231	15	26	of	of	ADP
ghmj-1231	15	27	0.592	0.592	NUM
ghmj-1231	15	28	(	(	PUNCT
ghmj-1231	15	29	p	p	X
ghmj-1231	15	30	>	>	X
ghmj-1231	15	31	0.05	0.05	NUM
ghmj-1231	15	32	)	)	PUNCT
ghmj-1231	15	33	(	(	PUNCT
ghmj-1231	15	34	or	or	CCONJ
ghmj-1231	15	35	=	=	SYM
ghmj-1231	15	36	0.750	0.750	NUM
ghmj-1231	15	37	;	;	PUNCT
ghmj-1231	15	38	ci	ci	NOUN
ghmj-1231	15	39	=	=	SYM
ghmj-1231	15	40	0.262–2.151	0.262–2.151	PROPN
ghmj-1231	15	41	)	)	PUNCT
ghmj-1231	15	42	.	.	PUNCT
ghmj-1231	16	1	conclusion	conclusion	NOUN
ghmj-1231	16	2	:	:	PUNCT
ghmj-1231	16	3	the	the	DET
ghmj-1231	16	4	ace2	ace2	PROPN
ghmj-1231	16	5	gene	gene	NOUN
ghmj-1231	16	6	g8790a	g8790a	PROPN
ghmj-1231	16	7	polymorphism	polymorphism	NOUN
ghmj-1231	16	8	and	and	CCONJ
ghmj-1231	16	9	the	the	DET
ghmj-1231	16	10	rate	rate	NOUN
ghmj-1231	16	11	of	of	ADP
ghmj-1231	16	12	hypertension	hypertension	NOUN
ghmj-1231	16	13	in	in	ADP
ghmj-1231	16	14	cirebon	cirebon	NOUN
ghmj-1231	16	15	,	,	PUNCT
ghmj-1231	16	16	west	west	PROPN
ghmj-1231	16	17	java	java	PROPN
ghmj-1231	16	18	,	,	PUNCT
ghmj-1231	16	19	were	be	AUX
ghmj-1231	16	20	not	not	PART
ghmj-1231	16	21	significantly	significantly	ADV
ghmj-1231	16	22	correlated	correlate	VERB
ghmj-1231	16	23	.	.	PUNCT
ghmj-1231	17	1	further	further	ADJ
ghmj-1231	17	2	research	research	NOUN
ghmj-1231	17	3	is	be	AUX
ghmj-1231	17	4	required	require	VERB
ghmj-1231	17	5	on	on	ADP
ghmj-1231	17	6	a	a	DET
ghmj-1231	17	7	larger	large	ADJ
ghmj-1231	17	8	scale	scale	NOUN
ghmj-1231	17	9	to	to	PART
ghmj-1231	17	10	investigate	investigate	VERB
ghmj-1231	17	11	the	the	DET
ghmj-1231	17	12	effects	effect	NOUN
ghmj-1231	17	13	of	of	ADP
ghmj-1231	17	14	gene	gene	NOUN
ghmj-1231	17	15	combinations	combination	NOUN
ghmj-1231	17	16	or	or	CCONJ
ghmj-1231	17	17	interactions	interaction	NOUN
ghmj-1231	17	18	with	with	ADP
ghmj-1231	17	19	other	other	ADJ
ghmj-1231	17	20	locus	locus	NOUN
ghmj-1231	17	21	genes	gene	NOUN
ghmj-1231	17	22	on	on	ADP
ghmj-1231	17	23	essential	essential	ADJ
ghmj-1231	17	24	hypertension	hypertension	NOUN
ghmj-1231	17	25	.	.	PUNCT
ghmj-1231	18	1	keywords	keyword	NOUN
ghmj-1231	18	2	:	:	PUNCT
ghmj-1231	18	3	ace2	ace2	PROPN
ghmj-1231	18	4	gene	gene	NOUN
ghmj-1231	18	5	;	;	PUNCT
ghmj-1231	18	6	g8790a	g8790a	NOUN
ghmj-1231	18	7	polymorphism	polymorphism	NOUN
ghmj-1231	18	8	;	;	PUNCT
ghmj-1231	18	9	essential	essential	ADJ
ghmj-1231	18	10	hypertension	hypertension	NOUN
ghmj-1231	18	11	.	.	PUNCT
ghmj-1231	19	1	received	receive	VERB
ghmj-1231	19	2	:	:	PUNCT
ghmj-1231	19	3	10	10	NUM
ghmj-1231	19	4	july	july	NOUN
ghmj-1231	19	5	2025	2025	NUM
ghmj-1231	19	6	reviewed	review	VERB
ghmj-1231	19	7	:	:	PUNCT
ghmj-1231	19	8	14	14	NUM
ghmj-1231	19	9	july	july	PROPN
ghmj-1231	19	10	2025	2025	NUM
ghmj-1231	19	11	revised	revise	VERB
ghmj-1231	19	12	:	:	PUNCT
ghmj-1231	19	13	27	27	NUM
ghmj-1231	19	14	july	july	PROPN
ghmj-1231	19	15	2025	2025	NUM
ghmj-1231	19	16	accepted	accept	VERB
ghmj-1231	19	17	:	:	PUNCT
ghmj-1231	19	18	15	15	NUM
ghmj-1231	19	19	august	august	PROPN
ghmj-1231	19	20	2025	2025	NUM
ghmj-1231	19	21	.	.	PUNCT
ghmj-1231	20	1	©	©	PROPN
ghmj-1231	20	2	yayasan	yayasan	PROPN
ghmj-1231	20	3	aliansi	aliansi	PROPN
ghmj-1231	20	4	cendekiawan	cendekiawan	PROPN
ghmj-1231	20	5	indonesia	indonesia	PROPN
ghmj-1231	20	6	thailand	thailand	PROPN
ghmj-1231	20	7	(	(	PUNCT
ghmj-1231	20	8	indonesian	indonesian	ADJ
ghmj-1231	20	9	scholars	scholar	NOUN
ghmj-1231	20	10	’	’	PART
ghmj-1231	20	11	alliance	alliance	NOUN
ghmj-1231	20	12	)	)	PUNCT
ghmj-1231	20	13	.	.	PUNCT
ghmj-1231	21	1	this	this	PRON
ghmj-1231	21	2	is	be	AUX
ghmj-1231	21	3	an	an	DET
ghmj-1231	21	4	open	open	ADJ
ghmj-1231	21	5	-	-	PUNCT
ghmj-1231	21	6	access	access	NOUN
ghmj-1231	21	7	following	follow	VERB
ghmj-1231	21	8	creative	creative	ADJ
ghmj-1231	21	9	commons	common	NOUN
ghmj-1231	21	10	license	license	NOUN
ghmj-1231	21	11	deed	deed	NOUN
ghmj-1231	21	12	attribution	attribution	NOUN
ghmj-1231	21	13	-	-	PUNCT
ghmj-1231	21	14	noncommercial	noncommercial	ADJ
ghmj-1231	21	15	-	-	PUNCT
ghmj-1231	21	16	sharealike	sharealike	ADJ
ghmj-1231	21	17	4.0	4.0	NUM
ghmj-1231	21	18	international	international	ADJ
ghmj-1231	21	19	(	(	PUNCT
ghmj-1231	21	20	cc	cc	NOUN
ghmj-1231	21	21	by	by	ADP
ghmj-1231	21	22	-	-	PUNCT
ghmj-1231	21	23	nc	nc	PROPN
ghmj-1231	21	24	-	-	PUNCT
ghmj-1231	21	25	sa	sa	PROPN
ghmj-1231	21	26	4.0	4.0	NUM
ghmj-1231	21	27	)	)	PUNCT
ghmj-1231	22	1	mailto:drtyarladala@gmail.com	mailto:drtyarladala@gmail.com	NOUN
ghmj-1231	22	2	mailto:nazaulh12@gmail.com	mailto:nazaulh12@gmail.com	PROPN
ghmj-1231	22	3	https://doi.org/10.35898/ghmj-82s1231	https://doi.org/10.35898/ghmj-82s1231	PROPN
ghmj-1231	22	4	https://orcid.org/0009-0008-1515-0526	https://orcid.org/0009-0008-1515-0526	PROPN
ghmj-1231	22	5	https://orcid.org/0000-0002-8708-4715	https://orcid.org/0000-0002-8708-4715	NOUN
ghmj-1231	22	6	https://orcid.org/0000-0002-2844-9307	https://orcid.org/0000-0002-2844-9307	NOUN
ghmj-1231	22	7	husna	husna	ADJ
ghmj-1231	22	8	,	,	PUNCT
ghmj-1231	22	9	et	et	PROPN
ghmj-1231	22	10	.	.	PUNCT
ghmj-1231	23	1	al	al	PROPN
ghmj-1231	23	2	ghmj	ghmj	PROPN
ghmj-1231	23	3	(	(	PUNCT
ghmj-1231	23	4	global	global	ADJ
ghmj-1231	23	5	health	health	PROPN
ghmj-1231	23	6	management	management	NOUN
ghmj-1231	23	7	journal	journal	PROPN
ghmj-1231	23	8	)	)	PUNCT
ghmj-1231	23	9	2025	2025	NUM
ghmj-1231	23	10	,	,	PUNCT
ghmj-1231	23	11	vol	vol	NOUN
ghmj-1231	23	12	.	.	NOUN
ghmj-1231	23	13	8	8	NUM
ghmj-1231	23	14	,	,	PUNCT
ghmj-1231	23	15	no	no	INTJ
ghmj-1231	23	16	.	.	PUNCT
ghmj-1231	24	1	2s	2s	NUM
ghmj-1231	24	2	286	286	NUM
ghmj-1231	24	3	1	1	NUM
ghmj-1231	24	4	.	.	PUNCT
ghmj-1231	25	1	introduction	introduction	NOUN
ghmj-1231	25	2	hypertension	hypertension	NOUN
ghmj-1231	25	3	is	be	AUX
ghmj-1231	25	4	a	a	DET
ghmj-1231	25	5	dangerous	dangerous	ADJ
ghmj-1231	25	6	condition	condition	NOUN
ghmj-1231	25	7	that	that	PRON
ghmj-1231	25	8	can	can	AUX
ghmj-1231	25	9	lead	lead	VERB
ghmj-1231	25	10	to	to	ADP
ghmj-1231	25	11	major	major	ADJ
ghmj-1231	25	12	side	side	NOUN
ghmj-1231	25	13	effects	effect	NOUN
ghmj-1231	25	14	like	like	ADP
ghmj-1231	25	15	heart	heart	NOUN
ghmj-1231	25	16	attack	attack	NOUN
ghmj-1231	25	17	,	,	PUNCT
ghmj-1231	25	18	stroke	stroke	NOUN
ghmj-1231	25	19	,	,	PUNCT
ghmj-1231	25	20	retinopathy	retinopathy	ADJ
ghmj-1231	25	21	,	,	PUNCT
ghmj-1231	25	22	and	and	CCONJ
ghmj-1231	25	23	renal	renal	ADJ
ghmj-1231	25	24	failure	failure	NOUN
ghmj-1231	25	25	(	(	PUNCT
ghmj-1231	25	26	unger	unger	PROPN
ghmj-1231	25	27	et	et	PROPN
ghmj-1231	25	28	al	al	PROPN
ghmj-1231	25	29	.	.	PROPN
ghmj-1231	25	30	,	,	PUNCT
ghmj-1231	25	31	2020	2020	NUM
ghmj-1231	25	32	)	)	PUNCT
ghmj-1231	25	33	.	.	PUNCT
ghmj-1231	26	1	it	it	PRON
ghmj-1231	26	2	is	be	AUX
ghmj-1231	26	3	occurred	occur	VERB
ghmj-1231	26	4	when	when	SCONJ
ghmj-1231	26	5	the	the	DET
ghmj-1231	26	6	systolic	systolic	ADJ
ghmj-1231	26	7	blood	blood	NOUN
ghmj-1231	26	8	pressure	pressure	NOUN
ghmj-1231	26	9	(	(	PUNCT
ghmj-1231	26	10	sbp	sbp	NOUN
ghmj-1231	26	11	)	)	PUNCT
ghmj-1231	26	12	rises	rise	VERB
ghmj-1231	26	13	by	by	ADP
ghmj-1231	26	14	more	more	ADJ
ghmj-1231	26	15	than	than	ADP
ghmj-1231	26	16	140	140	NUM
ghmj-1231	26	17	mmhg	mmhg	NOUN
ghmj-1231	26	18	and/or	and/or	CCONJ
ghmj-1231	26	19	the	the	DET
ghmj-1231	26	20	diastolic	diastolic	ADJ
ghmj-1231	26	21	blood	blood	NOUN
ghmj-1231	26	22	pressure	pressure	NOUN
ghmj-1231	26	23	(	(	PUNCT
ghmj-1231	26	24	dbp	dbp	PROPN
ghmj-1231	26	25	)	)	PUNCT
ghmj-1231	26	26	rises	rise	VERB
ghmj-1231	26	27	by	by	ADP
ghmj-1231	26	28	more	more	ADJ
ghmj-1231	26	29	than	than	ADP
ghmj-1231	26	30	90	90	NUM
ghmj-1231	26	31	mmhg	mmhg	NOUN
ghmj-1231	26	32	(	(	PUNCT
ghmj-1231	26	33	kemenkes	kemenke	NOUN
ghmj-1231	26	34	,	,	PUNCT
ghmj-1231	26	35	2021	2021	NUM
ghmj-1231	26	36	)	)	PUNCT
ghmj-1231	26	37	.	.	PUNCT
ghmj-1231	27	1	the	the	DET
ghmj-1231	27	2	update	update	NOUN
ghmj-1231	27	3	jnc-8	jnc-8	PUNCT
ghmj-1231	27	4	guideline	guideline	NOUN
ghmj-1231	27	5	recommendation	recommendation	NOUN
ghmj-1231	27	6	divides	divide	VERB
ghmj-1231	27	7	hypertension	hypertension	NOUN
ghmj-1231	27	8	into	into	ADP
ghmj-1231	27	9	two	two	NUM
ghmj-1231	27	10	categories	category	NOUN
ghmj-1231	27	11	:	:	PUNCT
ghmj-1231	27	12	primary	primary	ADJ
ghmj-1231	27	13	hypertension	hypertension	NOUN
ghmj-1231	27	14	(	(	PUNCT
ghmj-1231	27	15	90	90	NUM
ghmj-1231	27	16	%	%	NOUN
ghmj-1231	27	17	of	of	ADP
ghmj-1231	27	18	the	the	DET
ghmj-1231	27	19	cases	case	NOUN
ghmj-1231	27	20	)	)	PUNCT
ghmj-1231	27	21	,	,	PUNCT
ghmj-1231	27	22	which	which	PRON
ghmj-1231	27	23	people	people	NOUN
ghmj-1231	27	24	have	have	VERB
ghmj-1231	27	25	an	an	DET
ghmj-1231	27	26	unknown	unknown	ADJ
ghmj-1231	27	27	etiology	etiology	NOUN
ghmj-1231	27	28	,	,	PUNCT
ghmj-1231	27	29	and	and	CCONJ
ghmj-1231	27	30	secondary	secondary	ADJ
ghmj-1231	27	31	hypertension	hypertension	NOUN
ghmj-1231	27	32	(	(	PUNCT
ghmj-1231	27	33	10	10	NUM
ghmj-1231	27	34	%	%	NOUN
ghmj-1231	27	35	of	of	ADP
ghmj-1231	27	36	the	the	DET
ghmj-1231	27	37	cases	case	NOUN
ghmj-1231	27	38	)	)	PUNCT
ghmj-1231	27	39	,	,	PUNCT
ghmj-1231	27	40	which	which	PRON
ghmj-1231	27	41	people	people	NOUN
ghmj-1231	27	42	have	have	VERB
ghmj-1231	27	43	a	a	DET
ghmj-1231	27	44	known	know	VERB
ghmj-1231	27	45	cause	cause	NOUN
ghmj-1231	27	46	for	for	ADP
ghmj-1231	27	47	their	their	PRON
ghmj-1231	27	48	high	high	ADJ
ghmj-1231	27	49	blood	blood	NOUN
ghmj-1231	27	50	pressure	pressure	NOUN
ghmj-1231	27	51	(	(	PUNCT
ghmj-1231	27	52	olin	olin	PROPN
ghmj-1231	27	53	&	&	CCONJ
ghmj-1231	27	54	pharm	pharm	PROPN
ghmj-1231	27	55	,	,	PUNCT
ghmj-1231	27	56	2018	2018	NUM
ghmj-1231	27	57	)	)	PUNCT
ghmj-1231	27	58	.	.	PUNCT
ghmj-1231	28	1	since	since	SCONJ
ghmj-1231	28	2	hypertension	hypertension	NOUN
ghmj-1231	28	3	typically	typically	ADV
ghmj-1231	28	4	has	have	VERB
ghmj-1231	28	5	no	no	DET
ghmj-1231	28	6	symptoms	symptom	NOUN
ghmj-1231	28	7	,	,	PUNCT
ghmj-1231	28	8	it	it	PRON
ghmj-1231	28	9	is	be	AUX
ghmj-1231	28	10	known	know	VERB
ghmj-1231	28	11	as	as	ADP
ghmj-1231	28	12	the	the	DET
ghmj-1231	28	13	"	"	PUNCT
ghmj-1231	28	14	silent	silent	ADJ
ghmj-1231	28	15	killer	killer	NOUN
ghmj-1231	28	16	"	"	PUNCT
ghmj-1231	28	17	because	because	SCONJ
ghmj-1231	28	18	most	most	ADJ
ghmj-1231	28	19	people	people	NOUN
ghmj-1231	28	20	are	be	AUX
ghmj-1231	28	21	unaware	unaware	ADJ
ghmj-1231	28	22	of	of	ADP
ghmj-1231	28	23	their	their	PRON
ghmj-1231	28	24	illness	illness	NOUN
ghmj-1231	28	25	until	until	SCONJ
ghmj-1231	28	26	they	they	PRON
ghmj-1231	28	27	have	have	VERB
ghmj-1231	28	28	clinical	clinical	ADJ
ghmj-1231	28	29	difficulties	difficulty	NOUN
ghmj-1231	28	30	such	such	ADJ
ghmj-1231	28	31	as	as	ADP
ghmj-1231	28	32	kidney	kidney	NOUN
ghmj-1231	28	33	damage	damage	NOUN
ghmj-1231	28	34	,	,	PUNCT
ghmj-1231	28	35	heart	heart	NOUN
ghmj-1231	28	36	failure	failure	NOUN
ghmj-1231	28	37	,	,	PUNCT
ghmj-1231	28	38	stroke	stroke	NOUN
ghmj-1231	28	39	,	,	PUNCT
ghmj-1231	28	40	heart	heart	NOUN
ghmj-1231	28	41	attack	attack	NOUN
ghmj-1231	28	42	,	,	PUNCT
ghmj-1231	28	43	and	and	CCONJ
ghmj-1231	28	44	many	many	ADJ
ghmj-1231	28	45	other	other	ADJ
ghmj-1231	28	46	health	health	NOUN
ghmj-1231	28	47	issues	issue	NOUN
ghmj-1231	28	48	.	.	PUNCT
ghmj-1231	29	1	(	(	PUNCT
ghmj-1231	29	2	p2ptm	p2ptm	PROPN
ghmj-1231	29	3	kemenkes	kemenkes	PROPN
ghmj-1231	29	4	ri	ri	PROPN
ghmj-1231	29	5	,	,	PUNCT
ghmj-1231	29	6	2024	2024	NUM
ghmj-1231	29	7	)	)	PUNCT
ghmj-1231	29	8	.	.	PUNCT
ghmj-1231	30	1	globally	globally	ADV
ghmj-1231	30	2	,	,	PUNCT
ghmj-1231	30	3	there	there	PRON
ghmj-1231	30	4	are	be	VERB
ghmj-1231	30	5	now	now	ADV
ghmj-1231	30	6	1.3	1.3	NUM
ghmj-1231	30	7	billion	billion	NUM
ghmj-1231	30	8	hypertensive	hypertensive	ADJ
ghmj-1231	30	9	individuals	individual	NOUN
ghmj-1231	30	10	,	,	PUNCT
ghmj-1231	30	11	up	up	ADV
ghmj-1231	30	12	from	from	ADP
ghmj-1231	30	13	650	650	NUM
ghmj-1231	30	14	million	million	NUM
ghmj-1231	30	15	previously	previously	ADV
ghmj-1231	30	16	(	(	PUNCT
ghmj-1231	30	17	zhou	zhou	X
ghmj-1231	30	18	et	et	PROPN
ghmj-1231	30	19	al	al	PROPN
ghmj-1231	30	20	.	.	PROPN
ghmj-1231	30	21	,	,	PUNCT
ghmj-1231	30	22	2021	2021	NUM
ghmj-1231	30	23	)	)	PUNCT
ghmj-1231	30	24	.	.	PUNCT
ghmj-1231	31	1	over	over	ADP
ghmj-1231	31	2	10	10	NUM
ghmj-1231	31	3	million	million	NUM
ghmj-1231	31	4	fatalities	fatality	NOUN
ghmj-1231	31	5	are	be	AUX
ghmj-1231	31	6	attributed	attribute	VERB
ghmj-1231	31	7	to	to	ADP
ghmj-1231	31	8	hypertension	hypertension	NOUN
ghmj-1231	31	9	each	each	DET
ghmj-1231	31	10	year	year	NOUN
ghmj-1231	31	11	,	,	PUNCT
ghmj-1231	31	12	more	more	ADJ
ghmj-1231	31	13	than	than	ADP
ghmj-1231	31	14	all	all	DET
ghmj-1231	31	15	other	other	ADJ
ghmj-1231	31	16	health	health	NOUN
ghmj-1231	31	17	risks	risk	NOUN
ghmj-1231	31	18	combined	combine	VERB
ghmj-1231	31	19	,	,	PUNCT
ghmj-1231	31	20	according	accord	VERB
ghmj-1231	31	21	to	to	ADP
ghmj-1231	31	22	the	the	DET
ghmj-1231	31	23	world	world	PROPN
ghmj-1231	31	24	health	health	NOUN
ghmj-1231	31	25	organization	organization	NOUN
ghmj-1231	31	26	(	(	PUNCT
ghmj-1231	31	27	who	who	PRON
ghmj-1231	31	28	)	)	PUNCT
ghmj-1231	31	29	(	(	PUNCT
ghmj-1231	31	30	world	world	NOUN
ghmj-1231	31	31	health	health	NOUN
ghmj-1231	31	32	organization	organization	NOUN
ghmj-1231	31	33	,	,	PUNCT
ghmj-1231	31	34	2023	2023	NUM
ghmj-1231	31	35	)	)	PUNCT
ghmj-1231	31	36	.	.	PUNCT
ghmj-1231	32	1	with	with	ADP
ghmj-1231	32	2	a	a	DET
ghmj-1231	32	3	prevalence	prevalence	NOUN
ghmj-1231	32	4	of	of	ADP
ghmj-1231	32	5	34.1	34.1	NUM
ghmj-1231	32	6	%	%	NOUN
ghmj-1231	32	7	among	among	ADP
ghmj-1231	32	8	those	those	PRON
ghmj-1231	32	9	over	over	ADP
ghmj-1231	32	10	the	the	DET
ghmj-1231	32	11	age	age	NOUN
ghmj-1231	32	12	of	of	ADP
ghmj-1231	32	13	18	18	NUM
ghmj-1231	32	14	,	,	PUNCT
ghmj-1231	32	15	west	west	PROPN
ghmj-1231	32	16	java	java	PROPN
ghmj-1231	32	17	is	be	AUX
ghmj-1231	32	18	now	now	ADV
ghmj-1231	32	19	the	the	DET
ghmj-1231	32	20	second	second	ADV
ghmj-1231	32	21	-	-	PUNCT
ghmj-1231	32	22	highest	high	ADJ
ghmj-1231	32	23	area	area	NOUN
ghmj-1231	32	24	(	(	PUNCT
ghmj-1231	32	25	kemenkes	kemenkes	PROPN
ghmj-1231	32	26	ri	ri	PROPN
ghmj-1231	32	27	,	,	PUNCT
ghmj-1231	32	28	2018	2018	NUM
ghmj-1231	32	29	)	)	PUNCT
ghmj-1231	32	30	.	.	PUNCT
ghmj-1231	33	1	the	the	DET
ghmj-1231	33	2	estimated	estimate	VERB
ghmj-1231	33	3	number	number	NOUN
ghmj-1231	33	4	of	of	ADP
ghmj-1231	33	5	hypertension	hypertension	NOUN
ghmj-1231	33	6	patients	patient	NOUN
ghmj-1231	33	7	in	in	ADP
ghmj-1231	33	8	cirebon	cirebon	PROPN
ghmj-1231	33	9	regency	regency	PROPN
ghmj-1231	33	10	in	in	ADP
ghmj-1231	33	11	2021	2021	NUM
ghmj-1231	33	12	is	be	AUX
ghmj-1231	33	13	648,030	648,030	NUM
ghmj-1231	33	14	,	,	PUNCT
ghmj-1231	33	15	and	and	CCONJ
ghmj-1231	33	16	73,173	73,173	NUM
ghmj-1231	33	17	,	,	PUNCT
ghmj-1231	33	18	or	or	CCONJ
ghmj-1231	33	19	11.3	11.3	NUM
ghmj-1231	33	20	%	%	NOUN
ghmj-1231	33	21	of	of	ADP
ghmj-1231	33	22	the	the	DET
ghmj-1231	33	23	total	total	ADJ
ghmj-1231	33	24	number	number	NOUN
ghmj-1231	33	25	of	of	ADP
ghmj-1231	33	26	hypertension	hypertension	NOUN
ghmj-1231	33	27	patients	patient	NOUN
ghmj-1231	33	28	,	,	PUNCT
ghmj-1231	33	29	have	have	AUX
ghmj-1231	33	30	received	receive	VERB
ghmj-1231	33	31	medical	medical	ADJ
ghmj-1231	33	32	treatment	treatment	NOUN
ghmj-1231	33	33	according	accord	VERB
ghmj-1231	33	34	to	to	ADP
ghmj-1231	33	35	standards	standard	NOUN
ghmj-1231	33	36	(	(	PUNCT
ghmj-1231	33	37	dinas	dinas	PROPN
ghmj-1231	33	38	kesehatan	kesehatan	PROPN
ghmj-1231	33	39	kabupaten	kabupaten	PROPN
ghmj-1231	33	40	cirebon	cirebon	NOUN
ghmj-1231	33	41	,	,	PUNCT
ghmj-1231	33	42	2021	2021	NUM
ghmj-1231	33	43	)	)	PUNCT
ghmj-1231	33	44	.	.	PUNCT
ghmj-1231	34	1	essential	essential	ADJ
ghmj-1231	34	2	hypertension	hypertension	NOUN
ghmj-1231	34	3	is	be	AUX
ghmj-1231	34	4	a	a	DET
ghmj-1231	34	5	manifestation	manifestation	NOUN
ghmj-1231	34	6	of	of	ADP
ghmj-1231	34	7	the	the	DET
ghmj-1231	34	8	presence	presence	NOUN
ghmj-1231	34	9	of	of	ADP
ghmj-1231	34	10	hemodynamic	hemodynamic	ADJ
ghmj-1231	34	11	imbalance	imbalance	NOUN
ghmj-1231	34	12	of	of	ADP
ghmj-1231	34	13	the	the	DET
ghmj-1231	34	14	cardiovascular	cardiovascular	ADJ
ghmj-1231	34	15	system	system	NOUN
ghmj-1231	34	16	,	,	PUNCT
ghmj-1231	34	17	the	the	DET
ghmj-1231	34	18	cause	cause	NOUN
ghmj-1231	34	19	of	of	ADP
ghmj-1231	34	20	which	which	PRON
ghmj-1231	34	21	is	be	AUX
ghmj-1231	34	22	multifactorial	multifactorial	ADJ
ghmj-1231	34	23	,	,	PUNCT
ghmj-1231	34	24	including	include	VERB
ghmj-1231	34	25	relating	relate	VERB
ghmj-1231	34	26	to	to	ADP
ghmj-1231	34	27	genetic	genetic	ADJ
ghmj-1231	34	28	factors	factor	NOUN
ghmj-1231	34	29	,	,	PUNCT
ghmj-1231	34	30	the	the	DET
ghmj-1231	34	31	environment	environment	NOUN
ghmj-1231	34	32	,	,	PUNCT
ghmj-1231	34	33	and	and	CCONJ
ghmj-1231	34	34	the	the	DET
ghmj-1231	34	35	centers	center	NOUN
ghmj-1231	34	36	of	of	ADP
ghmj-1231	34	37	regulation	regulation	NOUN
ghmj-1231	34	38	of	of	ADP
ghmj-1231	34	39	hemodynamics	hemodynamic	NOUN
ghmj-1231	34	40	(	(	PUNCT
ghmj-1231	34	41	alwi	alwi	PROPN
ghmj-1231	34	42	,	,	PUNCT
ghmj-1231	34	43	2014	2014	NUM
ghmj-1231	34	44	)	)	PUNCT
ghmj-1231	34	45	.	.	PUNCT
ghmj-1231	35	1	patients	patient	NOUN
ghmj-1231	35	2	with	with	ADP
ghmj-1231	35	3	essential	essential	ADJ
ghmj-1231	35	4	hypertension	hypertension	NOUN
ghmj-1231	35	5	often	often	ADV
ghmj-1231	35	6	experience	experience	VERB
ghmj-1231	35	7	a	a	DET
ghmj-1231	35	8	wide	wide	ADJ
ghmj-1231	35	9	range	range	NOUN
ghmj-1231	35	10	of	of	ADP
ghmj-1231	35	11	symptoms	symptom	NOUN
ghmj-1231	35	12	,	,	PUNCT
ghmj-1231	35	13	including	include	VERB
ghmj-1231	35	14	headache	headache	NOUN
ghmj-1231	35	15	,	,	PUNCT
ghmj-1231	35	16	irregular	irregular	ADJ
ghmj-1231	35	17	heartbeat	heartbeat	NOUN
ghmj-1231	35	18	,	,	PUNCT
ghmj-1231	35	19	visual	visual	ADJ
ghmj-1231	35	20	abnormalities	abnormality	NOUN
ghmj-1231	35	21	,	,	PUNCT
ghmj-1231	35	22	chest	chest	NOUN
ghmj-1231	35	23	discomfort	discomfort	NOUN
ghmj-1231	35	24	,	,	PUNCT
ghmj-1231	35	25	nausea	nausea	NOUN
ghmj-1231	35	26	,	,	PUNCT
ghmj-1231	35	27	vomiting	vomiting	NOUN
ghmj-1231	35	28	,	,	PUNCT
ghmj-1231	35	29	and	and	CCONJ
ghmj-1231	35	30	convulsions	convulsion	NOUN
ghmj-1231	35	31	.	.	PUNCT
ghmj-1231	36	1	nowadays	nowadays	ADV
ghmj-1231	36	2	,	,	PUNCT
ghmj-1231	36	3	a	a	DET
ghmj-1231	36	4	digital	digital	ADJ
ghmj-1231	36	5	blood	blood	NOUN
ghmj-1231	36	6	pressure	pressure	NOUN
ghmj-1231	36	7	monitor	monitor	NOUN
ghmj-1231	36	8	is	be	AUX
ghmj-1231	36	9	used	use	VERB
ghmj-1231	36	10	to	to	PART
ghmj-1231	36	11	take	take	VERB
ghmj-1231	36	12	three	three	NUM
ghmj-1231	36	13	readings	reading	NOUN
ghmj-1231	36	14	of	of	ADP
ghmj-1231	36	15	blood	blood	NOUN
ghmj-1231	36	16	pressure	pressure	NOUN
ghmj-1231	36	17	at	at	ADP
ghmj-1231	36	18	5	5	NUM
ghmj-1231	36	19	-	-	PUNCT
ghmj-1231	36	20	minute	minute	NOUN
ghmj-1231	36	21	intervals	interval	NOUN
ghmj-1231	36	22	in	in	ADP
ghmj-1231	36	23	order	order	NOUN
ghmj-1231	36	24	to	to	PART
ghmj-1231	36	25	detect	detect	VERB
ghmj-1231	36	26	essential	essential	ADJ
ghmj-1231	36	27	hypertension	hypertension	NOUN
ghmj-1231	36	28	.	.	PUNCT
ghmj-1231	37	1	the	the	DET
ghmj-1231	37	2	patient	patient	NOUN
ghmj-1231	37	3	will	will	AUX
ghmj-1231	37	4	have	have	VERB
ghmj-1231	37	5	an	an	DET
ghmj-1231	37	6	ecg	ecg	PROPN
ghmj-1231	37	7	and	and	CCONJ
ghmj-1231	37	8	blood	blood	NOUN
ghmj-1231	37	9	glucose	glucose	NOUN
ghmj-1231	37	10	tests	test	NOUN
ghmj-1231	37	11	after	after	ADP
ghmj-1231	37	12	being	be	AUX
ghmj-1231	37	13	diagnosed	diagnose	VERB
ghmj-1231	37	14	with	with	ADP
ghmj-1231	37	15	high	high	ADJ
ghmj-1231	37	16	blood	blood	NOUN
ghmj-1231	37	17	pressure	pressure	NOUN
ghmj-1231	37	18	to	to	PART
ghmj-1231	37	19	rule	rule	VERB
ghmj-1231	37	20	out	out	ADP
ghmj-1231	37	21	diabetes	diabetes	NOUN
ghmj-1231	37	22	and	and	CCONJ
ghmj-1231	37	23	other	other	ADJ
ghmj-1231	37	24	cardiovascular	cardiovascular	ADJ
ghmj-1231	37	25	diseases	disease	NOUN
ghmj-1231	37	26	.	.	PUNCT
ghmj-1231	38	1	treatments	treatment	NOUN
ghmj-1231	38	2	for	for	ADP
ghmj-1231	38	3	essential	essential	ADJ
ghmj-1231	38	4	hypertension	hypertension	NOUN
ghmj-1231	38	5	include	include	VERB
ghmj-1231	38	6	angiotensin	angiotensin	NOUN
ghmj-1231	38	7	-	-	PUNCT
ghmj-1231	38	8	converting	convert	VERB
ghmj-1231	38	9	enzyme	enzyme	NOUN
ghmj-1231	38	10	inhibitors	inhibitor	NOUN
ghmj-1231	38	11	,	,	PUNCT
ghmj-1231	38	12	angiotensin	angiotensin	NOUN
ghmj-1231	38	13	receptor	receptor	NOUN
ghmj-1231	38	14	blockers	blocker	NOUN
ghmj-1231	38	15	,	,	PUNCT
ghmj-1231	38	16	calcium	calcium	NOUN
ghmj-1231	38	17	channel	channel	NOUN
ghmj-1231	38	18	blockers	blocker	NOUN
ghmj-1231	38	19	,	,	PUNCT
ghmj-1231	38	20	diuretics	diuretic	NOUN
ghmj-1231	38	21	,	,	PUNCT
ghmj-1231	38	22	and	and	CCONJ
ghmj-1231	38	23	beta	beta	NOUN
ghmj-1231	38	24	-	-	PUNCT
ghmj-1231	38	25	blockers	blocker	NOUN
ghmj-1231	38	26	.	.	PUNCT
ghmj-1231	39	1	age	age	NOUN
ghmj-1231	39	2	,	,	PUNCT
ghmj-1231	39	3	sex	sex	NOUN
ghmj-1231	39	4	,	,	PUNCT
ghmj-1231	39	5	and	and	CCONJ
ghmj-1231	39	6	genetics	genetic	NOUN
ghmj-1231	39	7	are	be	AUX
ghmj-1231	39	8	unmodifiable	unmodifiable	ADJ
ghmj-1231	39	9	risk	risk	NOUN
ghmj-1231	39	10	factors	factor	NOUN
ghmj-1231	39	11	for	for	ADP
ghmj-1231	39	12	hypertension	hypertension	NOUN
ghmj-1231	39	13	;	;	PUNCT
ghmj-1231	39	14	risk	risk	NOUN
ghmj-1231	39	15	variables	variable	NOUN
ghmj-1231	39	16	that	that	PRON
ghmj-1231	39	17	can	can	AUX
ghmj-1231	39	18	be	be	AUX
ghmj-1231	39	19	modified	modify	VERB
ghmj-1231	39	20	include	include	VERB
ghmj-1231	39	21	smoking	smoking	NOUN
ghmj-1231	39	22	,	,	PUNCT
ghmj-1231	39	23	a	a	DET
ghmj-1231	39	24	low	low	ADJ
ghmj-1231	39	25	-	-	PUNCT
ghmj-1231	39	26	fiber	fiber	NOUN
ghmj-1231	39	27	diet	diet	NOUN
ghmj-1231	39	28	,	,	PUNCT
ghmj-1231	39	29	dyslipidemia	dyslipidemia	NOUN
ghmj-1231	39	30	,	,	PUNCT
ghmj-1231	39	31	excessive	excessive	ADJ
ghmj-1231	39	32	salt	salt	NOUN
ghmj-1231	39	33	intake	intake	NOUN
ghmj-1231	39	34	,	,	PUNCT
ghmj-1231	39	35	a	a	DET
ghmj-1231	39	36	sedentary	sedentary	ADJ
ghmj-1231	39	37	lifestyle	lifestyle	NOUN
ghmj-1231	39	38	,	,	PUNCT
ghmj-1231	39	39	stress	stress	NOUN
ghmj-1231	39	40	,	,	PUNCT
ghmj-1231	39	41	obesity	obesity	NOUN
ghmj-1231	39	42	,	,	PUNCT
ghmj-1231	39	43	and	and	CCONJ
ghmj-1231	39	44	alcohol	alcohol	NOUN
ghmj-1231	39	45	use	use	NOUN
ghmj-1231	39	46	(	(	PUNCT
ghmj-1231	39	47	p2ptm	p2ptm	PROPN
ghmj-1231	39	48	kemenkes	kemenkes	PROPN
ghmj-1231	39	49	ri	ri	PROPN
ghmj-1231	39	50	,	,	PUNCT
ghmj-1231	39	51	2024	2024	NUM
ghmj-1231	39	52	)	)	PUNCT
ghmj-1231	39	53	.	.	PUNCT
ghmj-1231	40	1	in	in	ADP
ghmj-1231	40	2	most	most	ADJ
ghmj-1231	40	3	genetic	genetic	ADJ
ghmj-1231	40	4	research	research	NOUN
ghmj-1231	40	5	related	relate	VERB
ghmj-1231	40	6	to	to	ADP
ghmj-1231	40	7	hypertension	hypertension	NOUN
ghmj-1231	40	8	,	,	PUNCT
ghmj-1231	40	9	the	the	DET
ghmj-1231	40	10	reninangiotensin	reninangiotensin	NOUN
ghmj-1231	40	11	system	system	NOUN
ghmj-1231	40	12	(	(	PUNCT
ghmj-1231	40	13	ras	ras	NOUN
ghmj-1231	40	14	)	)	PUNCT
ghmj-1231	40	15	,	,	PUNCT
ghmj-1231	40	16	one	one	NUM
ghmj-1231	40	17	of	of	ADP
ghmj-1231	40	18	the	the	DET
ghmj-1231	40	19	physiological	physiological	ADJ
ghmj-1231	40	20	systems	system	NOUN
ghmj-1231	40	21	that	that	PRON
ghmj-1231	40	22	controls	control	VERB
ghmj-1231	40	23	blood	blood	NOUN
ghmj-1231	40	24	pressure	pressure	NOUN
ghmj-1231	40	25	,	,	PUNCT
ghmj-1231	40	26	is	be	AUX
ghmj-1231	40	27	the	the	DET
ghmj-1231	40	28	source	source	NOUN
ghmj-1231	40	29	of	of	ADP
ghmj-1231	40	30	the	the	DET
ghmj-1231	40	31	candidate	candidate	NOUN
ghmj-1231	40	32	genes	gene	NOUN
ghmj-1231	40	33	(	(	PUNCT
ghmj-1231	40	34	lu	lu	NOUN
ghmj-1231	40	35	et	et	PROPN
ghmj-1231	40	36	al	al	PROPN
ghmj-1231	40	37	.	.	PROPN
ghmj-1231	40	38	,	,	PUNCT
ghmj-1231	40	39	2012	2012	NUM
ghmj-1231	40	40	)	)	PUNCT
ghmj-1231	40	41	.	.	PUNCT
ghmj-1231	41	1	renin	renin	ADJ
ghmj-1231	41	2	-	-	PUNCT
ghmj-1231	41	3	angiotensin	angiotensin	NOUN
ghmj-1231	41	4	-	-	PUNCT
ghmj-1231	41	5	aldosterone	aldosterone	NOUN
ghmj-1231	41	6	system	system	NOUN
ghmj-1231	41	7	(	(	PUNCT
ghmj-1231	41	8	raas	raas	NOUN
ghmj-1231	41	9	)	)	PUNCT
ghmj-1231	41	10	genes	gene	NOUN
ghmj-1231	41	11	,	,	PUNCT
ghmj-1231	41	12	such	such	ADJ
ghmj-1231	41	13	as	as	ADP
ghmj-1231	41	14	those	those	PRON
ghmj-1231	41	15	involved	involve	VERB
ghmj-1231	41	16	in	in	ADP
ghmj-1231	41	17	making	make	VERB
ghmj-1231	41	18	aldosterone	aldosterone	NOUN
ghmj-1231	41	19	,	,	PUNCT
ghmj-1231	41	20	ace2	ace2	NOUN
ghmj-1231	41	21	,	,	PUNCT
ghmj-1231	41	22	ace	ace	NOUN
ghmj-1231	41	23	,	,	PUNCT
ghmj-1231	41	24	and	and	CCONJ
ghmj-1231	41	25	others	other	NOUN
ghmj-1231	41	26	,	,	PUNCT
ghmj-1231	41	27	are	be	AUX
ghmj-1231	41	28	linked	link	VERB
ghmj-1231	41	29	to	to	ADP
ghmj-1231	41	30	a	a	DET
ghmj-1231	41	31	higher	high	ADJ
ghmj-1231	41	32	risk	risk	NOUN
ghmj-1231	41	33	of	of	ADP
ghmj-1231	41	34	hypertension	hypertension	NOUN
ghmj-1231	41	35	.	.	PUNCT
ghmj-1231	42	1	furthermore	furthermore	ADV
ghmj-1231	42	2	,	,	PUNCT
ghmj-1231	42	3	there	there	PRON
ghmj-1231	42	4	is	be	VERB
ghmj-1231	42	5	a	a	DET
ghmj-1231	42	6	correlation	correlation	NOUN
ghmj-1231	42	7	between	between	ADP
ghmj-1231	42	8	the	the	DET
ghmj-1231	42	9	ace2	ace2	PROPN
ghmj-1231	42	10	gene	gene	NOUN
ghmj-1231	42	11	and	and	CCONJ
ghmj-1231	42	12	essential	essential	ADJ
ghmj-1231	42	13	hypertension	hypertension	NOUN
ghmj-1231	42	14	,	,	PUNCT
ghmj-1231	42	15	diabetes	diabetes	NOUN
ghmj-1231	42	16	mellitus	mellitus	NOUN
ghmj-1231	42	17	,	,	PUNCT
ghmj-1231	42	18	coronary	coronary	ADJ
ghmj-1231	42	19	heart	heart	NOUN
ghmj-1231	42	20	disease	disease	NOUN
ghmj-1231	42	21	,	,	PUNCT
ghmj-1231	42	22	and	and	CCONJ
ghmj-1231	42	23	the	the	DET
ghmj-1231	42	24	severity	severity	NOUN
ghmj-1231	42	25	of	of	ADP
ghmj-1231	42	26	covid-19	covid-19	PROPN
ghmj-1231	42	27	.	.	PUNCT
ghmj-1231	43	1	these	these	DET
ghmj-1231	43	2	studies	study	NOUN
ghmj-1231	43	3	include	include	VERB
ghmj-1231	43	4	findings	finding	NOUN
ghmj-1231	43	5	from	from	ADP
ghmj-1231	43	6	pan	pan	NOUN
ghmj-1231	43	7	(	(	PUNCT
ghmj-1231	43	8	2023	2023	NUM
ghmj-1231	43	9	)	)	PUNCT
ghmj-1231	43	10	,	,	PUNCT
ghmj-1231	43	11	yan	yan	PROPN
ghmj-1231	43	12	et	et	PROPN
ghmj-1231	43	13	al	al	PROPN
ghmj-1231	43	14	.	.	PROPN
ghmj-1231	44	1	(	(	PUNCT
ghmj-1231	44	2	2008	2008	NUM
ghmj-1231	44	3	)	)	PUNCT
ghmj-1231	44	4	,	,	PUNCT
ghmj-1231	44	5	m.	m.	NOUN
ghmj-1231	44	6	yang	yang	PROPN
ghmj-1231	44	7	,	,	PUNCT
ghmj-1231	44	8	zhao	zhao	PROPN
ghmj-1231	44	9	,	,	PUNCT
ghmj-1231	44	10	xing	xing	PROPN
ghmj-1231	44	11	,	,	PUNCT
ghmj-1231	44	12	and	and	CCONJ
ghmj-1231	44	13	shi	shi	PROPN
ghmj-1231	44	14	(	(	PUNCT
ghmj-1231	44	15	2015	2015	NUM
ghmj-1231	44	16	)	)	PUNCT
ghmj-1231	44	17	,	,	PUNCT
ghmj-1231	44	18	and	and	CCONJ
ghmj-1231	44	19	younas	youna	NOUN
ghmj-1231	44	20	,	,	PUNCT
ghmj-1231	44	21	ijaz	ijaz	PROPN
ghmj-1231	44	22	,	,	PUNCT
ghmj-1231	44	23	and	and	CCONJ
ghmj-1231	44	24	choudhry	choudhry	NOUN
ghmj-1231	44	25	(	(	PUNCT
ghmj-1231	44	26	2022	2022	NUM
ghmj-1231	44	27	)	)	PUNCT
ghmj-1231	44	28	.	.	PUNCT
ghmj-1231	45	1	the	the	DET
ghmj-1231	45	2	ace2	ace2	PROPN
ghmj-1231	45	3	gene	gene	NOUN
ghmj-1231	45	4	manufactures	manufacture	VERB
ghmj-1231	45	5	the	the	DET
ghmj-1231	45	6	protease	protease	NOUN
ghmj-1231	45	7	enzyme	enzyme	NOUN
ghmj-1231	45	8	angiotensin	angiotensin	NOUN
ghmj-1231	45	9	converting	convert	VERB
ghmj-1231	45	10	enzyme	enzyme	NOUN
ghmj-1231	45	11	2	2	NUM
ghmj-1231	45	12	,	,	PUNCT
ghmj-1231	45	13	which	which	PRON
ghmj-1231	45	14	sticks	stick	VERB
ghmj-1231	45	15	to	to	ADP
ghmj-1231	45	16	the	the	DET
ghmj-1231	45	17	surface	surface	NOUN
ghmj-1231	45	18	of	of	ADP
ghmj-1231	45	19	cell	cell	NOUN
ghmj-1231	45	20	membranes	membrane	NOUN
ghmj-1231	45	21	in	in	ADP
ghmj-1231	45	22	the	the	DET
ghmj-1231	45	23	heart	heart	NOUN
ghmj-1231	45	24	,	,	PUNCT
ghmj-1231	45	25	blood	blood	NOUN
ghmj-1231	45	26	vessels	vessel	NOUN
ghmj-1231	45	27	,	,	PUNCT
ghmj-1231	45	28	kidneys	kidney	NOUN
ghmj-1231	45	29	,	,	PUNCT
ghmj-1231	45	30	intestines	intestine	NOUN
ghmj-1231	45	31	,	,	PUNCT
ghmj-1231	45	32	testicles	testicle	NOUN
ghmj-1231	45	33	,	,	PUNCT
ghmj-1231	45	34	and	and	CCONJ
ghmj-1231	45	35	lungs	lung	NOUN
ghmj-1231	45	36	(	(	PUNCT
ghmj-1231	45	37	chappell	chappell	PROPN
ghmj-1231	45	38	,	,	PUNCT
ghmj-1231	45	39	marshall	marshall	PROPN
ghmj-1231	45	40	,	,	PUNCT
ghmj-1231	45	41	alzayadneh	alzayadneh	PROPN
ghmj-1231	45	42	,	,	PUNCT
ghmj-1231	45	43	shaltout	shaltout	PROPN
ghmj-1231	45	44	,	,	PUNCT
ghmj-1231	45	45	&	&	CCONJ
ghmj-1231	45	46	diz	diz	PROPN
ghmj-1231	45	47	,	,	PUNCT
ghmj-1231	45	48	2014	2014	NUM
ghmj-1231	45	49	)	)	PUNCT
ghmj-1231	45	50	.	.	PUNCT
ghmj-1231	46	1	this	this	DET
ghmj-1231	46	2	gene	gene	NOUN
ghmj-1231	46	3	has	have	VERB
ghmj-1231	46	4	805	805	NUM
ghmj-1231	46	5	amino	amino	ADJ
ghmj-1231	46	6	acids	acid	NOUN
ghmj-1231	46	7	and	and	CCONJ
ghmj-1231	46	8	is	be	AUX
ghmj-1231	46	9	located	locate	VERB
ghmj-1231	46	10	on	on	ADP
ghmj-1231	46	11	the	the	DET
ghmj-1231	46	12	xp22.2	xp22.2	PROPN
ghmj-1231	46	13	chromosome	chromosome	NOUN
ghmj-1231	46	14	(	(	PUNCT
ghmj-1231	46	15	ace2	ace2	NOUN
ghmj-1231	46	16	gene	gene	NOUN
ghmj-1231	46	17	,	,	PUNCT
ghmj-1231	46	18	2023	2023	NUM
ghmj-1231	46	19	)	)	PUNCT
ghmj-1231	46	20	.	.	PUNCT
ghmj-1231	47	1	ace2	ace2	PROPN
ghmj-1231	47	2	is	be	AUX
ghmj-1231	47	3	an	an	DET
ghmj-1231	47	4	ace	ace	NOUN
ghmj-1231	47	5	homologue	homologue	NOUN
ghmj-1231	47	6	that	that	PRON
ghmj-1231	47	7	maintains	maintain	VERB
ghmj-1231	47	8	blood	blood	NOUN
ghmj-1231	47	9	pressure	pressure	NOUN
ghmj-1231	47	10	homeostasis	homeostasis	NOUN
ghmj-1231	47	11	by	by	ADP
ghmj-1231	47	12	regulating	regulate	VERB
ghmj-1231	47	13	negative	negative	ADJ
ghmj-1231	47	14	ras	ra	NOUN
ghmj-1231	47	15	,	,	PUNCT
ghmj-1231	47	16	which	which	PRON
ghmj-1231	47	17	maintains	maintain	VERB
ghmj-1231	47	18	a	a	DET
ghmj-1231	47	19	balance	balance	NOUN
ghmj-1231	47	20	between	between	ADP
ghmj-1231	47	21	vasoconstrictor	vasoconstrictor	NOUN
ghmj-1231	47	22	and	and	CCONJ
ghmj-1231	47	23	vasodilator	vasodilator	NOUN
ghmj-1231	47	24	actions	action	NOUN
ghmj-1231	47	25	(	(	PUNCT
ghmj-1231	47	26	burrell	burrell	PROPN
ghmj-1231	47	27	,	,	PUNCT
ghmj-1231	47	28	johnston	johnston	PROPN
ghmj-1231	47	29	,	,	PUNCT
ghmj-1231	47	30	tikellis	tikellis	X
ghmj-1231	47	31	,	,	PUNCT
ghmj-1231	47	32	&	&	CCONJ
ghmj-1231	47	33	cooper	cooper	PROPN
ghmj-1231	47	34	,	,	PUNCT
ghmj-1231	47	35	2004	2004	NUM
ghmj-1231	47	36	)	)	PUNCT
ghmj-1231	47	37	.	.	PUNCT
ghmj-1231	48	1	the	the	DET
ghmj-1231	48	2	g8790a	g8790a	PROPN
ghmj-1231	48	3	gene	gene	NOUN
ghmj-1231	48	4	polymorphism	polymorphism	NOUN
ghmj-1231	48	5	of	of	ADP
ghmj-1231	48	6	ace2	ace2	PROPN
ghmj-1231	48	7	is	be	AUX
ghmj-1231	48	8	a	a	DET
ghmj-1231	48	9	restriction	restriction	NOUN
ghmj-1231	48	10	enzyme	enzyme	NOUN
ghmj-1231	48	11	truncation	truncation	NOUN
ghmj-1231	48	12	site	site	NOUN
ghmj-1231	48	13	located	locate	VERB
ghmj-1231	48	14	in	in	ADP
ghmj-1231	48	15	the	the	DET
ghmj-1231	48	16	fourth	fourth	ADJ
ghmj-1231	48	17	base	base	NOUN
ghmj-1231	48	18	of	of	ADP
ghmj-1231	48	19	the	the	DET
ghmj-1231	48	20	third	third	ADJ
ghmj-1231	48	21	intron	intron	NOUN
ghmj-1231	48	22	adjacent	adjacent	ADJ
ghmj-1231	48	23	to	to	ADP
ghmj-1231	48	24	the	the	DET
ghmj-1231	48	25	exon	exon	NOUN
ghmj-1231	48	26	and	and	CCONJ
ghmj-1231	48	27	shows	show	VERB
ghmj-1231	48	28	that	that	SCONJ
ghmj-1231	48	29	this	this	DET
ghmj-1231	48	30	locus	locus	NOUN
ghmj-1231	48	31	can	can	AUX
ghmj-1231	48	32	alter	alter	VERB
ghmj-1231	48	33	the	the	DET
ghmj-1231	48	34	alternative	alternative	ADJ
ghmj-1231	48	35	splicing	splicing	NOUN
ghmj-1231	48	36	of	of	ADP
ghmj-1231	48	37	mrna	mrna	PROPN
ghmj-1231	48	38	and	and	CCONJ
ghmj-1231	48	39	affect	affect	VERB
ghmj-1231	48	40	ace2	ace2	NOUN
ghmj-1231	48	41	gene	gene	NOUN
ghmj-1231	48	42	expression	expression	NOUN
ghmj-1231	48	43	.	.	PUNCT
ghmj-1231	49	1	the	the	DET
ghmj-1231	49	2	g8790a	g8790a	PROPN
ghmj-1231	49	3	gene	gene	NOUN
ghmj-1231	49	4	polymorphism	polymorphism	NOUN
ghmj-1231	49	5	of	of	ADP
ghmj-1231	49	6	ace2	ace2	PROPN
ghmj-1231	49	7	causes	cause	VERB
ghmj-1231	49	8	changes	change	NOUN
ghmj-1231	49	9	in	in	ADP
ghmj-1231	49	10	the	the	DET
ghmj-1231	49	11	amount	amount	NOUN
ghmj-1231	49	12	of	of	ADP
ghmj-1231	49	13	ang	ang	PROPN
ghmj-1231	49	14	serum	serum	NOUN
ghmj-1231	49	15	(	(	PUNCT
ghmj-1231	49	16	1–7	1–7	NUM
ghmj-1231	49	17	)	)	PUNCT
ghmj-1231	49	18	that	that	PRON
ghmj-1231	49	19	functions	function	NOUN
ghmj-1231	49	20	to	to	PART
ghmj-1231	49	21	inhibit	inhibit	VERB
ghmj-1231	49	22	vasoconstriction	vasoconstriction	NOUN
ghmj-1231	49	23	,	,	PUNCT
ghmj-1231	49	24	which	which	PRON
ghmj-1231	49	25	can	can	AUX
ghmj-1231	49	26	lead	lead	VERB
ghmj-1231	49	27	to	to	ADP
ghmj-1231	49	28	increased	increase	VERB
ghmj-1231	49	29	blood	blood	NOUN
ghmj-1231	49	30	pressure	pressure	NOUN
ghmj-1231	49	31	(	(	PUNCT
ghmj-1231	49	32	li	li	PROPN
ghmj-1231	49	33	,	,	PUNCT
ghmj-1231	49	34	2012	2012	NUM
ghmj-1231	49	35	)	)	PUNCT
ghmj-1231	49	36	.	.	PUNCT
ghmj-1231	50	1	blood	blood	NOUN
ghmj-1231	50	2	pressure	pressure	NOUN
ghmj-1231	50	3	is	be	AUX
ghmj-1231	50	4	currently	currently	ADV
ghmj-1231	50	5	associated	associate	VERB
ghmj-1231	50	6	with	with	ADP
ghmj-1231	50	7	genetic	genetic	ADJ
ghmj-1231	50	8	causes	cause	NOUN
ghmj-1231	50	9	.	.	PUNCT
ghmj-1231	51	1	many	many	ADJ
ghmj-1231	51	2	polymorphisms	polymorphism	NOUN
ghmj-1231	51	3	that	that	PRON
ghmj-1231	51	4	raise	raise	VERB
ghmj-1231	51	5	an	an	DET
ghmj-1231	51	6	individual	individual	NOUN
ghmj-1231	51	7	's	's	PART
ghmj-1231	51	8	risk	risk	NOUN
ghmj-1231	51	9	of	of	ADP
ghmj-1231	51	10	acquiring	acquire	VERB
ghmj-1231	51	11	high	high	ADJ
ghmj-1231	51	12	blood	blood	NOUN
ghmj-1231	51	13	pressure	pressure	NOUN
ghmj-1231	51	14	have	have	AUX
ghmj-1231	51	15	been	be	AUX
ghmj-1231	51	16	found	find	VERB
ghmj-1231	51	17	by	by	ADP
ghmj-1231	51	18	researching	research	VERB
ghmj-1231	51	19	genes	gene	NOUN
ghmj-1231	51	20	that	that	PRON
ghmj-1231	51	21	produce	produce	VERB
ghmj-1231	51	22	monogenic	monogenic	ADJ
ghmj-1231	51	23	forms	form	NOUN
ghmj-1231	51	24	of	of	ADP
ghmj-1231	51	25	hypertension	hypertension	NOUN
ghmj-1231	51	26	and	and	CCONJ
ghmj-1231	51	27	pathways	pathway	NOUN
ghmj-1231	51	28	related	relate	VERB
ghmj-1231	51	29	to	to	ADP
ghmj-1231	51	30	blood	blood	NOUN
ghmj-1231	51	31	pressure	pressure	NOUN
ghmj-1231	51	32	regulation	regulation	NOUN
ghmj-1231	51	33	(	(	PUNCT
ghmj-1231	51	34	lupton	lupton	PROPN
ghmj-1231	51	35	,	,	PUNCT
ghmj-1231	51	36	chiu	chiu	PROPN
ghmj-1231	51	37	,	,	PUNCT
ghmj-1231	51	38	&	&	CCONJ
ghmj-1231	51	39	lind	lind	PROPN
ghmj-1231	51	40	,	,	PUNCT
ghmj-1231	51	41	2011	2011	NUM
ghmj-1231	51	42	)	)	PUNCT
ghmj-1231	51	43	.	.	PUNCT
ghmj-1231	52	1	there	there	PRON
ghmj-1231	52	2	is	be	VERB
ghmj-1231	52	3	no	no	DET
ghmj-1231	52	4	recent	recent	ADJ
ghmj-1231	52	5	research	research	NOUN
ghmj-1231	52	6	on	on	ADP
ghmj-1231	52	7	the	the	DET
ghmj-1231	52	8	ace2	ace2	PROPN
ghmj-1231	52	9	g8790a	g8790a	PROPN
ghmj-1231	52	10	gene	gene	NOUN
ghmj-1231	52	11	polymorphism	polymorphism	NOUN
ghmj-1231	52	12	being	be	AUX
ghmj-1231	52	13	a	a	DET
ghmj-1231	52	14	risk	risk	NOUN
ghmj-1231	52	15	factor	factor	NOUN
ghmj-1231	52	16	for	for	ADP
ghmj-1231	52	17	high	high	ADJ
ghmj-1231	52	18	blood	blood	NOUN
ghmj-1231	52	19	pressure	pressure	NOUN
ghmj-1231	52	20	in	in	ADP
ghmj-1231	52	21	cirebon	cirebon	NOUN
ghmj-1231	52	22	,	,	PUNCT
ghmj-1231	52	23	west	west	PROPN
ghmj-1231	52	24	java	java	PROPN
ghmj-1231	52	25	,	,	PUNCT
ghmj-1231	52	26	indonesia	indonesia	PROPN
ghmj-1231	52	27	.	.	PUNCT
ghmj-1231	53	1	this	this	DET
ghmj-1231	53	2	study	study	NOUN
ghmj-1231	53	3	was	be	AUX
ghmj-1231	53	4	conducted	conduct	VERB
ghmj-1231	53	5	to	to	PART
ghmj-1231	53	6	determine	determine	VERB
ghmj-1231	53	7	whether	whether	SCONJ
ghmj-1231	53	8	the	the	DET
ghmj-1231	53	9	ace2	ace2	PROPN
ghmj-1231	53	10	g8790a	g8790a	PROPN
ghmj-1231	53	11	gene	gene	NOUN
ghmj-1231	53	12	polymorphism	polymorphism	NOUN
ghmj-1231	53	13	in	in	ADP
ghmj-1231	53	14	cirebon	cirebon	NOUN
ghmj-1231	53	15	,	,	PUNCT
ghmj-1231	53	16	west	west	PROPN
ghmj-1231	53	17	java	java	PROPN
ghmj-1231	53	18	,	,	PUNCT
ghmj-1231	53	19	is	be	AUX
ghmj-1231	53	20	associated	associate	VERB
ghmj-1231	53	21	with	with	ADP
ghmj-1231	53	22	an	an	DET
ghmj-1231	53	23	increased	increase	VERB
ghmj-1231	53	24	risk	risk	NOUN
ghmj-1231	53	25	of	of	ADP
ghmj-1231	53	26	essential	essential	ADJ
ghmj-1231	53	27	hypertension	hypertension	NOUN
ghmj-1231	53	28	.	.	PUNCT
ghmj-1231	54	1	husna	husna	PROPN
ghmj-1231	54	2	,	,	PUNCT
ghmj-1231	54	3	et	et	PROPN
ghmj-1231	54	4	.	.	PUNCT
ghmj-1231	55	1	al	al	PROPN
ghmj-1231	55	2	.	.	PROPN
ghmj-1231	55	3	ghmj	ghmj	PROPN
ghmj-1231	55	4	(	(	PUNCT
ghmj-1231	55	5	global	global	ADJ
ghmj-1231	55	6	health	health	PROPN
ghmj-1231	55	7	management	management	NOUN
ghmj-1231	55	8	journal	journal	PROPN
ghmj-1231	55	9	)	)	PUNCT
ghmj-1231	55	10	2025	2025	NUM
ghmj-1231	55	11	,	,	PUNCT
ghmj-1231	55	12	vol	vol	NOUN
ghmj-1231	55	13	.	.	NOUN
ghmj-1231	55	14	8	8	NUM
ghmj-1231	55	15	,	,	PUNCT
ghmj-1231	55	16	no	no	INTJ
ghmj-1231	55	17	.	.	PUNCT
ghmj-1231	56	1	2s	2s	NUM
ghmj-1231	56	2	287	287	NUM
ghmj-1231	56	3	2	2	NUM
ghmj-1231	56	4	.	.	PUNCT
ghmj-1231	56	5	methods	method	NOUN
ghmj-1231	56	6	study	study	VERB
ghmj-1231	56	7	design	design	NOUN
ghmj-1231	56	8	and	and	CCONJ
ghmj-1231	56	9	research	research	NOUN
ghmj-1231	56	10	procedures	procedure	NOUN
ghmj-1231	56	11	an	an	DET
ghmj-1231	56	12	analytical	analytical	ADJ
ghmj-1231	56	13	study	study	NOUN
ghmj-1231	56	14	was	be	AUX
ghmj-1231	56	15	carried	carry	VERB
ghmj-1231	56	16	out	out	ADP
ghmj-1231	56	17	at	at	ADP
ghmj-1231	56	18	the	the	DET
ghmj-1231	56	19	talun	talun	ADJ
ghmj-1231	56	20	health	health	NOUN
ghmj-1231	56	21	center	center	NOUN
ghmj-1231	56	22	in	in	ADP
ghmj-1231	56	23	cirebon	cirebon	PROPN
ghmj-1231	56	24	regency	regency	PROPN
ghmj-1231	56	25	from	from	ADP
ghmj-1231	56	26	april	april	PROPN
ghmj-1231	56	27	to	to	ADP
ghmj-1231	56	28	august	august	PROPN
ghmj-1231	56	29	2024	2024	NUM
ghmj-1231	56	30	to	to	PART
ghmj-1231	56	31	examine	examine	VERB
ghmj-1231	56	32	the	the	DET
ghmj-1231	56	33	link	link	NOUN
ghmj-1231	56	34	between	between	ADP
ghmj-1231	56	35	essential	essential	ADJ
ghmj-1231	56	36	hypertension	hypertension	NOUN
ghmj-1231	56	37	and	and	CCONJ
ghmj-1231	56	38	the	the	DET
ghmj-1231	56	39	g8790a	g8790a	PROPN
ghmj-1231	56	40	gene	gene	NOUN
ghmj-1231	56	41	variation	variation	NOUN
ghmj-1231	56	42	of	of	ADP
ghmj-1231	56	43	the	the	DET
ghmj-1231	56	44	angiotensin	angiotensin	NOUN
ghmj-1231	56	45	converting	convert	VERB
ghmj-1231	56	46	enzyme	enzyme	NOUN
ghmj-1231	56	47	2	2	NUM
ghmj-1231	56	48	(	(	PUNCT
ghmj-1231	56	49	ace2	ace2	PROPN
ghmj-1231	56	50	)	)	PUNCT
ghmj-1231	56	51	.	.	PUNCT
ghmj-1231	57	1	participants	participant	NOUN
ghmj-1231	57	2	were	be	AUX
ghmj-1231	57	3	selected	select	VERB
ghmj-1231	57	4	using	use	VERB
ghmj-1231	57	5	purposive	purposive	ADJ
ghmj-1231	57	6	sampling	sampling	NOUN
ghmj-1231	57	7	according	accord	VERB
ghmj-1231	57	8	to	to	ADP
ghmj-1231	57	9	established	establish	VERB
ghmj-1231	57	10	inclusion	inclusion	NOUN
ghmj-1231	57	11	and	and	CCONJ
ghmj-1231	57	12	exclusion	exclusion	NOUN
ghmj-1231	57	13	criteria	criterion	NOUN
ghmj-1231	57	14	.	.	PUNCT
ghmj-1231	58	1	the	the	DET
ghmj-1231	58	2	case	case	NOUN
ghmj-1231	58	3	-	-	PUNCT
ghmj-1231	58	4	control	control	NOUN
ghmj-1231	58	5	study	study	NOUN
ghmj-1231	58	6	identified	identify	VERB
ghmj-1231	58	7	a	a	DET
ghmj-1231	58	8	sample	sample	NOUN
ghmj-1231	58	9	size	size	NOUN
ghmj-1231	58	10	of	of	ADP
ghmj-1231	58	11	60	60	NUM
ghmj-1231	58	12	participants	participant	NOUN
ghmj-1231	58	13	,	,	PUNCT
ghmj-1231	58	14	with	with	ADP
ghmj-1231	58	15	30	30	NUM
ghmj-1231	58	16	individuals	individual	NOUN
ghmj-1231	58	17	in	in	ADP
ghmj-1231	58	18	the	the	DET
ghmj-1231	58	19	case	case	NOUN
ghmj-1231	58	20	group	group	NOUN
ghmj-1231	58	21	and	and	CCONJ
ghmj-1231	58	22	30	30	NUM
ghmj-1231	58	23	individuals	individual	NOUN
ghmj-1231	58	24	in	in	ADP
ghmj-1231	58	25	the	the	DET
ghmj-1231	58	26	control	control	NOUN
ghmj-1231	58	27	group	group	NOUN
ghmj-1231	58	28	.	.	PUNCT
ghmj-1231	59	1	inclusion	inclusion	NOUN
ghmj-1231	59	2	criteria	criterion	NOUN
ghmj-1231	59	3	for	for	ADP
ghmj-1231	59	4	the	the	DET
ghmj-1231	59	5	case	case	NOUN
ghmj-1231	59	6	group	group	NOUN
ghmj-1231	59	7	included	include	VERB
ghmj-1231	59	8	(	(	PUNCT
ghmj-1231	59	9	1	1	X
ghmj-1231	59	10	)	)	PUNCT
ghmj-1231	59	11	a	a	DET
ghmj-1231	59	12	diagnosis	diagnosis	NOUN
ghmj-1231	59	13	of	of	ADP
ghmj-1231	59	14	essential	essential	ADJ
ghmj-1231	59	15	hypertension	hypertension	NOUN
ghmj-1231	59	16	based	base	VERB
ghmj-1231	59	17	on	on	ADP
ghmj-1231	59	18	the	the	DET
ghmj-1231	59	19	updated	update	VERB
ghmj-1231	59	20	eighth	eighth	ADJ
ghmj-1231	59	21	joint	joint	ADJ
ghmj-1231	59	22	national	national	PROPN
ghmj-1231	59	23	committee	committee	PROPN
ghmj-1231	59	24	(	(	PUNCT
ghmj-1231	59	25	jnc-8	jnc-8	NOUN
ghmj-1231	59	26	)	)	PUNCT
ghmj-1231	59	27	guideline	guideline	NOUN
ghmj-1231	59	28	recommendations	recommendation	NOUN
ghmj-1231	59	29	and	and	CCONJ
ghmj-1231	59	30	(	(	PUNCT
ghmj-1231	59	31	2	2	X
ghmj-1231	59	32	)	)	PUNCT
ghmj-1231	59	33	a	a	DET
ghmj-1231	59	34	family	family	NOUN
ghmj-1231	59	35	history	history	NOUN
ghmj-1231	59	36	of	of	ADP
ghmj-1231	59	37	hypertension	hypertension	NOUN
ghmj-1231	59	38	.	.	PUNCT
ghmj-1231	60	1	the	the	DET
ghmj-1231	60	2	exclusion	exclusion	NOUN
ghmj-1231	60	3	criteria	criterion	NOUN
ghmj-1231	60	4	include	include	VERB
ghmj-1231	60	5	(	(	PUNCT
ghmj-1231	60	6	1	1	X
ghmj-1231	60	7	)	)	PUNCT
ghmj-1231	60	8	patients	patient	NOUN
ghmj-1231	60	9	who	who	PRON
ghmj-1231	60	10	are	be	AUX
ghmj-1231	60	11	pregnant	pregnant	ADJ
ghmj-1231	60	12	or	or	CCONJ
ghmj-1231	60	13	lactating	lactating	NOUN
ghmj-1231	60	14	,	,	PUNCT
ghmj-1231	60	15	and	and	CCONJ
ghmj-1231	60	16	(	(	PUNCT
ghmj-1231	60	17	2	2	X
ghmj-1231	60	18	)	)	PUNCT
ghmj-1231	60	19	patients	patient	NOUN
ghmj-1231	60	20	with	with	ADP
ghmj-1231	60	21	hypertension	hypertension	NOUN
ghmj-1231	60	22	who	who	PRON
ghmj-1231	60	23	also	also	ADV
ghmj-1231	60	24	have	have	VERB
ghmj-1231	60	25	diabetes	diabetes	NOUN
ghmj-1231	60	26	,	,	PUNCT
ghmj-1231	60	27	kidney	kidney	NOUN
ghmj-1231	60	28	disease	disease	NOUN
ghmj-1231	60	29	,	,	PUNCT
ghmj-1231	60	30	liver	liver	NOUN
ghmj-1231	60	31	disease	disease	NOUN
ghmj-1231	60	32	,	,	PUNCT
ghmj-1231	60	33	stroke	stroke	NOUN
ghmj-1231	60	34	,	,	PUNCT
ghmj-1231	60	35	or	or	CCONJ
ghmj-1231	60	36	other	other	ADJ
ghmj-1231	60	37	cardiovascular	cardiovascular	ADJ
ghmj-1231	60	38	disease	disease	NOUN
ghmj-1231	60	39	.	.	PUNCT
ghmj-1231	61	1	the	the	DET
ghmj-1231	61	2	control	control	PROPN
ghmj-1231	61	3	group	group	NOUN
ghmj-1231	61	4	's	's	PART
ghmj-1231	61	5	members	member	NOUN
ghmj-1231	61	6	fit	fit	VERB
ghmj-1231	61	7	the	the	DET
ghmj-1231	61	8	same	same	ADJ
ghmj-1231	61	9	inclusion	inclusion	NOUN
ghmj-1231	61	10	and	and	CCONJ
ghmj-1231	61	11	exclusion	exclusion	NOUN
ghmj-1231	61	12	criteria	criterion	NOUN
ghmj-1231	61	13	as	as	ADP
ghmj-1231	61	14	the	the	DET
ghmj-1231	61	15	case	case	NOUN
ghmj-1231	61	16	group	group	NOUN
ghmj-1231	61	17	,	,	PUNCT
ghmj-1231	61	18	and	and	CCONJ
ghmj-1231	61	19	they	they	PRON
ghmj-1231	61	20	were	be	AUX
ghmj-1231	61	21	diagnosed	diagnose	VERB
ghmj-1231	61	22	as	as	ADP
ghmj-1231	61	23	nonhypertensive	nonhypertensive	ADJ
ghmj-1231	61	24	based	base	VERB
ghmj-1231	61	25	on	on	ADP
ghmj-1231	61	26	the	the	DET
ghmj-1231	61	27	same	same	ADJ
ghmj-1231	61	28	diagnostic	diagnostic	ADJ
ghmj-1231	61	29	standards	standard	NOUN
ghmj-1231	61	30	.	.	PUNCT
ghmj-1231	62	1	control	control	NOUN
ghmj-1231	62	2	subjects	subject	NOUN
ghmj-1231	62	3	were	be	AUX
ghmj-1231	62	4	matched	match	VERB
ghmj-1231	62	5	to	to	PART
ghmj-1231	62	6	case	case	VERB
ghmj-1231	62	7	subjects	subject	NOUN
ghmj-1231	62	8	based	base	VERB
ghmj-1231	62	9	on	on	ADP
ghmj-1231	62	10	age	age	NOUN
ghmj-1231	62	11	(	(	PUNCT
ghmj-1231	62	12	±	±	NOUN
ghmj-1231	62	13	2	2	NUM
ghmj-1231	62	14	years	year	NOUN
ghmj-1231	62	15	)	)	PUNCT
ghmj-1231	62	16	.	.	PUNCT
ghmj-1231	63	1	to	to	PART
ghmj-1231	63	2	minimize	minimize	VERB
ghmj-1231	63	3	bias	bias	NOUN
ghmj-1231	63	4	,	,	PUNCT
ghmj-1231	63	5	patients	patient	NOUN
ghmj-1231	63	6	who	who	PRON
ghmj-1231	63	7	were	be	AUX
ghmj-1231	63	8	pregnant	pregnant	ADJ
ghmj-1231	63	9	or	or	CCONJ
ghmj-1231	63	10	breastfeeding	breastfeed	VERB
ghmj-1231	63	11	or	or	CCONJ
ghmj-1231	63	12	had	have	VERB
ghmj-1231	63	13	a	a	DET
ghmj-1231	63	14	history	history	NOUN
ghmj-1231	63	15	of	of	ADP
ghmj-1231	63	16	diabetes	diabetes	NOUN
ghmj-1231	63	17	mellitus	mellitus	NOUN
ghmj-1231	63	18	,	,	PUNCT
ghmj-1231	63	19	renal	renal	ADJ
ghmj-1231	63	20	disease	disease	NOUN
ghmj-1231	63	21	,	,	PUNCT
ghmj-1231	63	22	coronary	coronary	ADJ
ghmj-1231	63	23	heart	heart	NOUN
ghmj-1231	63	24	disease	disease	NOUN
ghmj-1231	63	25	,	,	PUNCT
ghmj-1231	63	26	or	or	CCONJ
ghmj-1231	63	27	other	other	ADJ
ghmj-1231	63	28	cardiovascular	cardiovascular	ADJ
ghmj-1231	63	29	diseases	disease	NOUN
ghmj-1231	63	30	were	be	AUX
ghmj-1231	63	31	excluded	exclude	VERB
ghmj-1231	63	32	from	from	ADP
ghmj-1231	63	33	the	the	DET
ghmj-1231	63	34	case	case	NOUN
ghmj-1231	63	35	group	group	NOUN
ghmj-1231	63	36	(	(	PUNCT
ghmj-1231	63	37	kuswara	kuswara	PROPN
ghmj-1231	63	38	et	et	PROPN
ghmj-1231	63	39	al	al	PROPN
ghmj-1231	63	40	.	.	PROPN
ghmj-1231	63	41	,	,	PUNCT
ghmj-1231	63	42	2024	2024	NUM
ghmj-1231	63	43	)	)	PUNCT
ghmj-1231	63	44	.	.	PUNCT
ghmj-1231	64	1	the	the	DET
ghmj-1231	64	2	researchers	researcher	NOUN
ghmj-1231	64	3	collected	collect	VERB
ghmj-1231	64	4	demographic	demographic	ADJ
ghmj-1231	64	5	data	datum	NOUN
ghmj-1231	64	6	and	and	CCONJ
ghmj-1231	64	7	measured	measure	VERB
ghmj-1231	64	8	the	the	DET
ghmj-1231	64	9	blood	blood	NOUN
ghmj-1231	64	10	pressure	pressure	NOUN
ghmj-1231	64	11	of	of	ADP
ghmj-1231	64	12	all	all	DET
ghmj-1231	64	13	study	study	NOUN
ghmj-1231	64	14	subjects	subject	NOUN
ghmj-1231	64	15	throughout	throughout	ADP
ghmj-1231	64	16	the	the	DET
ghmj-1231	64	17	study	study	NOUN
ghmj-1231	64	18	.	.	PUNCT
ghmj-1231	65	1	measurement	measurement	NOUN
ghmj-1231	65	2	blood	blood	NOUN
ghmj-1231	65	3	samples	sample	NOUN
ghmj-1231	65	4	were	be	AUX
ghmj-1231	65	5	collected	collect	VERB
ghmj-1231	65	6	from	from	ADP
ghmj-1231	65	7	the	the	DET
ghmj-1231	65	8	peripheral	peripheral	ADJ
ghmj-1231	65	9	vein	vein	NOUN
ghmj-1231	65	10	.	.	PUNCT
ghmj-1231	66	1	the	the	DET
ghmj-1231	66	2	samples	sample	NOUN
ghmj-1231	66	3	were	be	AUX
ghmj-1231	66	4	thereafter	thereafter	ADV
ghmj-1231	66	5	kept	keep	VERB
ghmj-1231	66	6	at	at	ADP
ghmj-1231	66	7	ambient	ambient	ADJ
ghmj-1231	66	8	temperatures	temperature	NOUN
ghmj-1231	66	9	in	in	ADP
ghmj-1231	66	10	tubes	tube	NOUN
ghmj-1231	66	11	treated	treat	VERB
ghmj-1231	66	12	with	with	ADP
ghmj-1231	66	13	edta	edta	NOUN
ghmj-1231	66	14	.	.	PUNCT
ghmj-1231	67	1	participants	participant	NOUN
ghmj-1231	67	2	who	who	PRON
ghmj-1231	67	3	fulfilled	fulfil	VERB
ghmj-1231	67	4	the	the	DET
ghmj-1231	67	5	research	research	NOUN
ghmj-1231	67	6	criteria	criterion	NOUN
ghmj-1231	67	7	were	be	AUX
ghmj-1231	67	8	evaluated	evaluate	VERB
ghmj-1231	67	9	by	by	ADP
ghmj-1231	67	10	a	a	DET
ghmj-1231	67	11	questionnaire	questionnaire	NOUN
ghmj-1231	67	12	administered	administer	VERB
ghmj-1231	67	13	by	by	ADP
ghmj-1231	67	14	a	a	DET
ghmj-1231	67	15	physician	physician	NOUN
ghmj-1231	67	16	to	to	PART
ghmj-1231	67	17	ensure	ensure	VERB
ghmj-1231	67	18	accurate	accurate	ADJ
ghmj-1231	67	19	data	datum	NOUN
ghmj-1231	67	20	entry	entry	NOUN
ghmj-1231	67	21	.	.	PUNCT
ghmj-1231	68	1	clinical	clinical	ADJ
ghmj-1231	68	2	characteristics	characteristic	NOUN
ghmj-1231	68	3	gathered	gather	VERB
ghmj-1231	68	4	during	during	ADP
ghmj-1231	68	5	screening	screening	NOUN
ghmj-1231	68	6	include	include	VERB
ghmj-1231	68	7	age	age	NOUN
ghmj-1231	68	8	,	,	PUNCT
ghmj-1231	68	9	gender	gender	NOUN
ghmj-1231	68	10	,	,	PUNCT
ghmj-1231	68	11	and	and	CCONJ
ghmj-1231	68	12	familial	familial	ADJ
ghmj-1231	68	13	history	history	NOUN
ghmj-1231	68	14	of	of	ADP
ghmj-1231	68	15	hypertension	hypertension	NOUN
ghmj-1231	68	16	.	.	PUNCT
ghmj-1231	69	1	additionally	additionally	ADV
ghmj-1231	69	2	,	,	PUNCT
ghmj-1231	69	3	blood	blood	NOUN
ghmj-1231	69	4	pressure	pressure	NOUN
ghmj-1231	69	5	was	be	AUX
ghmj-1231	69	6	assessed	assess	VERB
ghmj-1231	69	7	three	three	NUM
ghmj-1231	69	8	times	time	NOUN
ghmj-1231	69	9	,	,	PUNCT
ghmj-1231	69	10	with	with	ADP
ghmj-1231	69	11	an	an	DET
ghmj-1231	69	12	interval	interval	NOUN
ghmj-1231	69	13	of	of	ADP
ghmj-1231	69	14	3	3	NUM
ghmj-1231	69	15	to	to	PART
ghmj-1231	69	16	5	5	NUM
ghmj-1231	69	17	minutes	minute	NOUN
ghmj-1231	69	18	between	between	ADP
ghmj-1231	69	19	each	each	DET
ghmj-1231	69	20	test	test	NOUN
ghmj-1231	69	21	.	.	PUNCT
ghmj-1231	70	1	blood	blood	NOUN
ghmj-1231	70	2	samples	sample	NOUN
ghmj-1231	70	3	(	(	PUNCT
ghmj-1231	70	4	3–5	3–5	NUM
ghmj-1231	70	5	cc	cc	NOUN
ghmj-1231	70	6	)	)	PUNCT
ghmj-1231	70	7	were	be	AUX
ghmj-1231	70	8	obtained	obtain	VERB
ghmj-1231	70	9	at	at	ADP
ghmj-1231	70	10	the	the	DET
ghmj-1231	70	11	talun	talun	ADJ
ghmj-1231	70	12	public	public	ADJ
ghmj-1231	70	13	health	health	NOUN
ghmj-1231	70	14	centre	centre	NOUN
ghmj-1231	70	15	,	,	PUNCT
ghmj-1231	70	16	transferred	transfer	VERB
ghmj-1231	70	17	to	to	ADP
ghmj-1231	70	18	edta	edta	NOUN
ghmj-1231	70	19	tubes	tube	NOUN
ghmj-1231	70	20	,	,	PUNCT
ghmj-1231	70	21	and	and	CCONJ
ghmj-1231	70	22	transferred	transfer	VERB
ghmj-1231	70	23	to	to	ADP
ghmj-1231	70	24	the	the	DET
ghmj-1231	70	25	research	research	NOUN
ghmj-1231	70	26	laboratory	laboratory	NOUN
ghmj-1231	70	27	at	at	ADP
ghmj-1231	70	28	universitas	universita	NOUN
ghmj-1231	70	29	swadaya	swadaya	VERB
ghmj-1231	70	30	gunung	gunung	NOUN
ghmj-1231	70	31	jati	jati	NOUN
ghmj-1231	70	32	cirebon	cirebon	NOUN
ghmj-1231	70	33	for	for	ADP
ghmj-1231	70	34	genetic	genetic	ADJ
ghmj-1231	70	35	analysis	analysis	NOUN
ghmj-1231	70	36	.	.	PUNCT
ghmj-1231	71	1	dna	dna	NOUN
ghmj-1231	71	2	from	from	ADP
ghmj-1231	71	3	leukocytes	leukocyte	NOUN
ghmj-1231	71	4	was	be	AUX
ghmj-1231	71	5	extracted	extract	VERB
ghmj-1231	71	6	using	use	VERB
ghmj-1231	71	7	the	the	DET
ghmj-1231	71	8	qiaamp	qiaamp	NOUN
ghmj-1231	71	9	kit	kit	NOUN
ghmj-1231	71	10	(	(	PUNCT
ghmj-1231	71	11	qiagen	qiagen	PROPN
ghmj-1231	71	12	,	,	PUNCT
ghmj-1231	71	13	tokyo	tokyo	PROPN
ghmj-1231	71	14	,	,	PUNCT
ghmj-1231	71	15	japan	japan	PROPN
ghmj-1231	71	16	)	)	PUNCT
ghmj-1231	71	17	following	follow	VERB
ghmj-1231	71	18	the	the	DET
ghmj-1231	71	19	recommended	recommend	VERB
ghmj-1231	71	20	protocol	protocol	NOUN
ghmj-1231	71	21	.	.	PUNCT
ghmj-1231	72	1	instruments	instrument	VERB
ghmj-1231	72	2	the	the	DET
ghmj-1231	72	3	gene	gene	NOUN
ghmj-1231	72	4	polymorphisms	polymorphism	NOUN
ghmj-1231	72	5	were	be	AUX
ghmj-1231	72	6	amplified	amplify	VERB
ghmj-1231	72	7	using	use	VERB
ghmj-1231	72	8	the	the	DET
ghmj-1231	72	9	restriction	restriction	NOUN
ghmj-1231	72	10	fragment	fragment	NOUN
ghmj-1231	72	11	length	length	NOUN
ghmj-1231	72	12	polymorphism	polymorphism	NOUN
ghmj-1231	72	13	(	(	PUNCT
ghmj-1231	72	14	rflp	rflp	PROPN
ghmj-1231	72	15	)	)	PUNCT
ghmj-1231	72	16	and	and	CCONJ
ghmj-1231	72	17	polymerase	polymerase	NOUN
ghmj-1231	72	18	chain	chain	NOUN
ghmj-1231	72	19	reaction	reaction	NOUN
ghmj-1231	72	20	(	(	PUNCT
ghmj-1231	72	21	pcr	pcr	NOUN
ghmj-1231	72	22	)	)	PUNCT
ghmj-1231	72	23	techniques	technique	NOUN
ghmj-1231	72	24	.	.	PUNCT
ghmj-1231	73	1	the	the	DET
ghmj-1231	73	2	amplification	amplification	NOUN
ghmj-1231	73	3	process	process	NOUN
ghmj-1231	73	4	contained	contain	VERB
ghmj-1231	73	5	12.5	12.5	NUM
ghmj-1231	73	6	μl	μl	ADP
ghmj-1231	73	7	of	of	ADP
ghmj-1231	73	8	pcr	pcr	NOUN
ghmj-1231	73	9	taq	taq	NOUN
ghmj-1231	73	10	master	master	NOUN
ghmj-1231	73	11	mix	mix	NOUN
ghmj-1231	73	12	,	,	PUNCT
ghmj-1231	73	13	1.0	1.0	NUM
ghmj-1231	73	14	μl	μl	NOUN
ghmj-1231	73	15	of	of	ADP
ghmj-1231	73	16	upstream	upstream	ADJ
ghmj-1231	73	17	and	and	CCONJ
ghmj-1231	73	18	downstream	downstream	ADJ
ghmj-1231	73	19	primers	primer	NOUN
ghmj-1231	73	20	,	,	PUNCT
ghmj-1231	73	21	1.0	1.0	NUM
ghmj-1231	73	22	μl	μl	NOUN
ghmj-1231	73	23	of	of	ADP
ghmj-1231	73	24	dna	dna	PROPN
ghmj-1231	73	25	template	template	NOUN
ghmj-1231	73	26	,	,	PUNCT
ghmj-1231	73	27	and	and	CCONJ
ghmj-1231	73	28	9.5	9.5	NUM
ghmj-1231	73	29	μl	μl	ADP
ghmj-1231	73	30	of	of	ADP
ghmj-1231	73	31	deionized	deionize	VERB
ghmj-1231	73	32	water	water	NOUN
ghmj-1231	73	33	,	,	PUNCT
ghmj-1231	73	34	for	for	ADP
ghmj-1231	73	35	a	a	DET
ghmj-1231	73	36	total	total	ADJ
ghmj-1231	73	37	volume	volume	NOUN
ghmj-1231	73	38	of	of	ADP
ghmj-1231	73	39	25	25	NUM
ghmj-1231	73	40	μl	μl	NOUN
ghmj-1231	73	41	.	.	PUNCT
ghmj-1231	74	1	we	we	PRON
ghmj-1231	74	2	used	use	VERB
ghmj-1231	74	3	pcr	pcr	NOUN
ghmj-1231	74	4	-	-	PUNCT
ghmj-1231	74	5	rflp	rflp	PROPN
ghmj-1231	74	6	for	for	ADP
ghmj-1231	74	7	ace2	ace2	PROPN
ghmj-1231	74	8	g8790a	g8790a	PROPN
ghmj-1231	74	9	,	,	PUNCT
ghmj-1231	74	10	using	use	VERB
ghmj-1231	74	11	the	the	DET
ghmj-1231	74	12	forward	forward	ADJ
ghmj-1231	74	13	primer	primer	NOUN
ghmj-1231	74	14	5'–catgtggtcaaaaggatatct	5'–catgtggtcaaaaggatatct	NUM
ghmj-1231	74	15	–	–	PUNCT
ghmj-1231	74	16	3	3	NUM
ghmj-1231	74	17	'	'	PUNCT
ghmj-1231	74	18	and	and	CCONJ
ghmj-1231	74	19	the	the	DET
ghmj-1231	74	20	reverse	reverse	ADJ
ghmj-1231	74	21	primer	primer	NOUN
ghmj-1231	74	22	5'–aaagtaaggttggcagacat–3	5'–aaagtaaggttggcagacat–3	NUM
ghmj-1231	74	23	'	'	NUM
ghmj-1231	74	24	.	.	PUNCT
ghmj-1231	75	1	the	the	DET
ghmj-1231	75	2	following	follow	VERB
ghmj-1231	75	3	conditions	condition	NOUN
ghmj-1231	75	4	were	be	AUX
ghmj-1231	75	5	used	use	VERB
ghmj-1231	75	6	for	for	ADP
ghmj-1231	75	7	the	the	DET
ghmj-1231	75	8	pcr	pcr	NOUN
ghmj-1231	75	9	:	:	PUNCT
ghmj-1231	75	10	5	5	NUM
ghmj-1231	75	11	minutes	minute	NOUN
ghmj-1231	75	12	of	of	ADP
ghmj-1231	75	13	pre	pre	NOUN
ghmj-1231	75	14	-	-	NOUN
ghmj-1231	75	15	denaturation	denaturation	ADJ
ghmj-1231	75	16	at	at	ADP
ghmj-1231	75	17	94	94	NUM
ghmj-1231	75	18	°	°	NOUN
ghmj-1231	75	19	c	c	NOUN
ghmj-1231	75	20	,	,	PUNCT
ghmj-1231	75	21	32	32	NUM
ghmj-1231	75	22	cycles	cycle	NOUN
ghmj-1231	75	23	of	of	ADP
ghmj-1231	75	24	denaturation	denaturation	NOUN
ghmj-1231	75	25	at	at	ADP
ghmj-1231	75	26	94	94	NUM
ghmj-1231	75	27	°	°	ADP
ghmj-1231	75	28	c	c	NOUN
ghmj-1231	75	29	for	for	ADP
ghmj-1231	75	30	40	40	NUM
ghmj-1231	75	31	seconds	second	NOUN
ghmj-1231	75	32	,	,	PUNCT
ghmj-1231	75	33	30	30	NUM
ghmj-1231	75	34	seconds	second	NOUN
ghmj-1231	75	35	of	of	ADP
ghmj-1231	75	36	annealing	anneal	VERB
ghmj-1231	75	37	at	at	ADP
ghmj-1231	75	38	58	58	NUM
ghmj-1231	75	39	°	°	NOUN
ghmj-1231	75	40	c	c	NOUN
ghmj-1231	75	41	,	,	PUNCT
ghmj-1231	75	42	30	30	NUM
ghmj-1231	75	43	seconds	second	NOUN
ghmj-1231	75	44	of	of	ADP
ghmj-1231	75	45	extension	extension	NOUN
ghmj-1231	75	46	at	at	ADP
ghmj-1231	75	47	72	72	NUM
ghmj-1231	75	48	°	°	NOUN
ghmj-1231	75	49	c	c	NOUN
ghmj-1231	75	50	,	,	PUNCT
ghmj-1231	75	51	and	and	CCONJ
ghmj-1231	75	52	5	5	NUM
ghmj-1231	75	53	minutes	minute	NOUN
ghmj-1231	75	54	of	of	ADP
ghmj-1231	75	55	terminal	terminal	ADJ
ghmj-1231	75	56	extension	extension	NOUN
ghmj-1231	75	57	at	at	ADP
ghmj-1231	75	58	72	72	NUM
ghmj-1231	75	59	°	°	NOUN
ghmj-1231	75	60	c	c	NOUN
ghmj-1231	75	61	.	.	PUNCT
ghmj-1231	76	1	the	the	DET
ghmj-1231	76	2	ace2	ace2	PROPN
ghmj-1231	76	3	g8790a	g8790a	PROPN
ghmj-1231	76	4	pcr	pcr	NOUN
ghmj-1231	76	5	products	product	NOUN
ghmj-1231	76	6	were	be	AUX
ghmj-1231	76	7	subjected	subject	VERB
ghmj-1231	76	8	to	to	ADP
ghmj-1231	76	9	a	a	DET
ghmj-1231	76	10	water	water	NOUN
ghmj-1231	76	11	bath	bath	NOUN
ghmj-1231	76	12	reaction	reaction	NOUN
ghmj-1231	76	13	with	with	ADP
ghmj-1231	76	14	alui	alui	NOUN
ghmj-1231	76	15	endonuclease	endonuclease	NOUN
ghmj-1231	76	16	at	at	ADP
ghmj-1231	76	17	37	37	NUM
ghmj-1231	76	18	°	°	ADP
ghmj-1231	76	19	c	c	NOUN
ghmj-1231	76	20	for	for	ADP
ghmj-1231	76	21	3–16	3–16	PROPN
ghmj-1231	76	22	hours	hour	NOUN
ghmj-1231	76	23	.	.	PUNCT
ghmj-1231	77	1	the	the	DET
ghmj-1231	77	2	resulting	result	VERB
ghmj-1231	77	3	mixture	mixture	NOUN
ghmj-1231	77	4	was	be	AUX
ghmj-1231	77	5	then	then	ADV
ghmj-1231	77	6	electrophoresed	electrophorese	VERB
ghmj-1231	77	7	on	on	ADP
ghmj-1231	77	8	a	a	DET
ghmj-1231	77	9	1.5	1.5	NUM
ghmj-1231	77	10	%	%	NOUN
ghmj-1231	77	11	agarose	agarose	NOUN
ghmj-1231	77	12	gel	gel	NOUN
ghmj-1231	77	13	and	and	CCONJ
ghmj-1231	77	14	stained	stain	VERB
ghmj-1231	77	15	with	with	ADP
ghmj-1231	77	16	1.0	1.0	NUM
ghmj-1231	77	17	μl	μl	NUM
ghmj-1231	77	18	gel	gel	NOUN
ghmj-1231	77	19	red	red	ADJ
ghmj-1231	77	20	/	/	SYM
ghmj-1231	77	21	ethidium	ethidium	NOUN
ghmj-1231	77	22	bromide	bromide	NOUN
ghmj-1231	77	23	.	.	PUNCT
ghmj-1231	78	1	a	a	DET
ghmj-1231	78	2	uv	uv	NOUN
ghmj-1231	78	3	analyzer	analyzer	NOUN
ghmj-1231	78	4	was	be	AUX
ghmj-1231	78	5	used	use	VERB
ghmj-1231	78	6	to	to	PART
ghmj-1231	78	7	determine	determine	VERB
ghmj-1231	78	8	genetic	genetic	ADJ
ghmj-1231	78	9	polymorphism	polymorphism	NOUN
ghmj-1231	78	10	.	.	PUNCT
ghmj-1231	79	1	statistical	statistical	ADJ
ghmj-1231	79	2	analysis	analysis	NOUN
ghmj-1231	79	3	with	with	ADP
ghmj-1231	79	4	the	the	DET
ghmj-1231	79	5	essential	essential	ADJ
ghmj-1231	79	6	hypertension	hypertension	NOUN
ghmj-1231	79	7	serving	serve	VERB
ghmj-1231	79	8	as	as	ADP
ghmj-1231	79	9	the	the	DET
ghmj-1231	79	10	dependent	dependent	ADJ
ghmj-1231	79	11	variable	variable	NOUN
ghmj-1231	79	12	and	and	CCONJ
ghmj-1231	79	13	the	the	DET
ghmj-1231	79	14	ace2	ace2	PROPN
ghmj-1231	79	15	g8790a	g8790a	PROPN
ghmj-1231	79	16	gene	gene	NOUN
ghmj-1231	79	17	polymorphism	polymorphism	NOUN
ghmj-1231	79	18	serving	serve	VERB
ghmj-1231	79	19	as	as	ADP
ghmj-1231	79	20	the	the	DET
ghmj-1231	79	21	independent	independent	ADJ
ghmj-1231	79	22	variable	variable	NOUN
ghmj-1231	79	23	,	,	PUNCT
ghmj-1231	79	24	univariate	univariate	ADJ
ghmj-1231	79	25	analysis	analysis	NOUN
ghmj-1231	79	26	is	be	AUX
ghmj-1231	79	27	used	use	VERB
ghmj-1231	79	28	to	to	PART
ghmj-1231	79	29	characterize	characterize	VERB
ghmj-1231	79	30	the	the	DET
ghmj-1231	79	31	study	study	NOUN
ghmj-1231	79	32	sample	sample	NOUN
ghmj-1231	79	33	by	by	ADP
ghmj-1231	79	34	displaying	display	VERB
ghmj-1231	79	35	the	the	DET
ghmj-1231	79	36	frequency	frequency	NOUN
ghmj-1231	79	37	distribution	distribution	NOUN
ghmj-1231	79	38	of	of	ADP
ghmj-1231	79	39	each	each	DET
ghmj-1231	79	40	study	study	NOUN
ghmj-1231	79	41	variable	variable	NOUN
ghmj-1231	79	42	.	.	PUNCT
ghmj-1231	80	1	the	the	DET
ghmj-1231	80	2	chi	chi	ADJ
ghmj-1231	80	3	-	-	PUNCT
ghmj-1231	80	4	square	square	ADJ
ghmj-1231	80	5	test	test	NOUN
ghmj-1231	80	6	is	be	AUX
ghmj-1231	80	7	used	use	VERB
ghmj-1231	80	8	to	to	PART
ghmj-1231	80	9	compare	compare	VERB
ghmj-1231	80	10	results	result	NOUN
ghmj-1231	80	11	in	in	ADP
ghmj-1231	80	12	bivariate	bivariate	ADJ
ghmj-1231	80	13	analysis	analysis	NOUN
ghmj-1231	80	14	,	,	PUNCT
ghmj-1231	80	15	including	include	VERB
ghmj-1231	80	16	category	category	NOUN
ghmj-1231	80	17	variables	variable	NOUN
ghmj-1231	80	18	.	.	PUNCT
ghmj-1231	81	1	odds	odd	NOUN
ghmj-1231	81	2	ratios	ratio	NOUN
ghmj-1231	81	3	(	(	PUNCT
ghmj-1231	81	4	or	or	CCONJ
ghmj-1231	81	5	)	)	PUNCT
ghmj-1231	81	6	with	with	ADP
ghmj-1231	81	7	95	95	NUM
ghmj-1231	81	8	%	%	NOUN
ghmj-1231	81	9	confidence	confidence	NOUN
ghmj-1231	81	10	intervals	interval	NOUN
ghmj-1231	81	11	(	(	PUNCT
ghmj-1231	81	12	ci	ci	NOUN
ghmj-1231	81	13	)	)	PUNCT
ghmj-1231	81	14	were	be	AUX
ghmj-1231	81	15	calculated	calculate	VERB
ghmj-1231	81	16	to	to	PART
ghmj-1231	81	17	evaluate	evaluate	VERB
ghmj-1231	81	18	the	the	DET
ghmj-1231	81	19	risk	risk	NOUN
ghmj-1231	81	20	associated	associate	VERB
ghmj-1231	81	21	with	with	ADP
ghmj-1231	81	22	variables	variable	NOUN
ghmj-1231	81	23	including	include	VERB
ghmj-1231	81	24	genotype	genotype	NOUN
ghmj-1231	81	25	,	,	PUNCT
ghmj-1231	81	26	allele	allele	NOUN
ghmj-1231	81	27	frequency	frequency	NOUN
ghmj-1231	81	28	,	,	PUNCT
ghmj-1231	81	29	and	and	CCONJ
ghmj-1231	81	30	the	the	DET
ghmj-1231	81	31	presence	presence	NOUN
ghmj-1231	81	32	of	of	ADP
ghmj-1231	81	33	gene	gene	NOUN
ghmj-1231	81	34	polymorphism	polymorphism	NOUN
ghmj-1231	81	35	,	,	PUNCT
ghmj-1231	81	36	with	with	ADP
ghmj-1231	81	37	significance	significance	NOUN
ghmj-1231	81	38	established	establish	VERB
ghmj-1231	81	39	at	at	ADP
ghmj-1231	81	40	p<0.05	p<0.05	PROPN
ghmj-1231	81	41	.	.	PUNCT
ghmj-1231	82	1	husna	husna	PROPN
ghmj-1231	82	2	,	,	PUNCT
ghmj-1231	82	3	et	et	PROPN
ghmj-1231	82	4	.	.	PUNCT
ghmj-1231	83	1	al	al	PROPN
ghmj-1231	83	2	ghmj	ghmj	PROPN
ghmj-1231	83	3	(	(	PUNCT
ghmj-1231	83	4	global	global	ADJ
ghmj-1231	83	5	health	health	PROPN
ghmj-1231	83	6	management	management	NOUN
ghmj-1231	83	7	journal	journal	PROPN
ghmj-1231	83	8	)	)	PUNCT
ghmj-1231	83	9	2025	2025	NUM
ghmj-1231	83	10	,	,	PUNCT
ghmj-1231	83	11	vol	vol	NOUN
ghmj-1231	83	12	.	.	NOUN
ghmj-1231	83	13	8	8	NUM
ghmj-1231	83	14	,	,	PUNCT
ghmj-1231	83	15	no	no	INTJ
ghmj-1231	83	16	.	.	PUNCT
ghmj-1231	84	1	2s	2s	NOUN
ghmj-1231	84	2	288	288	NUM
ghmj-1231	84	3	ethical	ethical	ADJ
ghmj-1231	84	4	clearance	clearance	NOUN
ghmj-1231	84	5	the	the	DET
ghmj-1231	84	6	ethics	ethic	NOUN
ghmj-1231	84	7	committee	committee	PROPN
ghmj-1231	84	8	of	of	ADP
ghmj-1231	84	9	the	the	DET
ghmj-1231	84	10	faculty	faculty	NOUN
ghmj-1231	84	11	of	of	ADP
ghmj-1231	84	12	medicine	medicine	NOUN
ghmj-1231	84	13	at	at	ADP
ghmj-1231	84	14	universitas	universita	NOUN
ghmj-1231	84	15	swadaya	swadaya	VERB
ghmj-1231	84	16	gunung	gunung	NOUN
ghmj-1231	84	17	jati	jati	NOUN
ghmj-1231	84	18	in	in	ADP
ghmj-1231	84	19	cirebon	cirebon	PROPN
ghmj-1231	84	20	,	,	PUNCT
ghmj-1231	84	21	indonesia	indonesia	PROPN
ghmj-1231	84	22	,	,	PUNCT
ghmj-1231	84	23	authorized	authorize	VERB
ghmj-1231	84	24	the	the	DET
ghmj-1231	84	25	study	study	NOUN
ghmj-1231	84	26	protocol	protocol	NOUN
ghmj-1231	84	27	and	and	CCONJ
ghmj-1231	84	28	ensured	ensure	VERB
ghmj-1231	84	29	that	that	SCONJ
ghmj-1231	84	30	it	it	PRON
ghmj-1231	84	31	adhered	adhere	VERB
ghmj-1231	84	32	to	to	ADP
ghmj-1231	84	33	the	the	DET
ghmj-1231	84	34	1975	1975	NUM
ghmj-1231	84	35	declaration	declaration	NOUN
ghmj-1231	84	36	of	of	ADP
ghmj-1231	84	37	helsinki	helsinki	PROPN
ghmj-1231	84	38	and	and	CCONJ
ghmj-1231	84	39	its	its	PRON
ghmj-1231	84	40	revisions	revision	NOUN
ghmj-1231	84	41	'	'	PART
ghmj-1231	84	42	ethical	ethical	ADJ
ghmj-1231	84	43	guidelines	guideline	NOUN
ghmj-1231	84	44	.	.	PUNCT
ghmj-1231	85	1	each	each	DET
ghmj-1231	85	2	patient	patient	NOUN
ghmj-1231	85	3	signed	sign	VERB
ghmj-1231	85	4	a	a	DET
ghmj-1231	85	5	written	write	VERB
ghmj-1231	85	6	informed	inform	VERB
ghmj-1231	85	7	consent	consent	NOUN
ghmj-1231	85	8	form	form	NOUN
ghmj-1231	85	9	prior	prior	ADV
ghmj-1231	85	10	to	to	ADP
ghmj-1231	85	11	the	the	DET
ghmj-1231	85	12	study	study	NOUN
ghmj-1231	85	13	.	.	PUNCT
ghmj-1231	86	1	prior	prior	ADV
ghmj-1231	86	2	to	to	ADP
ghmj-1231	86	3	enrollment	enrollment	NOUN
ghmj-1231	86	4	,	,	PUNCT
ghmj-1231	86	5	written	write	VERB
ghmj-1231	86	6	informed	inform	VERB
ghmj-1231	86	7	permission	permission	NOUN
ghmj-1231	86	8	was	be	AUX
ghmj-1231	86	9	obtained	obtain	VERB
ghmj-1231	86	10	from	from	ADP
ghmj-1231	86	11	each	each	DET
ghmj-1231	86	12	patient	patient	NOUN
ghmj-1231	86	13	.	.	PUNCT
ghmj-1231	87	1	for	for	ADP
ghmj-1231	87	2	patients	patient	NOUN
ghmj-1231	87	3	who	who	PRON
ghmj-1231	87	4	were	be	AUX
ghmj-1231	87	5	younger	young	ADJ
ghmj-1231	87	6	than	than	ADP
ghmj-1231	87	7	18	18	NUM
ghmj-1231	87	8	,	,	PUNCT
ghmj-1231	87	9	written	write	VERB
ghmj-1231	87	10	agreement	agreement	NOUN
ghmj-1231	87	11	was	be	AUX
ghmj-1231	87	12	acquired	acquire	VERB
ghmj-1231	87	13	from	from	ADP
ghmj-1231	87	14	their	their	PRON
ghmj-1231	87	15	parents	parent	NOUN
ghmj-1231	87	16	or	or	CCONJ
ghmj-1231	87	17	legal	legal	ADJ
ghmj-1231	87	18	guardians	guardian	NOUN
ghmj-1231	87	19	.	.	PUNCT
ghmj-1231	88	1	3	3	X
ghmj-1231	88	2	.	.	NOUN
ghmj-1231	88	3	results	result	NOUN
ghmj-1231	88	4	respondent	respondent	NOUN
ghmj-1231	88	5	characteristics	characteristic	NOUN
ghmj-1231	88	6	in	in	ADP
ghmj-1231	88	7	table	table	NOUN
ghmj-1231	88	8	1	1	NUM
ghmj-1231	88	9	,	,	PUNCT
ghmj-1231	88	10	it	it	PRON
ghmj-1231	88	11	can	can	AUX
ghmj-1231	88	12	be	be	AUX
ghmj-1231	88	13	seen	see	VERB
ghmj-1231	88	14	that	that	SCONJ
ghmj-1231	88	15	all	all	DET
ghmj-1231	88	16	research	research	NOUN
ghmj-1231	88	17	subjects	subject	NOUN
ghmj-1231	88	18	were	be	AUX
ghmj-1231	88	19	60	60	NUM
ghmj-1231	88	20	people	people	NOUN
ghmj-1231	88	21	.	.	PUNCT
ghmj-1231	89	1	the	the	DET
ghmj-1231	89	2	matching	matching	NOUN
ghmj-1231	89	3	process	process	NOUN
ghmj-1231	89	4	between	between	ADP
ghmj-1231	89	5	the	the	DET
ghmj-1231	89	6	case	case	NOUN
ghmj-1231	89	7	group	group	NOUN
ghmj-1231	89	8	and	and	CCONJ
ghmj-1231	89	9	the	the	DET
ghmj-1231	89	10	control	control	NOUN
ghmj-1231	89	11	group	group	NOUN
ghmj-1231	89	12	resulted	result	VERB
ghmj-1231	89	13	in	in	ADP
ghmj-1231	89	14	no	no	DET
ghmj-1231	89	15	differences	difference	NOUN
ghmj-1231	89	16	in	in	ADP
ghmj-1231	89	17	the	the	DET
ghmj-1231	89	18	frequency	frequency	NOUN
ghmj-1231	89	19	distribution	distribution	NOUN
ghmj-1231	89	20	of	of	ADP
ghmj-1231	89	21	gender	gender	NOUN
ghmj-1231	89	22	and	and	CCONJ
ghmj-1231	89	23	age	age	NOUN
ghmj-1231	89	24	among	among	ADP
ghmj-1231	89	25	the	the	DET
ghmj-1231	89	26	research	research	NOUN
ghmj-1231	89	27	subjects	subject	NOUN
ghmj-1231	89	28	.	.	PUNCT
ghmj-1231	90	1	the	the	DET
ghmj-1231	90	2	frequency	frequency	NOUN
ghmj-1231	90	3	distribution	distribution	NOUN
ghmj-1231	90	4	of	of	ADP
ghmj-1231	90	5	characteristics	characteristic	NOUN
ghmj-1231	90	6	in	in	ADP
ghmj-1231	90	7	the	the	DET
ghmj-1231	90	8	case	case	NOUN
ghmj-1231	90	9	group	group	NOUN
ghmj-1231	90	10	who	who	PRON
ghmj-1231	90	11	had	have	VERB
ghmj-1231	90	12	a	a	DET
ghmj-1231	90	13	family	family	NOUN
ghmj-1231	90	14	history	history	NOUN
ghmj-1231	90	15	of	of	ADP
ghmj-1231	90	16	hypertension	hypertension	NOUN
ghmj-1231	90	17	was	be	AUX
ghmj-1231	90	18	19	19	NUM
ghmj-1231	90	19	subjects	subject	NOUN
ghmj-1231	90	20	(	(	PUNCT
ghmj-1231	90	21	63.3	63.3	NUM
ghmj-1231	90	22	%	%	NOUN
ghmj-1231	90	23	)	)	PUNCT
ghmj-1231	90	24	,	,	PUNCT
ghmj-1231	90	25	and	and	CCONJ
ghmj-1231	90	26	who	who	PRON
ghmj-1231	90	27	did	do	AUX
ghmj-1231	90	28	not	not	PART
ghmj-1231	90	29	have	have	VERB
ghmj-1231	90	30	a	a	DET
ghmj-1231	90	31	family	family	NOUN
ghmj-1231	90	32	history	history	NOUN
ghmj-1231	90	33	of	of	ADP
ghmj-1231	90	34	hypertension	hypertension	NOUN
ghmj-1231	90	35	was	be	AUX
ghmj-1231	90	36	11	11	NUM
ghmj-1231	90	37	subjects	subject	NOUN
ghmj-1231	90	38	(	(	PUNCT
ghmj-1231	90	39	36.7	36.7	NUM
ghmj-1231	90	40	%	%	NOUN
ghmj-1231	90	41	)	)	PUNCT
ghmj-1231	90	42	,	,	PUNCT
ghmj-1231	90	43	while	while	SCONJ
ghmj-1231	90	44	in	in	ADP
ghmj-1231	90	45	the	the	DET
ghmj-1231	90	46	control	control	NOUN
ghmj-1231	90	47	group	group	NOUN
ghmj-1231	90	48	who	who	PRON
ghmj-1231	90	49	had	have	VERB
ghmj-1231	90	50	a	a	DET
ghmj-1231	90	51	family	family	NOUN
ghmj-1231	90	52	history	history	NOUN
ghmj-1231	90	53	of	of	ADP
ghmj-1231	90	54	hypertension	hypertension	NOUN
ghmj-1231	90	55	was	be	AUX
ghmj-1231	90	56	3	3	NUM
ghmj-1231	90	57	subjects	subject	NOUN
ghmj-1231	90	58	(	(	PUNCT
ghmj-1231	90	59	10	10	NUM
ghmj-1231	90	60	%	%	NOUN
ghmj-1231	90	61	)	)	PUNCT
ghmj-1231	90	62	,	,	PUNCT
ghmj-1231	90	63	and	and	CCONJ
ghmj-1231	90	64	who	who	PRON
ghmj-1231	90	65	did	do	AUX
ghmj-1231	90	66	not	not	PART
ghmj-1231	90	67	have	have	VERB
ghmj-1231	90	68	a	a	DET
ghmj-1231	90	69	family	family	NOUN
ghmj-1231	90	70	history	history	NOUN
ghmj-1231	90	71	of	of	ADP
ghmj-1231	90	72	hypertension	hypertension	NOUN
ghmj-1231	90	73	was	be	AUX
ghmj-1231	90	74	27	27	NUM
ghmj-1231	90	75	subjects	subject	NOUN
ghmj-1231	90	76	(	(	PUNCT
ghmj-1231	90	77	90	90	NUM
ghmj-1231	90	78	%	%	NOUN
ghmj-1231	90	79	)	)	PUNCT
ghmj-1231	90	80	.	.	PUNCT
ghmj-1231	91	1	table	table	NOUN
ghmj-1231	91	2	1	1	NUM
ghmj-1231	91	3	.	.	PUNCT
ghmj-1231	92	1	participant	participant	PROPN
ghmj-1231	92	2	's	's	PART
ghmj-1231	92	3	demographic	demographic	ADJ
ghmj-1231	92	4	information	information	NOUN
ghmj-1231	92	5	genotypic	genotypic	NOUN
ghmj-1231	92	6	data	datum	NOUN
ghmj-1231	92	7	in	in	ADP
ghmj-1231	92	8	the	the	DET
ghmj-1231	92	9	case	case	NOUN
ghmj-1231	92	10	group	group	NOUN
ghmj-1231	92	11	,	,	PUNCT
ghmj-1231	92	12	the	the	DET
ghmj-1231	92	13	genotype	genotype	NOUN
ghmj-1231	92	14	distribution	distribution	NOUN
ghmj-1231	92	15	for	for	ADP
ghmj-1231	92	16	ace2	ace2	NOUN
ghmj-1231	92	17	g8790a	g8790a	PROPN
ghmj-1231	92	18	is	be	AUX
ghmj-1231	92	19	gg	gg	PROPN
ghmj-1231	92	20	12	12	NUM
ghmj-1231	92	21	(	(	PUNCT
ghmj-1231	92	22	40	40	NUM
ghmj-1231	92	23	%	%	NOUN
ghmj-1231	92	24	)	)	PUNCT
ghmj-1231	92	25	,	,	PUNCT
ghmj-1231	92	26	ga	ga	PROPN
ghmj-1231	92	27	9	9	NUM
ghmj-1231	92	28	(	(	PUNCT
ghmj-1231	92	29	30	30	NUM
ghmj-1231	92	30	%	%	NOUN
ghmj-1231	92	31	)	)	PUNCT
ghmj-1231	92	32	,	,	PUNCT
ghmj-1231	92	33	and	and	CCONJ
ghmj-1231	92	34	aa	aa	NOUN
ghmj-1231	92	35	9	9	NUM
ghmj-1231	92	36	(	(	PUNCT
ghmj-1231	92	37	30	30	NUM
ghmj-1231	92	38	%	%	NOUN
ghmj-1231	92	39	)	)	PUNCT
ghmj-1231	92	40	.	.	PUNCT
ghmj-1231	93	1	in	in	ADP
ghmj-1231	93	2	the	the	DET
ghmj-1231	93	3	control	control	NOUN
ghmj-1231	93	4	group	group	NOUN
ghmj-1231	93	5	,	,	PUNCT
ghmj-1231	93	6	the	the	DET
ghmj-1231	93	7	genotype	genotype	NOUN
ghmj-1231	93	8	distribution	distribution	NOUN
ghmj-1231	93	9	is	be	AUX
ghmj-1231	93	10	gg	gg	PROPN
ghmj-1231	93	11	10	10	NUM
ghmj-1231	93	12	(	(	PUNCT
ghmj-1231	93	13	33.3	33.3	NUM
ghmj-1231	93	14	%	%	NOUN
ghmj-1231	93	15	)	)	PUNCT
ghmj-1231	93	16	,	,	PUNCT
ghmj-1231	93	17	ga	ga	PROPN
ghmj-1231	93	18	6	6	NUM
ghmj-1231	93	19	(	(	PUNCT
ghmj-1231	93	20	20	20	NUM
ghmj-1231	93	21	%	%	NOUN
ghmj-1231	93	22	)	)	PUNCT
ghmj-1231	93	23	,	,	PUNCT
ghmj-1231	93	24	and	and	CCONJ
ghmj-1231	93	25	aa	aa	NOUN
ghmj-1231	93	26	14	14	NUM
ghmj-1231	93	27	(	(	PUNCT
ghmj-1231	93	28	46.7	46.7	NUM
ghmj-1231	93	29	%	%	NOUN
ghmj-1231	93	30	)	)	PUNCT
ghmj-1231	93	31	.	.	PUNCT
ghmj-1231	94	1	the	the	DET
ghmj-1231	94	2	g	g	PROPN
ghmj-1231	94	3	allele	allele	NOUN
ghmj-1231	94	4	distribution	distribution	NOUN
ghmj-1231	94	5	in	in	ADP
ghmj-1231	94	6	the	the	DET
ghmj-1231	94	7	case	case	NOUN
ghmj-1231	94	8	group	group	NOUN
ghmj-1231	94	9	is	be	AUX
ghmj-1231	94	10	33	33	NUM
ghmj-1231	94	11	(	(	PUNCT
ghmj-1231	94	12	55	55	NUM
ghmj-1231	94	13	%	%	NOUN
ghmj-1231	94	14	)	)	PUNCT
ghmj-1231	94	15	and	and	CCONJ
ghmj-1231	94	16	26	26	NUM
ghmj-1231	94	17	(	(	PUNCT
ghmj-1231	94	18	80	80	NUM
ghmj-1231	94	19	%	%	NOUN
ghmj-1231	94	20	)	)	PUNCT
ghmj-1231	94	21	within	within	ADP
ghmj-1231	94	22	the	the	DET
ghmj-1231	94	23	control	control	NOUN
ghmj-1231	94	24	group	group	NOUN
ghmj-1231	94	25	,	,	PUNCT
ghmj-1231	94	26	while	while	SCONJ
ghmj-1231	94	27	the	the	DET
ghmj-1231	94	28	a	a	DET
ghmj-1231	94	29	allele	allele	NOUN
ghmj-1231	94	30	distribution	distribution	NOUN
ghmj-1231	94	31	is	be	AUX
ghmj-1231	94	32	27	27	NUM
ghmj-1231	94	33	(	(	PUNCT
ghmj-1231	94	34	45	45	NUM
ghmj-1231	94	35	%	%	NOUN
ghmj-1231	94	36	)	)	PUNCT
ghmj-1231	94	37	in	in	ADP
ghmj-1231	94	38	the	the	DET
ghmj-1231	94	39	case	case	NOUN
ghmj-1231	94	40	group	group	NOUN
ghmj-1231	94	41	and	and	CCONJ
ghmj-1231	94	42	34	34	NUM
ghmj-1231	94	43	(	(	PUNCT
ghmj-1231	94	44	56.7	56.7	NUM
ghmj-1231	94	45	%	%	NOUN
ghmj-1231	94	46	)	)	PUNCT
ghmj-1231	94	47	in	in	ADP
ghmj-1231	94	48	the	the	DET
ghmj-1231	94	49	control	control	NOUN
ghmj-1231	94	50	group	group	NOUN
ghmj-1231	94	51	.	.	PUNCT
ghmj-1231	95	1	p	p	X
ghmj-1231	95	2	-	-	PUNCT
ghmj-1231	95	3	value	value	NOUN
ghmj-1231	95	4	for	for	ADP
ghmj-1231	95	5	genotype	genotype	NOUN
ghmj-1231	95	6	(	(	PUNCT
ghmj-1231	95	7	p=0.393	p=0.393	X
ghmj-1231	95	8	)	)	PUNCT
ghmj-1231	95	9	and	and	CCONJ
ghmj-1231	95	10	allele	allele	NOUN
ghmj-1231	95	11	(	(	PUNCT
ghmj-1231	95	12	p=0.201	p=0.201	NOUN
ghmj-1231	95	13	)	)	PUNCT
ghmj-1231	95	14	did	do	AUX
ghmj-1231	95	15	not	not	PART
ghmj-1231	95	16	show	show	VERB
ghmj-1231	95	17	significance	significance	NOUN
ghmj-1231	95	18	(	(	PUNCT
ghmj-1231	95	19	table	table	NOUN
ghmj-1231	95	20	2	2	NUM
ghmj-1231	95	21	)	)	PUNCT
ghmj-1231	95	22	.	.	PUNCT
ghmj-1231	96	1	table	table	NOUN
ghmj-1231	96	2	2	2	NUM
ghmj-1231	96	3	.	.	PUNCT
ghmj-1231	96	4	genotype	genotype	NOUN
ghmj-1231	96	5	and	and	CCONJ
ghmj-1231	96	6	allele	allele	NOUN
ghmj-1231	96	7	distribution	distribution	NOUN
ghmj-1231	96	8	for	for	ADP
ghmj-1231	96	9	ace2	ace2	NOUN
ghmj-1231	96	10	g8790a	g8790a	PROPN
ghmj-1231	96	11	variables	variable	VERB
ghmj-1231	96	12	case	case	NOUN
ghmj-1231	96	13	(	(	PUNCT
ghmj-1231	96	14	n=30	n=30	NOUN
ghmj-1231	96	15	)	)	PUNCT
ghmj-1231	96	16	control	control	NOUN
ghmj-1231	96	17	(	(	PUNCT
ghmj-1231	96	18	n=30	n=30	NOUN
ghmj-1231	96	19	)	)	PUNCT
ghmj-1231	96	20	p	p	NOUN
ghmj-1231	96	21	-	-	PUNCT
ghmj-1231	96	22	values	value	NOUN
ghmj-1231	96	23	genotype	genotype	NOUN
ghmj-1231	96	24	n%	n%	PROPN
ghmj-1231	96	25	n%	n%	VERB
ghmj-1231	97	1	gg	gg	PROPN
ghmj-1231	97	2	12(40	12(40	NUM
ghmj-1231	97	3	%	%	NOUN
ghmj-1231	97	4	)	)	PUNCT
ghmj-1231	97	5	10(33.3	10(33.3	NUM
ghmj-1231	97	6	%	%	NOUN
ghmj-1231	97	7	)	)	PUNCT
ghmj-1231	97	8	0.393a	0.393a	NOUN
ghmj-1231	97	9	ga	ga	NOUN
ghmj-1231	97	10	9(30	9(30	NUM
ghmj-1231	97	11	%	%	NOUN
ghmj-1231	97	12	)	)	PUNCT
ghmj-1231	97	13	6(10	6(10	NUM
ghmj-1231	97	14	%	%	NOUN
ghmj-1231	97	15	)	)	PUNCT
ghmj-1231	98	1	aa	aa	NOUN
ghmj-1231	98	2	9(30	9(30	NUM
ghmj-1231	98	3	%	%	NOUN
ghmj-1231	98	4	)	)	PUNCT
ghmj-1231	98	5	14(46.7	14(46.7	NUM
ghmj-1231	98	6	%	%	NOUN
ghmj-1231	98	7	)	)	PUNCT
ghmj-1231	98	8	allele	allele	NOUN
ghmj-1231	98	9	g	g	ADP
ghmj-1231	98	10	33(55	33(55	NUM
ghmj-1231	98	11	%	%	NOUN
ghmj-1231	98	12	)	)	PUNCT
ghmj-1231	98	13	26(43.3	26(43.3	ADJ
ghmj-1231	98	14	%	%	NOUN
ghmj-1231	98	15	)	)	PUNCT
ghmj-1231	98	16	0.201a	0.201a	NOUN
ghmj-1231	98	17	a	a	DET
ghmj-1231	98	18	27(45	27(45	NUM
ghmj-1231	98	19	%	%	NOUN
ghmj-1231	98	20	)	)	PUNCT
ghmj-1231	98	21	34(56.7	34(56.7	NUM
ghmj-1231	98	22	%	%	NOUN
ghmj-1231	98	23	)	)	PUNCT
ghmj-1231	98	24	achi	achi	ADJ
ghmj-1231	98	25	-	-	PUNCT
ghmj-1231	98	26	square	square	ADJ
ghmj-1231	98	27	test	test	NOUN
ghmj-1231	98	28	characteristics	characteristic	NOUN
ghmj-1231	98	29	case	case	NOUN
ghmj-1231	98	30	control	control	NOUN
ghmj-1231	98	31	n	n	CCONJ
ghmj-1231	98	32	%	%	NOUN
ghmj-1231	99	1	n	n	PRON
ghmj-1231	99	2	%	%	NOUN
ghmj-1231	99	3	age	age	NOUN
ghmj-1231	99	4	<	<	X
ghmj-1231	99	5	45	45	NUM
ghmj-1231	99	6	8	8	NUM
ghmj-1231	99	7	26.7	26.7	NUM
ghmj-1231	99	8	%	%	NOUN
ghmj-1231	99	9	8	8	NUM
ghmj-1231	99	10	26.7	26.7	NUM
ghmj-1231	99	11	%	%	NOUN
ghmj-1231	99	12	>	>	PUNCT
ghmj-1231	99	13	45	45	NUM
ghmj-1231	99	14	22	22	NUM
ghmj-1231	99	15	73.3	73.3	NUM
ghmj-1231	99	16	%	%	NOUN
ghmj-1231	99	17	22	22	NUM
ghmj-1231	99	18	73.3	73.3	NUM
ghmj-1231	99	19	%	%	NOUN
ghmj-1231	99	20	total	total	NOUN
ghmj-1231	99	21	30	30	NUM
ghmj-1231	99	22	100	100	NUM
ghmj-1231	99	23	%	%	NOUN
ghmj-1231	99	24	30	30	NUM
ghmj-1231	99	25	100	100	NUM
ghmj-1231	99	26	%	%	NOUN
ghmj-1231	99	27	sex	sex	NOUN
ghmj-1231	99	28	male	male	ADJ
ghmj-1231	99	29	female	female	ADJ
ghmj-1231	99	30	total	total	NOUN
ghmj-1231	99	31	15	15	NUM
ghmj-1231	99	32	50.0	50.0	NUM
ghmj-1231	99	33	%	%	NOUN
ghmj-1231	99	34	15	15	NUM
ghmj-1231	99	35	50.0	50.0	NUM
ghmj-1231	99	36	%	%	NOUN
ghmj-1231	99	37	15	15	NUM
ghmj-1231	99	38	50.0	50.0	NUM
ghmj-1231	99	39	%	%	NOUN
ghmj-1231	99	40	15	15	NUM
ghmj-1231	99	41	50.0	50.0	NUM
ghmj-1231	99	42	%	%	NOUN
ghmj-1231	99	43	30	30	NUM
ghmj-1231	99	44	100	100	NUM
ghmj-1231	99	45	%	%	NOUN
ghmj-1231	99	46	30	30	NUM
ghmj-1231	99	47	100	100	NUM
ghmj-1231	99	48	%	%	NOUN
ghmj-1231	99	49	family	family	NOUN
ghmj-1231	99	50	history	history	NOUN
ghmj-1231	99	51	of	of	ADP
ghmj-1231	99	52	hypertension	hypertension	NOUN
ghmj-1231	100	1	yes	yes	INTJ
ghmj-1231	100	2	no	no	PRON
ghmj-1231	100	3	total	total	ADJ
ghmj-1231	100	4	19	19	NUM
ghmj-1231	100	5	63.3	63.3	NUM
ghmj-1231	100	6	%	%	NOUN
ghmj-1231	100	7	3	3	NUM
ghmj-1231	100	8	10	10	NUM
ghmj-1231	100	9	%	%	NOUN
ghmj-1231	100	10	11	11	NUM
ghmj-1231	100	11	36.7	36.7	NUM
ghmj-1231	100	12	%	%	NOUN
ghmj-1231	100	13	27	27	NUM
ghmj-1231	100	14	90	90	NUM
ghmj-1231	100	15	%	%	NOUN
ghmj-1231	100	16	30	30	NUM
ghmj-1231	100	17	100	100	NUM
ghmj-1231	100	18	%	%	NOUN
ghmj-1231	100	19	30	30	NUM
ghmj-1231	100	20	100	100	NUM
ghmj-1231	100	21	%	%	NOUN
ghmj-1231	100	22	husna	husna	ADJ
ghmj-1231	100	23	,	,	PUNCT
ghmj-1231	100	24	et	et	PROPN
ghmj-1231	100	25	.	.	PUNCT
ghmj-1231	101	1	al	al	PROPN
ghmj-1231	101	2	.	.	PROPN
ghmj-1231	101	3	ghmj	ghmj	PROPN
ghmj-1231	101	4	(	(	PUNCT
ghmj-1231	101	5	global	global	ADJ
ghmj-1231	101	6	health	health	PROPN
ghmj-1231	101	7	management	management	NOUN
ghmj-1231	101	8	journal	journal	PROPN
ghmj-1231	101	9	)	)	PUNCT
ghmj-1231	101	10	2025	2025	NUM
ghmj-1231	101	11	,	,	PUNCT
ghmj-1231	101	12	vol	vol	NOUN
ghmj-1231	101	13	.	.	NOUN
ghmj-1231	101	14	8	8	NUM
ghmj-1231	101	15	,	,	PUNCT
ghmj-1231	101	16	no	no	INTJ
ghmj-1231	101	17	.	.	PUNCT
ghmj-1231	102	1	2s	2s	NOUN
ghmj-1231	102	2	289	289	NUM
ghmj-1231	102	3	figure	figure	NOUN
ghmj-1231	102	4	1	1	NUM
ghmj-1231	102	5	.	.	PUNCT
ghmj-1231	103	1	pcr	pcr	ADJ
ghmj-1231	103	2	-	-	PUNCT
ghmj-1231	103	3	rflp	rflp	NOUN
ghmj-1231	103	4	product	product	NOUN
ghmj-1231	103	5	of	of	ADP
ghmj-1231	103	6	ace2	ace2	PROPN
ghmj-1231	103	7	g8790a	g8790a	PROPN
ghmj-1231	103	8	polymorphism	polymorphism	NOUN
ghmj-1231	103	9	on	on	ADP
ghmj-1231	103	10	an	an	DET
ghmj-1231	103	11	agarose	agarose	NOUN
ghmj-1231	103	12	gel	gel	NOUN
ghmj-1231	103	13	,	,	PUNCT
ghmj-1231	103	14	digestion	digestion	NOUN
ghmj-1231	103	15	outcome	outcome	NOUN
ghmj-1231	103	16	:	:	PUNCT
ghmj-1231	103	17	lane	lane	NOUN
ghmj-1231	103	18	(	(	PUNCT
ghmj-1231	103	19	1	1	NUM
ghmj-1231	103	20	)	)	PUNCT
ghmj-1231	103	21	dna	dna	NOUN
ghmj-1231	103	22	marker	marker	NOUN
ghmj-1231	103	23	;	;	PUNCT
ghmj-1231	103	24	(	(	PUNCT
ghmj-1231	103	25	2	2	X
ghmj-1231	103	26	)	)	PUNCT
ghmj-1231	103	27	aa=281	aa=281	PROPN
ghmj-1231	103	28	bp+185	bp+185	X
ghmj-1231	103	29	bp	bp	PROPN
ghmj-1231	103	30	;	;	PUNCT
ghmj-1231	103	31	(	(	PUNCT
ghmj-1231	103	32	3	3	X
ghmj-1231	103	33	)	)	PUNCT
ghmj-1231	103	34	gg=466	gg=466	PROPN
ghmj-1231	103	35	bp	bp	PROPN
ghmj-1231	103	36	;	;	PUNCT
ghmj-1231	103	37	and	and	CCONJ
ghmj-1231	103	38	(	(	PUNCT
ghmj-1231	103	39	4	4	X
ghmj-1231	103	40	)	)	PUNCT
ghmj-1231	103	41	ga=466	ga=466	PROPN
ghmj-1231	103	42	bp+281	bp+281	NUM
ghmj-1231	103	43	bp+185	bp+185	NUM
ghmj-1231	103	44	bp	bp	PROPN
ghmj-1231	103	45	bivariate	bivariate	ADJ
ghmj-1231	103	46	analysis	analysis	NOUN
ghmj-1231	103	47	bivariate	bivariate	ADJ
ghmj-1231	103	48	analysis	analysis	NOUN
ghmj-1231	103	49	results	result	NOUN
ghmj-1231	103	50	indicated	indicate	VERB
ghmj-1231	103	51	that	that	SCONJ
ghmj-1231	103	52	the	the	DET
ghmj-1231	103	53	prevalence	prevalence	NOUN
ghmj-1231	103	54	of	of	ADP
ghmj-1231	103	55	polymorphisms	polymorphism	NOUN
ghmj-1231	103	56	was	be	AUX
ghmj-1231	103	57	greater	great	ADJ
ghmj-1231	103	58	in	in	ADP
ghmj-1231	103	59	the	the	DET
ghmj-1231	103	60	control	control	NOUN
ghmj-1231	103	61	group	group	NOUN
ghmj-1231	103	62	,	,	PUNCT
ghmj-1231	103	63	with	with	ADP
ghmj-1231	103	64	20	20	NUM
ghmj-1231	103	65	subjects	subject	NOUN
ghmj-1231	103	66	(	(	PUNCT
ghmj-1231	103	67	66.7	66.7	NUM
ghmj-1231	103	68	%	%	NOUN
ghmj-1231	103	69	)	)	PUNCT
ghmj-1231	103	70	,	,	PUNCT
ghmj-1231	103	71	compared	compare	VERB
ghmj-1231	103	72	to	to	ADP
ghmj-1231	103	73	the	the	DET
ghmj-1231	103	74	case	case	NOUN
ghmj-1231	103	75	group	group	NOUN
ghmj-1231	103	76	,	,	PUNCT
ghmj-1231	103	77	which	which	PRON
ghmj-1231	103	78	comprised	comprise	VERB
ghmj-1231	103	79	18	18	NUM
ghmj-1231	103	80	subjects	subject	NOUN
ghmj-1231	103	81	(	(	PUNCT
ghmj-1231	103	82	60	60	NUM
ghmj-1231	103	83	%	%	NOUN
ghmj-1231	103	84	)	)	PUNCT
ghmj-1231	103	85	.	.	PUNCT
ghmj-1231	104	1	the	the	DET
ghmj-1231	104	2	adjusted	adjust	VERB
ghmj-1231	104	3	chi	chi	ADJ
ghmj-1231	104	4	-	-	PUNCT
ghmj-1231	104	5	square	square	ADJ
ghmj-1231	104	6	test	test	NOUN
ghmj-1231	104	7	(	(	PUNCT
ghmj-1231	104	8	pearson	pearson	PROPN
ghmj-1231	104	9	chi	chi	PROPN
ghmj-1231	104	10	-	-	PUNCT
ghmj-1231	104	11	square	square	NOUN
ghmj-1231	104	12	)	)	PUNCT
ghmj-1231	104	13	yielded	yield	VERB
ghmj-1231	104	14	a	a	DET
ghmj-1231	104	15	p	p	NOUN
ghmj-1231	104	16	-	-	PUNCT
ghmj-1231	104	17	value	value	NOUN
ghmj-1231	104	18	of	of	ADP
ghmj-1231	104	19	0.592	0.592	NUM
ghmj-1231	104	20	(	(	PUNCT
ghmj-1231	104	21	p>0.05	p>0.05	PROPN
ghmj-1231	104	22	)	)	PUNCT
ghmj-1231	104	23	,	,	PUNCT
ghmj-1231	104	24	indicating	indicate	VERB
ghmj-1231	104	25	no	no	DET
ghmj-1231	104	26	significant	significant	ADJ
ghmj-1231	104	27	association	association	NOUN
ghmj-1231	104	28	between	between	ADP
ghmj-1231	104	29	the	the	DET
ghmj-1231	104	30	ace2	ace2	PROPN
ghmj-1231	104	31	g8790a	g8790a	PROPN
ghmj-1231	104	32	gene	gene	NOUN
ghmj-1231	104	33	polymorphism	polymorphism	NOUN
ghmj-1231	104	34	and	and	CCONJ
ghmj-1231	104	35	the	the	DET
ghmj-1231	104	36	occurrence	occurrence	NOUN
ghmj-1231	104	37	of	of	ADP
ghmj-1231	104	38	essential	essential	ADJ
ghmj-1231	104	39	hypertension	hypertension	NOUN
ghmj-1231	104	40	.	.	PUNCT
ghmj-1231	105	1	further	further	ADJ
ghmj-1231	105	2	analysis	analysis	NOUN
ghmj-1231	105	3	yielded	yield	VERB
ghmj-1231	105	4	an	an	DET
ghmj-1231	105	5	odds	odd	NOUN
ghmj-1231	105	6	ratio	ratio	NOUN
ghmj-1231	105	7	(	(	PUNCT
ghmj-1231	105	8	or	or	CCONJ
ghmj-1231	105	9	)	)	PUNCT
ghmj-1231	105	10	of	of	ADP
ghmj-1231	105	11	0.750	0.750	NUM
ghmj-1231	105	12	,	,	PUNCT
ghmj-1231	105	13	indicating	indicate	VERB
ghmj-1231	105	14	that	that	SCONJ
ghmj-1231	105	15	individuals	individual	NOUN
ghmj-1231	105	16	with	with	ADP
ghmj-1231	105	17	the	the	DET
ghmj-1231	105	18	ace2	ace2	PROPN
ghmj-1231	105	19	g8790a	g8790a	PROPN
ghmj-1231	105	20	gene	gene	NOUN
ghmj-1231	105	21	polymorphism	polymorphism	NOUN
ghmj-1231	105	22	are	be	AUX
ghmj-1231	105	23	not	not	PART
ghmj-1231	105	24	at	at	ADP
ghmj-1231	105	25	significant	significant	ADJ
ghmj-1231	105	26	risk	risk	NOUN
ghmj-1231	105	27	for	for	ADP
ghmj-1231	105	28	developing	develop	VERB
ghmj-1231	105	29	essential	essential	ADJ
ghmj-1231	105	30	hypertension	hypertension	NOUN
ghmj-1231	105	31	and	and	CCONJ
ghmj-1231	105	32	have	have	VERB
ghmj-1231	105	33	a	a	DET
ghmj-1231	105	34	protective	protective	ADJ
ghmj-1231	105	35	factor	factor	NOUN
ghmj-1231	105	36	25	25	NUM
ghmj-1231	105	37	%	%	NOUN
ghmj-1231	105	38	greater	great	ADJ
ghmj-1231	105	39	than	than	ADP
ghmj-1231	105	40	those	those	PRON
ghmj-1231	105	41	without	without	ADP
ghmj-1231	105	42	the	the	DET
ghmj-1231	105	43	ace2	ace2	PROPN
ghmj-1231	105	44	g8790a	g8790a	PROPN
ghmj-1231	105	45	gene	gene	NOUN
ghmj-1231	105	46	polymorphism	polymorphism	NOUN
ghmj-1231	105	47	(	(	PUNCT
ghmj-1231	105	48	p=0.592	p=0.592	NOUN
ghmj-1231	105	49	;	;	PUNCT
ghmj-1231	105	50	or=0.750	or=0.750	ADJ
ghmj-1231	105	51	;	;	PUNCT
ghmj-1231	105	52	ci=0.262	ci=0.262	PROPN
ghmj-1231	105	53	-	-	PUNCT
ghmj-1231	105	54	2.151	2.151	NUM
ghmj-1231	105	55	)	)	PUNCT
ghmj-1231	105	56	.	.	PUNCT
ghmj-1231	106	1	table	table	NOUN
ghmj-1231	106	2	3	3	NUM
ghmj-1231	106	3	.	.	PUNCT
ghmj-1231	107	1	the	the	DET
ghmj-1231	107	2	polymorphism	polymorphism	NOUN
ghmj-1231	107	3	of	of	ADP
ghmj-1231	107	4	ace2	ace2	PROPN
ghmj-1231	107	5	g8790a	g8790a	PROPN
ghmj-1231	107	6	and	and	CCONJ
ghmj-1231	107	7	essential	essential	ADJ
ghmj-1231	107	8	hypertension	hypertension	NOUN
ghmj-1231	107	9	polymorphism	polymorphism	NOUN
ghmj-1231	107	10	ace2	ace2	PROPN
ghmj-1231	107	11	g8790a	g8790a	PROPN
ghmj-1231	107	12	case	case	NOUN
ghmj-1231	107	13	group	group	NOUN
ghmj-1231	107	14	control	control	NOUN
ghmj-1231	107	15	group	group	NOUN
ghmj-1231	107	16	p	p	NOUN
ghmj-1231	107	17	-	-	PUNCT
ghmj-1231	107	18	values	value	NOUN
ghmj-1231	107	19	or	or	CCONJ
ghmj-1231	107	20	(	(	PUNCT
ghmj-1231	107	21	95%ci	95%ci	NUM
ghmj-1231	107	22	)	)	PUNCT
ghmj-1231	107	23	n%	n%	VERB
ghmj-1231	107	24	n%	n%	VERB
ghmj-1231	107	25	polymorphism	polymorphism	NOUN
ghmj-1231	107	26	+	+	CCONJ
ghmj-1231	107	27	18(60	18(60	NUM
ghmj-1231	107	28	%	%	NOUN
ghmj-1231	107	29	)	)	PUNCT
ghmj-1231	108	1	20(66.7	20(66.7	NUM
ghmj-1231	108	2	%	%	NOUN
ghmj-1231	108	3	)	)	PUNCT
ghmj-1231	108	4	0.592a	0.592a	NOUN
ghmj-1231	108	5	0.750	0.750	NUM
ghmj-1231	108	6	(	(	PUNCT
ghmj-1231	108	7	0.2622.151	0.2622.151	NUM
ghmj-1231	108	8	)	)	PUNCT
ghmj-1231	108	9	polymorphism	polymorphism	NOUN
ghmj-1231	108	10	12(40	12(40	NUM
ghmj-1231	108	11	%	%	NOUN
ghmj-1231	108	12	)	)	PUNCT
ghmj-1231	108	13	10(33.3	10(33.3	NUM
ghmj-1231	108	14	%	%	NOUN
ghmj-1231	108	15	)	)	PUNCT
ghmj-1231	108	16	a	a	DET
ghmj-1231	108	17	pearson	pearson	NOUN
ghmj-1231	108	18	chi	chi	PROPN
ghmj-1231	108	19	-	-	PUNCT
ghmj-1231	108	20	square	square	ADJ
ghmj-1231	108	21	test	test	NOUN
ghmj-1231	108	22	4	4	NUM
ghmj-1231	108	23	.	.	PUNCT
ghmj-1231	109	1	discussion	discussion	NOUN
ghmj-1231	109	2	many	many	ADJ
ghmj-1231	109	3	genes	gene	NOUN
ghmj-1231	109	4	,	,	PUNCT
ghmj-1231	109	5	environmental	environmental	ADJ
ghmj-1231	109	6	factors	factor	NOUN
ghmj-1231	109	7	,	,	PUNCT
ghmj-1231	109	8	and	and	CCONJ
ghmj-1231	109	9	their	their	PRON
ghmj-1231	109	10	interactions	interaction	NOUN
ghmj-1231	109	11	influence	influence	VERB
ghmj-1231	109	12	the	the	DET
ghmj-1231	109	13	complex	complex	ADJ
ghmj-1231	109	14	aetiology	aetiology	NOUN
ghmj-1231	109	15	of	of	ADP
ghmj-1231	109	16	essential	essential	ADJ
ghmj-1231	109	17	hypertension	hypertension	NOUN
ghmj-1231	109	18	.	.	PUNCT
ghmj-1231	110	1	its	its	PRON
ghmj-1231	110	2	exact	exact	ADJ
ghmj-1231	110	3	mechanism	mechanism	NOUN
ghmj-1231	110	4	of	of	ADP
ghmj-1231	110	5	action	action	NOUN
ghmj-1231	110	6	is	be	AUX
ghmj-1231	110	7	still	still	ADV
ghmj-1231	110	8	unknown	unknown	ADJ
ghmj-1231	110	9	.	.	PUNCT
ghmj-1231	111	1	according	accord	VERB
ghmj-1231	111	2	to	to	ADP
ghmj-1231	111	3	studies	study	NOUN
ghmj-1231	111	4	,	,	PUNCT
ghmj-1231	111	5	the	the	DET
ghmj-1231	111	6	raas	raas	NOUN
ghmj-1231	111	7	is	be	AUX
ghmj-1231	111	8	crucial	crucial	ADJ
ghmj-1231	111	9	for	for	ADP
ghmj-1231	111	10	blood	blood	NOUN
ghmj-1231	111	11	pressure	pressure	NOUN
ghmj-1231	111	12	management	management	NOUN
ghmj-1231	111	13	,	,	PUNCT
ghmj-1231	111	14	maintaining	maintain	VERB
ghmj-1231	111	15	the	the	DET
ghmj-1231	111	16	proper	proper	ADJ
ghmj-1231	111	17	balance	balance	NOUN
ghmj-1231	111	18	of	of	ADP
ghmj-1231	111	19	water	water	NOUN
ghmj-1231	111	20	and	and	CCONJ
ghmj-1231	111	21	salt	salt	NOUN
ghmj-1231	111	22	in	in	ADP
ghmj-1231	111	23	the	the	DET
ghmj-1231	111	24	body	body	NOUN
ghmj-1231	111	25	,	,	PUNCT
ghmj-1231	111	26	and	and	CCONJ
ghmj-1231	111	27	modifying	modify	VERB
ghmj-1231	111	28	the	the	DET
ghmj-1231	111	29	tissues	tissue	NOUN
ghmj-1231	111	30	in	in	ADP
ghmj-1231	111	31	the	the	DET
ghmj-1231	111	32	cardiovascular	cardiovascular	ADJ
ghmj-1231	111	33	system	system	NOUN
ghmj-1231	111	34	(	(	PUNCT
ghmj-1231	111	35	y.	y.	PROPN
ghmj-1231	111	36	l.	l.	PROPN
ghmj-1231	111	37	yang	yang	PROPN
ghmj-1231	111	38	et	et	PROPN
ghmj-1231	111	39	al	al	PROPN
ghmj-1231	111	40	.	.	PROPN
ghmj-1231	111	41	,	,	PUNCT
ghmj-1231	111	42	2015	2015	NUM
ghmj-1231	111	43	)	)	PUNCT
ghmj-1231	111	44	.	.	PUNCT
ghmj-1231	112	1	the	the	DET
ghmj-1231	112	2	raas	raas	NOUN
ghmj-1231	112	3	system	system	NOUN
ghmj-1231	112	4	may	may	AUX
ghmj-1231	112	5	be	be	AUX
ghmj-1231	112	6	negatively	negatively	ADV
ghmj-1231	112	7	regulated	regulate	VERB
ghmj-1231	112	8	by	by	ADP
ghmj-1231	112	9	ace2	ace2	PROPN
ghmj-1231	112	10	(	(	PUNCT
ghmj-1231	112	11	zhang	zhang	PROPN
ghmj-1231	112	12	et	et	PROPN
ghmj-1231	112	13	al	al	PROPN
ghmj-1231	112	14	.	.	PROPN
ghmj-1231	112	15	,	,	PUNCT
ghmj-1231	112	16	2022	2022	NUM
ghmj-1231	112	17	)	)	PUNCT
ghmj-1231	112	18	.	.	PUNCT
ghmj-1231	113	1	the	the	DET
ghmj-1231	113	2	main	main	ADJ
ghmj-1231	113	3	part	part	NOUN
ghmj-1231	113	4	of	of	ADP
ghmj-1231	113	5	the	the	DET
ghmj-1231	113	6	ras	ras	PROPN
ghmj-1231	113	7	,	,	PUNCT
ghmj-1231	113	8	ang	ang	PROPN
ghmj-1231	113	9	ii	ii	PROPN
ghmj-1231	113	10	,	,	PUNCT
ghmj-1231	113	11	is	be	AUX
ghmj-1231	113	12	converted	convert	VERB
ghmj-1231	113	13	by	by	ADP
ghmj-1231	113	14	ace2	ace2	NOUN
ghmj-1231	113	15	into	into	ADP
ghmj-1231	113	16	ang	ang	PROPN
ghmj-1231	113	17	1	1	NUM
ghmj-1231	113	18	-	-	SYM
ghmj-1231	113	19	7	7	NUM
ghmj-1231	113	20	,	,	PUNCT
ghmj-1231	113	21	which	which	PRON
ghmj-1231	113	22	helps	help	VERB
ghmj-1231	113	23	widen	widen	VERB
ghmj-1231	113	24	blood	blood	NOUN
ghmj-1231	113	25	vessels	vessel	NOUN
ghmj-1231	113	26	,	,	PUNCT
ghmj-1231	113	27	and	and	CCONJ
ghmj-1231	113	28	it	it	PRON
ghmj-1231	113	29	also	also	ADV
ghmj-1231	113	30	changes	change	VERB
ghmj-1231	113	31	angiotensin	angiotensin	NOUN
ghmj-1231	113	32	i	i	PRON
ghmj-1231	113	33	(	(	PUNCT
ghmj-1231	113	34	ang	ang	INTJ
ghmj-1231	113	35	i	i	PROPN
ghmj-1231	113	36	)	)	PUNCT
ghmj-1231	113	37	into	into	ADP
ghmj-1231	113	38	ang	ang	PROPN
ghmj-1231	113	39	1	1	NUM
ghmj-1231	113	40	-	-	SYM
ghmj-1231	113	41	9	9	NUM
ghmj-1231	113	42	by	by	ADP
ghmj-1231	113	43	cutting	cut	VERB
ghmj-1231	113	44	off	off	ADP
ghmj-1231	113	45	one	one	NUM
ghmj-1231	113	46	piece	piece	NOUN
ghmj-1231	113	47	(	(	PUNCT
ghmj-1231	113	48	imai	imai	PROPN
ghmj-1231	113	49	,	,	PUNCT
ghmj-1231	113	50	kuba	kuba	PROPN
ghmj-1231	113	51	,	,	PUNCT
ghmj-1231	113	52	ohto	ohto	NOUN
ghmj-1231	113	53	-	-	PUNCT
ghmj-1231	113	54	nakanishi	nakanishi	ADJ
ghmj-1231	113	55	,	,	PUNCT
ghmj-1231	113	56	&	&	CCONJ
ghmj-1231	113	57	penninger	penninger	PROPN
ghmj-1231	113	58	,	,	PUNCT
ghmj-1231	113	59	2010	2010	NUM
ghmj-1231	113	60	)	)	PUNCT
ghmj-1231	113	61	.	.	PUNCT
ghmj-1231	114	1	husna	husna	PROPN
ghmj-1231	114	2	,	,	PUNCT
ghmj-1231	114	3	et	et	PROPN
ghmj-1231	114	4	.	.	PUNCT
ghmj-1231	115	1	al	al	PROPN
ghmj-1231	115	2	ghmj	ghmj	PROPN
ghmj-1231	115	3	(	(	PUNCT
ghmj-1231	115	4	global	global	ADJ
ghmj-1231	115	5	health	health	PROPN
ghmj-1231	115	6	management	management	NOUN
ghmj-1231	115	7	journal	journal	PROPN
ghmj-1231	115	8	)	)	PUNCT
ghmj-1231	115	9	2025	2025	NUM
ghmj-1231	115	10	,	,	PUNCT
ghmj-1231	115	11	vol	vol	NOUN
ghmj-1231	115	12	.	.	NOUN
ghmj-1231	115	13	8	8	NUM
ghmj-1231	115	14	,	,	PUNCT
ghmj-1231	115	15	no	no	INTJ
ghmj-1231	115	16	.	.	PUNCT
ghmj-1231	116	1	2s	2s	NOUN
ghmj-1231	116	2	290	290	NUM
ghmj-1231	116	3	in	in	ADP
ghmj-1231	116	4	this	this	DET
ghmj-1231	116	5	study	study	NOUN
ghmj-1231	116	6	,	,	PUNCT
ghmj-1231	116	7	the	the	DET
ghmj-1231	116	8	prevalence	prevalence	NOUN
ghmj-1231	116	9	of	of	ADP
ghmj-1231	116	10	the	the	DET
ghmj-1231	116	11	gg	gg	NOUN
ghmj-1231	116	12	genotype	genotype	NOUN
ghmj-1231	116	13	(	(	PUNCT
ghmj-1231	116	14	homozygous	homozygous	ADJ
ghmj-1231	116	15	wild	wild	ADJ
ghmj-1231	116	16	type	type	NOUN
ghmj-1231	116	17	)	)	PUNCT
ghmj-1231	116	18	was	be	AUX
ghmj-1231	116	19	higher	high	ADJ
ghmj-1231	116	20	in	in	ADP
ghmj-1231	116	21	the	the	DET
ghmj-1231	116	22	case	case	NOUN
ghmj-1231	116	23	group	group	NOUN
ghmj-1231	116	24	,	,	PUNCT
ghmj-1231	116	25	comprising	comprise	VERB
ghmj-1231	116	26	12	12	NUM
ghmj-1231	116	27	people	people	NOUN
ghmj-1231	116	28	(	(	PUNCT
ghmj-1231	116	29	40	40	NUM
ghmj-1231	116	30	%	%	NOUN
ghmj-1231	116	31	)	)	PUNCT
ghmj-1231	116	32	,	,	PUNCT
ghmj-1231	116	33	compared	compare	VERB
ghmj-1231	116	34	to	to	ADP
ghmj-1231	116	35	the	the	DET
ghmj-1231	116	36	control	control	NOUN
ghmj-1231	116	37	group	group	NOUN
ghmj-1231	116	38	,	,	PUNCT
ghmj-1231	116	39	which	which	PRON
ghmj-1231	116	40	had	have	VERB
ghmj-1231	116	41	10	10	NUM
ghmj-1231	116	42	subjects	subject	NOUN
ghmj-1231	116	43	(	(	PUNCT
ghmj-1231	116	44	33.3	33.3	NUM
ghmj-1231	116	45	%	%	NOUN
ghmj-1231	116	46	)	)	PUNCT
ghmj-1231	116	47	.	.	PUNCT
ghmj-1231	117	1	the	the	DET
ghmj-1231	117	2	occurrence	occurrence	NOUN
ghmj-1231	117	3	of	of	ADP
ghmj-1231	117	4	genotype	genotype	PROPN
ghmj-1231	117	5	ga	ga	PROPN
ghmj-1231	117	6	(	(	PUNCT
ghmj-1231	117	7	heterozygous	heterozygous	ADJ
ghmj-1231	117	8	mutant	mutant	NOUN
ghmj-1231	117	9	)	)	PUNCT
ghmj-1231	117	10	was	be	AUX
ghmj-1231	117	11	higher	high	ADJ
ghmj-1231	117	12	in	in	ADP
ghmj-1231	117	13	the	the	DET
ghmj-1231	117	14	case	case	NOUN
ghmj-1231	117	15	group	group	NOUN
ghmj-1231	117	16	,	,	PUNCT
ghmj-1231	117	17	with	with	ADP
ghmj-1231	117	18	9	9	NUM
ghmj-1231	117	19	cases	case	NOUN
ghmj-1231	117	20	(	(	PUNCT
ghmj-1231	117	21	30	30	NUM
ghmj-1231	117	22	%	%	NOUN
ghmj-1231	117	23	)	)	PUNCT
ghmj-1231	117	24	,	,	PUNCT
ghmj-1231	117	25	compared	compare	VERB
ghmj-1231	117	26	to	to	ADP
ghmj-1231	117	27	the	the	DET
ghmj-1231	117	28	control	control	NOUN
ghmj-1231	117	29	group	group	NOUN
ghmj-1231	117	30	,	,	PUNCT
ghmj-1231	117	31	which	which	PRON
ghmj-1231	117	32	had	have	VERB
ghmj-1231	117	33	6	6	NUM
ghmj-1231	117	34	subjects	subject	NOUN
ghmj-1231	117	35	(	(	PUNCT
ghmj-1231	117	36	10	10	NUM
ghmj-1231	117	37	%	%	NOUN
ghmj-1231	117	38	)	)	PUNCT
ghmj-1231	117	39	.	.	PUNCT
ghmj-1231	118	1	the	the	DET
ghmj-1231	118	2	prevalence	prevalence	NOUN
ghmj-1231	118	3	of	of	ADP
ghmj-1231	118	4	the	the	DET
ghmj-1231	118	5	aa	aa	NOUN
ghmj-1231	118	6	(	(	PUNCT
ghmj-1231	118	7	homozygous	homozygous	ADJ
ghmj-1231	118	8	mutant	mutant	NOUN
ghmj-1231	118	9	)	)	PUNCT
ghmj-1231	118	10	genotype	genotype	NOUN
ghmj-1231	118	11	was	be	AUX
ghmj-1231	118	12	higher	high	ADJ
ghmj-1231	118	13	in	in	ADP
ghmj-1231	118	14	the	the	DET
ghmj-1231	118	15	control	control	NOUN
ghmj-1231	118	16	group	group	NOUN
ghmj-1231	118	17	,	,	PUNCT
ghmj-1231	118	18	with	with	ADP
ghmj-1231	118	19	14	14	NUM
ghmj-1231	118	20	individuals	individual	NOUN
ghmj-1231	118	21	(	(	PUNCT
ghmj-1231	118	22	46.7	46.7	NUM
ghmj-1231	118	23	%	%	NOUN
ghmj-1231	118	24	)	)	PUNCT
ghmj-1231	118	25	,	,	PUNCT
ghmj-1231	118	26	compared	compare	VERB
ghmj-1231	118	27	to	to	ADP
ghmj-1231	118	28	the	the	DET
ghmj-1231	118	29	case	case	NOUN
ghmj-1231	118	30	group	group	NOUN
ghmj-1231	118	31	,	,	PUNCT
ghmj-1231	118	32	which	which	PRON
ghmj-1231	118	33	had	have	VERB
ghmj-1231	118	34	9	9	NUM
ghmj-1231	118	35	individuals	individual	NOUN
ghmj-1231	118	36	(	(	PUNCT
ghmj-1231	118	37	30	30	NUM
ghmj-1231	118	38	%	%	NOUN
ghmj-1231	118	39	)	)	PUNCT
ghmj-1231	118	40	.	.	PUNCT
ghmj-1231	119	1	the	the	DET
ghmj-1231	119	2	analysis	analysis	NOUN
ghmj-1231	119	3	yielded	yield	VERB
ghmj-1231	119	4	an	an	DET
ghmj-1231	119	5	odds	odd	NOUN
ghmj-1231	119	6	ratio	ratio	NOUN
ghmj-1231	119	7	of	of	ADP
ghmj-1231	119	8	0.750	0.750	NUM
ghmj-1231	119	9	and	and	CCONJ
ghmj-1231	119	10	a	a	DET
ghmj-1231	119	11	confidence	confidence	NOUN
ghmj-1231	119	12	interval	interval	NOUN
ghmj-1231	119	13	of	of	ADP
ghmj-1231	119	14	0.262	0.262	NUM
ghmj-1231	119	15	-	-	SYM
ghmj-1231	119	16	2.151	2.151	NUM
ghmj-1231	119	17	,	,	PUNCT
ghmj-1231	119	18	with	with	ADP
ghmj-1231	119	19	a	a	DET
ghmj-1231	119	20	p	p	NOUN
ghmj-1231	119	21	-	-	PUNCT
ghmj-1231	119	22	value	value	NOUN
ghmj-1231	119	23	of	of	ADP
ghmj-1231	119	24	0.592	0.592	NUM
ghmj-1231	119	25	(	(	PUNCT
ghmj-1231	119	26	p>0.05	p>0.05	PROPN
ghmj-1231	119	27	)	)	PUNCT
ghmj-1231	119	28	.	.	PUNCT
ghmj-1231	120	1	this	this	DET
ghmj-1231	120	2	result	result	NOUN
ghmj-1231	120	3	is	be	AUX
ghmj-1231	120	4	not	not	PART
ghmj-1231	120	5	consistent	consistent	ADJ
ghmj-1231	120	6	with	with	ADP
ghmj-1231	120	7	the	the	DET
ghmj-1231	120	8	previous	previous	ADJ
ghmj-1231	120	9	study	study	NOUN
ghmj-1231	120	10	conducted	conduct	VERB
ghmj-1231	120	11	in	in	ADP
ghmj-1231	120	12	dongxiang	dongxiang	NOUN
ghmj-1231	120	13	,	,	PUNCT
ghmj-1231	120	14	china	china	PROPN
ghmj-1231	120	15	,	,	PUNCT
ghmj-1231	120	16	which	which	PRON
ghmj-1231	120	17	found	find	VERB
ghmj-1231	120	18	that	that	SCONJ
ghmj-1231	120	19	the	the	DET
ghmj-1231	120	20	frequency	frequency	NOUN
ghmj-1231	120	21	of	of	ADP
ghmj-1231	120	22	the	the	DET
ghmj-1231	120	23	ace2	ace2	PROPN
ghmj-1231	120	24	allele	allele	PROPN
ghmj-1231	120	25	8790a	8790a	NOUN
ghmj-1231	120	26	was	be	AUX
ghmj-1231	120	27	considerably	considerably	ADV
ghmj-1231	120	28	greater	great	ADJ
ghmj-1231	120	29	in	in	ADP
ghmj-1231	120	30	essential	essential	ADJ
ghmj-1231	120	31	hypertension	hypertension	NOUN
ghmj-1231	120	32	patients	patient	NOUN
ghmj-1231	120	33	than	than	ADP
ghmj-1231	120	34	in	in	ADP
ghmj-1231	120	35	controls	control	NOUN
ghmj-1231	120	36	(	(	PUNCT
ghmj-1231	120	37	p<0.0001	p<0.0001	NOUN
ghmj-1231	120	38	)	)	PUNCT
ghmj-1231	120	39	(	(	PUNCT
ghmj-1231	120	40	yi	yi	NOUN
ghmj-1231	120	41	et	et	PROPN
ghmj-1231	120	42	al	al	PROPN
ghmj-1231	120	43	.	.	PROPN
ghmj-1231	120	44	,	,	PUNCT
ghmj-1231	120	45	2006	2006	NUM
ghmj-1231	120	46	)	)	PUNCT
ghmj-1231	120	47	.	.	PUNCT
ghmj-1231	121	1	the	the	DET
ghmj-1231	121	2	study	study	NOUN
ghmj-1231	121	3	's	's	PART
ghmj-1231	121	4	findings	finding	NOUN
ghmj-1231	121	5	are	be	AUX
ghmj-1231	121	6	in	in	ADP
ghmj-1231	121	7	line	line	NOUN
ghmj-1231	121	8	with	with	ADP
ghmj-1231	121	9	earlier	early	ADJ
ghmj-1231	121	10	research	research	NOUN
ghmj-1231	121	11	in	in	ADP
ghmj-1231	121	12	anglo	anglo	ADJ
ghmj-1231	121	13	-	-	PUNCT
ghmj-1231	121	14	celtic	celtic	ADJ
ghmj-1231	121	15	australian	australian	ADJ
ghmj-1231	121	16	subjects	subject	NOUN
ghmj-1231	121	17	with	with	ADP
ghmj-1231	121	18	hypertension	hypertension	NOUN
ghmj-1231	121	19	(	(	PUNCT
ghmj-1231	121	20	n=152	n=152	PROPN
ghmj-1231	121	21	)	)	PUNCT
ghmj-1231	121	22	and	and	CCONJ
ghmj-1231	121	23	normotension	normotension	NOUN
ghmj-1231	121	24	(	(	PUNCT
ghmj-1231	121	25	n=193	n=193	NUM
ghmj-1231	121	26	)	)	PUNCT
ghmj-1231	121	27	,	,	PUNCT
ghmj-1231	121	28	who	who	PRON
ghmj-1231	121	29	reported	report	VERB
ghmj-1231	121	30	that	that	SCONJ
ghmj-1231	121	31	snp	snp	ADJ
ghmj-1231	121	32	rs2285666	rs2285666	NOUN
ghmj-1231	121	33	was	be	AUX
ghmj-1231	121	34	not	not	PART
ghmj-1231	121	35	associated	associate	VERB
ghmj-1231	121	36	with	with	ADP
ghmj-1231	121	37	hypertension	hypertension	NOUN
ghmj-1231	121	38	(	(	PUNCT
ghmj-1231	121	39	benjafield	benjafield	PROPN
ghmj-1231	121	40	,	,	PUNCT
ghmj-1231	121	41	wang	wang	PROPN
ghmj-1231	121	42	,	,	PUNCT
ghmj-1231	121	43	&	&	CCONJ
ghmj-1231	121	44	morris	morris	PROPN
ghmj-1231	121	45	,	,	PUNCT
ghmj-1231	121	46	2004	2004	NUM
ghmj-1231	121	47	)	)	PUNCT
ghmj-1231	121	48	.	.	PUNCT
ghmj-1231	122	1	another	another	DET
ghmj-1231	122	2	research	research	NOUN
ghmj-1231	122	3	study	study	NOUN
ghmj-1231	122	4	in	in	ADP
ghmj-1231	122	5	xinyang	xinyang	PROPN
ghmj-1231	122	6	county	county	PROPN
ghmj-1231	122	7	,	,	PUNCT
ghmj-1231	122	8	china	china	PROPN
ghmj-1231	122	9	,	,	PUNCT
ghmj-1231	122	10	provides	provide	VERB
ghmj-1231	122	11	no	no	DET
ghmj-1231	122	12	evidence	evidence	NOUN
ghmj-1231	122	13	that	that	SCONJ
ghmj-1231	122	14	ace2	ace2	PROPN
ghmj-1231	122	15	g8790a	g8790a	PROPN
ghmj-1231	122	16	is	be	AUX
ghmj-1231	122	17	involved	involve	VERB
ghmj-1231	122	18	in	in	ADP
ghmj-1231	122	19	a	a	DET
ghmj-1231	122	20	hereditary	hereditary	ADJ
ghmj-1231	122	21	susceptibility	susceptibility	NOUN
ghmj-1231	122	22	to	to	ADP
ghmj-1231	122	23	orthostatic	orthostatic	ADJ
ghmj-1231	122	24	hypotension	hypotension	NOUN
ghmj-1231	122	25	or	or	CCONJ
ghmj-1231	122	26	hypertension	hypertension	NOUN
ghmj-1231	122	27	(	(	PUNCT
ghmj-1231	122	28	fan	fan	NOUN
ghmj-1231	122	29	et	et	PROPN
ghmj-1231	122	30	al	al	PROPN
ghmj-1231	122	31	.	.	PROPN
ghmj-1231	122	32	,	,	PUNCT
ghmj-1231	122	33	2009	2009	NUM
ghmj-1231	122	34	)	)	PUNCT
ghmj-1231	122	35	.	.	PUNCT
ghmj-1231	123	1	this	this	DET
ghmj-1231	123	2	study	study	NOUN
ghmj-1231	123	3	’s	’s	PART
ghmj-1231	123	4	outcome	outcome	NOUN
ghmj-1231	123	5	also	also	ADV
ghmj-1231	123	6	agrees	agree	VERB
ghmj-1231	123	7	with	with	ADP
ghmj-1231	123	8	the	the	DET
ghmj-1231	123	9	current	current	ADJ
ghmj-1231	123	10	meta	meta	ADJ
ghmj-1231	123	11	-	-	PUNCT
ghmj-1231	123	12	analysis	analysis	NOUN
ghmj-1231	123	13	,	,	PUNCT
ghmj-1231	123	14	which	which	PRON
ghmj-1231	123	15	suggests	suggest	VERB
ghmj-1231	123	16	there	there	PRON
ghmj-1231	123	17	may	may	AUX
ghmj-1231	123	18	be	be	AUX
ghmj-1231	123	19	no	no	DET
ghmj-1231	123	20	connection	connection	NOUN
ghmj-1231	123	21	between	between	ADP
ghmj-1231	123	22	the	the	DET
ghmj-1231	123	23	ace2	ace2	PROPN
ghmj-1231	123	24	g8790a	g8790a	PROPN
ghmj-1231	123	25	gene	gene	NOUN
ghmj-1231	123	26	polymorphism	polymorphism	NOUN
ghmj-1231	123	27	and	and	CCONJ
ghmj-1231	123	28	the	the	DET
ghmj-1231	123	29	higher	high	ADJ
ghmj-1231	123	30	risk	risk	NOUN
ghmj-1231	123	31	of	of	ADP
ghmj-1231	123	32	essential	essential	ADJ
ghmj-1231	123	33	hypertension	hypertension	NOUN
ghmj-1231	123	34	in	in	ADP
ghmj-1231	123	35	the	the	DET
ghmj-1231	123	36	chinese	chinese	ADJ
ghmj-1231	123	37	population	population	NOUN
ghmj-1231	123	38	(	(	PUNCT
ghmj-1231	123	39	pan	pan	NOUN
ghmj-1231	123	40	,	,	PUNCT
ghmj-1231	123	41	2023	2023	NUM
ghmj-1231	123	42	)	)	PUNCT
ghmj-1231	123	43	.	.	PUNCT
ghmj-1231	124	1	the	the	DET
ghmj-1231	124	2	response	response	NOUN
ghmj-1231	124	3	to	to	ADP
ghmj-1231	124	4	essential	essential	ADJ
ghmj-1231	124	5	hypertension	hypertension	NOUN
ghmj-1231	124	6	appeared	appear	VERB
ghmj-1231	124	7	unaffected	unaffected	ADJ
ghmj-1231	124	8	by	by	ADP
ghmj-1231	124	9	the	the	DET
ghmj-1231	124	10	genetic	genetic	ADJ
ghmj-1231	124	11	polymorphism	polymorphism	NOUN
ghmj-1231	124	12	of	of	ADP
ghmj-1231	124	13	ras	ras	PROPN
ghmj-1231	124	14	in	in	ADP
ghmj-1231	124	15	our	our	PRON
ghmj-1231	124	16	study	study	NOUN
ghmj-1231	124	17	.	.	PUNCT
ghmj-1231	125	1	the	the	DET
ghmj-1231	125	2	function	function	NOUN
ghmj-1231	125	3	of	of	ADP
ghmj-1231	125	4	ras	ras	X
ghmj-1231	125	5	in	in	ADP
ghmj-1231	125	6	physiological	physiological	ADJ
ghmj-1231	125	7	processes	process	NOUN
ghmj-1231	125	8	explains	explain	VERB
ghmj-1231	125	9	our	our	PRON
ghmj-1231	125	10	findings	finding	NOUN
ghmj-1231	125	11	.	.	PUNCT
ghmj-1231	126	1	essential	essential	ADJ
ghmj-1231	126	2	hypertension	hypertension	NOUN
ghmj-1231	126	3	is	be	AUX
ghmj-1231	126	4	predominantly	predominantly	ADV
ghmj-1231	126	5	attributed	attribute	VERB
ghmj-1231	126	6	to	to	ADP
ghmj-1231	126	7	four	four	NUM
ghmj-1231	126	8	factors	factor	NOUN
ghmj-1231	126	9	:	:	PUNCT
ghmj-1231	126	10	intravascular	intravascular	ADJ
ghmj-1231	126	11	volume	volume	NOUN
ghmj-1231	126	12	,	,	PUNCT
ghmj-1231	126	13	autonomic	autonomic	ADJ
ghmj-1231	126	14	nerve	nerve	NOUN
ghmj-1231	126	15	stimulation	stimulation	NOUN
ghmj-1231	126	16	,	,	PUNCT
ghmj-1231	126	17	the	the	DET
ghmj-1231	126	18	reninangiotensin	reninangiotensin	NOUN
ghmj-1231	126	19	system	system	NOUN
ghmj-1231	126	20	(	(	PUNCT
ghmj-1231	126	21	ras	ras	NOUN
ghmj-1231	126	22	)	)	PUNCT
ghmj-1231	126	23	,	,	PUNCT
ghmj-1231	126	24	and	and	CCONJ
ghmj-1231	126	25	the	the	DET
ghmj-1231	126	26	integrity	integrity	NOUN
ghmj-1231	126	27	of	of	ADP
ghmj-1231	126	28	blood	blood	NOUN
ghmj-1231	126	29	vessel	vessel	NOUN
ghmj-1231	126	30	walls	wall	NOUN
ghmj-1231	126	31	.	.	PUNCT
ghmj-1231	127	1	the	the	DET
ghmj-1231	127	2	underlying	underlie	VERB
ghmj-1231	127	3	causative	causative	ADJ
ghmj-1231	127	4	changes	change	NOUN
ghmj-1231	127	5	may	may	AUX
ghmj-1231	127	6	not	not	PART
ghmj-1231	127	7	be	be	AUX
ghmj-1231	127	8	associated	associate	VERB
ghmj-1231	127	9	with	with	ADP
ghmj-1231	127	10	ras	ras	PROPN
ghmj-1231	127	11	(	(	PUNCT
ghmj-1231	127	12	sherwood	sherwood	PROPN
ghmj-1231	127	13	,	,	PUNCT
ghmj-1231	127	14	2016	2016	NUM
ghmj-1231	127	15	)	)	PUNCT
ghmj-1231	127	16	.	.	PUNCT
ghmj-1231	128	1	genetic	genetic	ADJ
ghmj-1231	128	2	influences	influence	NOUN
ghmj-1231	128	3	on	on	ADP
ghmj-1231	128	4	complex	complex	ADJ
ghmj-1231	128	5	traits	trait	NOUN
ghmj-1231	128	6	in	in	ADP
ghmj-1231	128	7	indonesia	indonesia	PROPN
ghmj-1231	128	8	may	may	AUX
ghmj-1231	128	9	be	be	AUX
ghmj-1231	128	10	limited	limit	VERB
ghmj-1231	128	11	or	or	CCONJ
ghmj-1231	128	12	dependent	dependent	ADJ
ghmj-1231	128	13	on	on	ADP
ghmj-1231	128	14	context	context	NOUN
ghmj-1231	128	15	,	,	PUNCT
ghmj-1231	128	16	varying	vary	VERB
ghmj-1231	128	17	among	among	ADP
ghmj-1231	128	18	loci	locus	NOUN
ghmj-1231	128	19	,	,	PUNCT
ghmj-1231	128	20	populations	population	NOUN
ghmj-1231	128	21	,	,	PUNCT
ghmj-1231	128	22	and	and	CCONJ
ghmj-1231	128	23	environmental	environmental	ADJ
ghmj-1231	128	24	conditions	condition	NOUN
ghmj-1231	128	25	.	.	PUNCT
ghmj-1231	129	1	this	this	DET
ghmj-1231	129	2	research	research	NOUN
ghmj-1231	129	3	corresponds	correspond	VERB
ghmj-1231	129	4	with	with	ADP
ghmj-1231	129	5	earlier	early	ADJ
ghmj-1231	129	6	indonesian	indonesian	ADJ
ghmj-1231	129	7	investigations	investigation	NOUN
ghmj-1231	129	8	about	about	ADP
ghmj-1231	129	9	gene	gene	NOUN
ghmj-1231	129	10	-	-	PUNCT
ghmj-1231	129	11	disease	disease	NOUN
ghmj-1231	129	12	correlations	correlation	NOUN
ghmj-1231	129	13	,	,	PUNCT
ghmj-1231	129	14	including	include	VERB
ghmj-1231	129	15	the	the	DET
ghmj-1231	129	16	rs9939609	rs9939609	NOUN
ghmj-1231	129	17	fto	fto	VERB
ghmj-1231	129	18	gene	gene	NOUN
ghmj-1231	129	19	polymorphism	polymorphism	NOUN
ghmj-1231	129	20	associated	associate	VERB
ghmj-1231	129	21	with	with	ADP
ghmj-1231	129	22	obesity	obesity	NOUN
ghmj-1231	129	23	in	in	ADP
ghmj-1231	129	24	cirebon	cirebon	NOUN
ghmj-1231	129	25	(	(	PUNCT
ghmj-1231	129	26	pratamawati	pratamawati	PROPN
ghmj-1231	129	27	et	et	PROPN
ghmj-1231	129	28	al	al	PROPN
ghmj-1231	129	29	.	.	PROPN
ghmj-1231	129	30	,	,	PUNCT
ghmj-1231	129	31	2024	2024	NUM
ghmj-1231	129	32	)	)	PUNCT
ghmj-1231	129	33	and	and	CCONJ
ghmj-1231	129	34	the	the	DET
ghmj-1231	129	35	ace	ace	NOUN
ghmj-1231	129	36	i	i	PROPN
ghmj-1231	129	37	/	/	SYM
ghmj-1231	129	38	d	d	PROPN
ghmj-1231	129	39	polymorphism	polymorphism	NOUN
ghmj-1231	129	40	related	relate	VERB
ghmj-1231	129	41	to	to	ADP
ghmj-1231	129	42	essential	essential	ADJ
ghmj-1231	129	43	hypertension	hypertension	NOUN
ghmj-1231	129	44	in	in	ADP
ghmj-1231	129	45	cirebon	cirebon	NOUN
ghmj-1231	129	46	(	(	PUNCT
ghmj-1231	129	47	kuswara	kuswara	PROPN
ghmj-1231	129	48	et	et	PROPN
ghmj-1231	129	49	al	al	PROPN
ghmj-1231	129	50	.	.	PROPN
ghmj-1231	129	51	,	,	PUNCT
ghmj-1231	129	52	2024	2024	NUM
ghmj-1231	129	53	)	)	PUNCT
ghmj-1231	129	54	.	.	PUNCT
ghmj-1231	130	1	both	both	DET
ghmj-1231	130	2	studies	study	NOUN
ghmj-1231	130	3	employ	employ	VERB
ghmj-1231	130	4	identical	identical	ADJ
ghmj-1231	130	5	geographic	geographic	ADJ
ghmj-1231	130	6	and	and	CCONJ
ghmj-1231	130	7	demographic	demographic	ADJ
ghmj-1231	130	8	contexts	context	NOUN
ghmj-1231	130	9	in	in	ADP
ghmj-1231	130	10	cirebon	cirebon	NOUN
ghmj-1231	130	11	.	.	PUNCT
ghmj-1231	131	1	this	this	DET
ghmj-1231	131	2	study	study	NOUN
ghmj-1231	131	3	also	also	ADV
ghmj-1231	131	4	indicated	indicate	VERB
ghmj-1231	131	5	a	a	DET
ghmj-1231	131	6	non	non	ADJ
ghmj-1231	131	7	-	-	ADJ
ghmj-1231	131	8	significant	significant	ADJ
ghmj-1231	131	9	or	or	CCONJ
ghmj-1231	131	10	context	context	NOUN
ghmj-1231	131	11	-	-	PUNCT
ghmj-1231	131	12	dependent	dependent	ADJ
ghmj-1231	131	13	relationship	relationship	NOUN
ghmj-1231	131	14	between	between	ADP
ghmj-1231	131	15	gene	gene	NOUN
ghmj-1231	131	16	polymorphisms	polymorphism	NOUN
ghmj-1231	131	17	and	and	CCONJ
ghmj-1231	131	18	the	the	DET
ghmj-1231	131	19	complex	complex	ADJ
ghmj-1231	131	20	diseases	disease	NOUN
ghmj-1231	131	21	analyzed	analyze	VERB
ghmj-1231	131	22	in	in	ADP
ghmj-1231	131	23	the	the	DET
ghmj-1231	131	24	cirebon	cirebon	NOUN
ghmj-1231	131	25	population	population	NOUN
ghmj-1231	131	26	of	of	ADP
ghmj-1231	131	27	west	west	PROPN
ghmj-1231	131	28	java	java	PROPN
ghmj-1231	131	29	.	.	PUNCT
ghmj-1231	132	1	the	the	DET
ghmj-1231	132	2	ace2	ace2	PROPN
ghmj-1231	132	3	gene	gene	NOUN
ghmj-1231	132	4	at	at	ADP
ghmj-1231	132	5	snp	snp	ADJ
ghmj-1231	132	6	rs2285666	rs2285666	PROPN
ghmj-1231	132	7	exhibits	exhibit	VERB
ghmj-1231	132	8	variations	variation	NOUN
ghmj-1231	132	9	between	between	ADP
ghmj-1231	132	10	ethnicities	ethnicity	NOUN
ghmj-1231	132	11	,	,	PUNCT
ghmj-1231	132	12	distinguished	distinguish	VERB
ghmj-1231	132	13	by	by	ADP
ghmj-1231	132	14	the	the	DET
ghmj-1231	132	15	presence	presence	NOUN
ghmj-1231	132	16	of	of	ADP
ghmj-1231	132	17	minor	minor	ADJ
ghmj-1231	132	18	allele	allele	NOUN
ghmj-1231	132	19	frequency	frequency	NOUN
ghmj-1231	132	20	(	(	PUNCT
ghmj-1231	132	21	maf	maf	PROPN
ghmj-1231	132	22	)	)	PUNCT
ghmj-1231	132	23	.	.	PUNCT
ghmj-1231	133	1	maf	maf	PROPN
ghmj-1231	133	2	denotes	denote	VERB
ghmj-1231	133	3	the	the	DET
ghmj-1231	133	4	frequency	frequency	NOUN
ghmj-1231	133	5	of	of	ADP
ghmj-1231	133	6	less	less	ADV
ghmj-1231	133	7	common	common	ADJ
ghmj-1231	133	8	alleles	allele	NOUN
ghmj-1231	133	9	and	and	CCONJ
ghmj-1231	133	10	may	may	AUX
ghmj-1231	133	11	fluctuate	fluctuate	VERB
ghmj-1231	133	12	within	within	ADP
ghmj-1231	133	13	a	a	DET
ghmj-1231	133	14	population	population	NOUN
ghmj-1231	133	15	and	and	CCONJ
ghmj-1231	133	16	between	between	ADP
ghmj-1231	133	17	different	different	ADJ
ghmj-1231	133	18	ethnic	ethnic	ADJ
ghmj-1231	133	19	groups	group	NOUN
ghmj-1231	133	20	.	.	PUNCT
ghmj-1231	134	1	in	in	ADP
ghmj-1231	134	2	population	population	NOUN
ghmj-1231	134	3	genetics	genetic	NOUN
ghmj-1231	134	4	,	,	PUNCT
ghmj-1231	134	5	maf	maf	PROPN
ghmj-1231	134	6	denotes	denote	VERB
ghmj-1231	134	7	the	the	DET
ghmj-1231	134	8	extent	extent	NOUN
ghmj-1231	134	9	of	of	ADP
ghmj-1231	134	10	genetic	genetic	ADJ
ghmj-1231	134	11	variation	variation	NOUN
ghmj-1231	134	12	within	within	ADP
ghmj-1231	134	13	an	an	DET
ghmj-1231	134	14	individual	individual	ADJ
ghmj-1231	134	15	,	,	PUNCT
ghmj-1231	134	16	population	population	NOUN
ghmj-1231	134	17	,	,	PUNCT
ghmj-1231	134	18	and	and	CCONJ
ghmj-1231	134	19	species	specie	NOUN
ghmj-1231	134	20	.	.	PUNCT
ghmj-1231	135	1	in	in	ADP
ghmj-1231	135	2	this	this	DET
ghmj-1231	135	3	study	study	NOUN
ghmj-1231	135	4	,	,	PUNCT
ghmj-1231	135	5	the	the	DET
ghmj-1231	135	6	frequency	frequency	NOUN
ghmj-1231	135	7	of	of	ADP
ghmj-1231	135	8	the	the	DET
ghmj-1231	135	9	g	g	PROPN
ghmj-1231	135	10	allele	allele	NOUN
ghmj-1231	135	11	was	be	AUX
ghmj-1231	135	12	0.49	0.49	NUM
ghmj-1231	135	13	,	,	PUNCT
ghmj-1231	135	14	while	while	SCONJ
ghmj-1231	135	15	the	the	DET
ghmj-1231	135	16	frequency	frequency	NOUN
ghmj-1231	135	17	of	of	ADP
ghmj-1231	135	18	the	the	DET
ghmj-1231	135	19	a	a	DET
ghmj-1231	135	20	allele	allele	NOUN
ghmj-1231	135	21	was	be	AUX
ghmj-1231	135	22	0.51	0.51	NUM
ghmj-1231	135	23	.	.	PUNCT
ghmj-1231	136	1	according	accord	VERB
ghmj-1231	136	2	to	to	ADP
ghmj-1231	136	3	maf	maf	PROPN
ghmj-1231	136	4	data	datum	NOUN
ghmj-1231	136	5	from	from	ADP
ghmj-1231	136	6	dbsnp	dbsnp	ADJ
ghmj-1231	136	7	ncbi	ncbi	PROPN
ghmj-1231	136	8	,	,	PUNCT
ghmj-1231	136	9	the	the	DET
ghmj-1231	136	10	japanese	japanese	ADJ
ghmj-1231	136	11	population	population	NOUN
ghmj-1231	136	12	exhibited	exhibit	VERB
ghmj-1231	136	13	a	a	DET
ghmj-1231	136	14	g	g	NOUN
ghmj-1231	136	15	allele	allele	NOUN
ghmj-1231	136	16	frequency	frequency	NOUN
ghmj-1231	136	17	of	of	ADP
ghmj-1231	136	18	0.50	0.50	NUM
ghmj-1231	136	19	and	and	CCONJ
ghmj-1231	136	20	an	an	DET
ghmj-1231	136	21	a	a	DET
ghmj-1231	136	22	allele	allele	NOUN
ghmj-1231	136	23	frequency	frequency	NOUN
ghmj-1231	136	24	of	of	ADP
ghmj-1231	136	25	0.50	0.50	NUM
ghmj-1231	136	26	.	.	PUNCT
ghmj-1231	137	1	in	in	ADP
ghmj-1231	137	2	the	the	DET
ghmj-1231	137	3	vietnamese	vietnamese	ADJ
ghmj-1231	137	4	population	population	NOUN
ghmj-1231	137	5	,	,	PUNCT
ghmj-1231	137	6	the	the	DET
ghmj-1231	137	7	frequency	frequency	NOUN
ghmj-1231	137	8	of	of	ADP
ghmj-1231	137	9	the	the	DET
ghmj-1231	137	10	g	g	PROPN
ghmj-1231	137	11	allele	allele	NOUN
ghmj-1231	137	12	is	be	AUX
ghmj-1231	137	13	0.51	0.51	NUM
ghmj-1231	137	14	,	,	PUNCT
ghmj-1231	137	15	while	while	SCONJ
ghmj-1231	137	16	that	that	PRON
ghmj-1231	137	17	of	of	ADP
ghmj-1231	137	18	the	the	DET
ghmj-1231	137	19	a	a	DET
ghmj-1231	137	20	allele	allele	NOUN
ghmj-1231	137	21	is	be	AUX
ghmj-1231	137	22	0.49	0.49	NUM
ghmj-1231	137	23	.	.	PUNCT
ghmj-1231	138	1	in	in	ADP
ghmj-1231	138	2	the	the	DET
ghmj-1231	138	3	korean	korean	ADJ
ghmj-1231	138	4	population	population	NOUN
ghmj-1231	138	5	,	,	PUNCT
ghmj-1231	138	6	the	the	DET
ghmj-1231	138	7	frequencies	frequency	NOUN
ghmj-1231	138	8	of	of	ADP
ghmj-1231	138	9	the	the	DET
ghmj-1231	138	10	g	g	NOUN
ghmj-1231	138	11	and	and	CCONJ
ghmj-1231	138	12	a	a	DET
ghmj-1231	138	13	alleles	allele	NOUN
ghmj-1231	138	14	are	be	AUX
ghmj-1231	138	15	0.48	0.48	NUM
ghmj-1231	138	16	and	and	CCONJ
ghmj-1231	138	17	0.52	0.52	NUM
ghmj-1231	138	18	,	,	PUNCT
ghmj-1231	138	19	respectively	respectively	ADV
ghmj-1231	138	20	.	.	PUNCT
ghmj-1231	139	1	this	this	DET
ghmj-1231	139	2	research	research	NOUN
ghmj-1231	139	3	suggests	suggest	VERB
ghmj-1231	139	4	that	that	SCONJ
ghmj-1231	139	5	the	the	DET
ghmj-1231	139	6	minor	minor	ADJ
ghmj-1231	139	7	allele	allele	NOUN
ghmj-1231	139	8	frequency	frequency	NOUN
ghmj-1231	139	9	distribution	distribution	NOUN
ghmj-1231	139	10	in	in	ADP
ghmj-1231	139	11	the	the	DET
ghmj-1231	139	12	indonesian	indonesian	ADJ
ghmj-1231	139	13	population	population	NOUN
ghmj-1231	139	14	closely	closely	ADV
ghmj-1231	139	15	resembles	resemble	VERB
ghmj-1231	139	16	those	those	PRON
ghmj-1231	139	17	of	of	ADP
ghmj-1231	139	18	other	other	ADJ
ghmj-1231	139	19	asian	asian	ADJ
ghmj-1231	139	20	groups	group	NOUN
ghmj-1231	139	21	,	,	PUNCT
ghmj-1231	139	22	including	include	VERB
ghmj-1231	139	23	japan	japan	PROPN
ghmj-1231	139	24	,	,	PUNCT
ghmj-1231	139	25	vietnam	vietnam	PROPN
ghmj-1231	139	26	,	,	PUNCT
ghmj-1231	139	27	and	and	CCONJ
ghmj-1231	139	28	korea	korea	PROPN
ghmj-1231	139	29	.	.	PUNCT
ghmj-1231	140	1	limitations	limitation	NOUN
ghmj-1231	140	2	should	should	AUX
ghmj-1231	140	3	be	be	AUX
ghmj-1231	140	4	noted	note	VERB
ghmj-1231	140	5	.	.	PUNCT
ghmj-1231	141	1	the	the	DET
ghmj-1231	141	2	study	study	NOUN
ghmj-1231	141	3	's	's	PART
ghmj-1231	141	4	sample	sample	NOUN
ghmj-1231	141	5	size	size	NOUN
ghmj-1231	141	6	is	be	AUX
ghmj-1231	141	7	insufficiently	insufficiently	ADV
ghmj-1231	141	8	large	large	ADJ
ghmj-1231	141	9	.	.	PUNCT
ghmj-1231	142	1	to	to	PART
ghmj-1231	142	2	assess	assess	VERB
ghmj-1231	142	3	the	the	DET
ghmj-1231	142	4	genetic	genetic	ADJ
ghmj-1231	142	5	basis	basis	NOUN
ghmj-1231	142	6	of	of	ADP
ghmj-1231	142	7	essential	essential	ADJ
ghmj-1231	142	8	hypertension	hypertension	NOUN
ghmj-1231	142	9	dysregulation	dysregulation	NOUN
ghmj-1231	142	10	,	,	PUNCT
ghmj-1231	142	11	more	more	ADJ
ghmj-1231	142	12	research	research	NOUN
ghmj-1231	142	13	is	be	AUX
ghmj-1231	142	14	needed	need	VERB
ghmj-1231	142	15	to	to	PART
ghmj-1231	142	16	investigate	investigate	VERB
ghmj-1231	142	17	polymorphisms	polymorphism	NOUN
ghmj-1231	142	18	in	in	ADP
ghmj-1231	142	19	other	other	ADJ
ghmj-1231	142	20	gene	gene	NOUN
ghmj-1231	142	21	loci	locus	NOUN
ghmj-1231	142	22	that	that	PRON
ghmj-1231	142	23	encode	encode	VERB
ghmj-1231	142	24	pathways	pathway	NOUN
ghmj-1231	142	25	related	relate	VERB
ghmj-1231	142	26	to	to	ADP
ghmj-1231	142	27	the	the	DET
ghmj-1231	142	28	sympathetic	sympathetic	ADJ
ghmj-1231	142	29	nervous	nervous	ADJ
ghmj-1231	142	30	system	system	NOUN
ghmj-1231	142	31	,	,	PUNCT
ghmj-1231	142	32	ras	ras	NOUN
ghmj-1231	142	33	,	,	PUNCT
ghmj-1231	142	34	vascular	vascular	ADJ
ghmj-1231	142	35	system	system	NOUN
ghmj-1231	142	36	,	,	PUNCT
ghmj-1231	142	37	or	or	CCONJ
ghmj-1231	142	38	kidney	kidney	NOUN
ghmj-1231	142	39	system	system	NOUN
ghmj-1231	142	40	.	.	PUNCT
ghmj-1231	143	1	the	the	DET
ghmj-1231	143	2	researchers	researcher	NOUN
ghmj-1231	143	3	were	be	AUX
ghmj-1231	143	4	unable	unable	ADJ
ghmj-1231	143	5	to	to	PART
ghmj-1231	143	6	assess	assess	VERB
ghmj-1231	143	7	the	the	DET
ghmj-1231	143	8	hardy	hardy	ADJ
ghmj-1231	143	9	-	-	PUNCT
ghmj-1231	143	10	weinberg	weinberg	NOUN
ghmj-1231	143	11	equilibrium	equilibrium	NOUN
ghmj-1231	143	12	in	in	ADP
ghmj-1231	143	13	the	the	DET
ghmj-1231	143	14	control	control	NOUN
ghmj-1231	143	15	group	group	NOUN
ghmj-1231	143	16	due	due	ADP
ghmj-1231	143	17	to	to	ADP
ghmj-1231	143	18	inadequate	inadequate	ADJ
ghmj-1231	143	19	sample	sample	NOUN
ghmj-1231	143	20	size	size	NOUN
ghmj-1231	143	21	.	.	PUNCT
ghmj-1231	144	1	sex	sex	NOUN
ghmj-1231	144	2	-	-	PUNCT
ghmj-1231	144	3	stratified	stratify	VERB
ghmj-1231	144	4	analysis	analysis	NOUN
ghmj-1231	144	5	is	be	AUX
ghmj-1231	144	6	necessary	necessary	ADJ
ghmj-1231	144	7	to	to	PART
ghmj-1231	144	8	ascertain	ascertain	VERB
ghmj-1231	144	9	if	if	SCONJ
ghmj-1231	144	10	hemizygous	hemizygous	ADJ
ghmj-1231	144	11	males	male	NOUN
ghmj-1231	144	12	and	and	CCONJ
ghmj-1231	144	13	heterozygous	heterozygous	ADJ
ghmj-1231	144	14	or	or	CCONJ
ghmj-1231	144	15	homozygous	homozygous	ADJ
ghmj-1231	144	16	females	female	NOUN
ghmj-1231	144	17	exhibit	exhibit	VERB
ghmj-1231	144	18	distinct	distinct	ADJ
ghmj-1231	144	19	genetic	genetic	ADJ
ghmj-1231	144	20	risk	risk	NOUN
ghmj-1231	144	21	profiles	profile	NOUN
ghmj-1231	144	22	.	.	PUNCT
ghmj-1231	145	1	moreover	moreover	ADV
ghmj-1231	145	2	,	,	PUNCT
ghmj-1231	145	3	a	a	DET
ghmj-1231	145	4	haplotype	haplotype	NOUN
ghmj-1231	145	5	-	-	PUNCT
ghmj-1231	145	6	based	base	VERB
ghmj-1231	145	7	methodology	methodology	NOUN
ghmj-1231	145	8	may	may	AUX
ghmj-1231	145	9	enhance	enhance	VERB
ghmj-1231	145	10	our	our	PRON
ghmj-1231	145	11	comprehension	comprehension	NOUN
ghmj-1231	145	12	of	of	ADP
ghmj-1231	145	13	the	the	DET
ghmj-1231	145	14	interactions	interaction	NOUN
ghmj-1231	145	15	among	among	ADP
ghmj-1231	145	16	various	various	ADJ
ghmj-1231	145	17	ace2	ace2	NOUN
ghmj-1231	145	18	variations	variation	NOUN
ghmj-1231	145	19	.	.	PUNCT
ghmj-1231	146	1	more	more	ADJ
ghmj-1231	146	2	research	research	NOUN
ghmj-1231	146	3	is	be	AUX
ghmj-1231	146	4	recommended	recommend	VERB
ghmj-1231	146	5	with	with	ADP
ghmj-1231	146	6	larger	large	ADJ
ghmj-1231	146	7	groups	group	NOUN
ghmj-1231	146	8	of	of	ADP
ghmj-1231	146	9	people	people	NOUN
ghmj-1231	146	10	and	and	CCONJ
ghmj-1231	146	11	better	well	ADJ
ghmj-1231	146	12	statistics	statistic	NOUN
ghmj-1231	146	13	to	to	PART
ghmj-1231	146	14	improve	improve	VERB
ghmj-1231	146	15	our	our	PRON
ghmj-1231	146	16	understanding	understanding	NOUN
ghmj-1231	146	17	of	of	ADP
ghmj-1231	146	18	the	the	DET
ghmj-1231	146	19	link	link	NOUN
ghmj-1231	146	20	between	between	ADP
ghmj-1231	146	21	essential	essential	ADJ
ghmj-1231	146	22	hypertension	hypertension	NOUN
ghmj-1231	146	23	and	and	CCONJ
ghmj-1231	146	24	ace2	ace2	PROPN
ghmj-1231	146	25	g8790a	g8790a	PROPN
ghmj-1231	146	26	.	.	PROPN
ghmj-1231	146	27	husna	husna	PROPN
ghmj-1231	146	28	,	,	PUNCT
ghmj-1231	146	29	et	et	PROPN
ghmj-1231	146	30	.	.	PUNCT
ghmj-1231	147	1	al	al	PROPN
ghmj-1231	147	2	.	.	PROPN
ghmj-1231	147	3	ghmj	ghmj	PROPN
ghmj-1231	147	4	(	(	PUNCT
ghmj-1231	147	5	global	global	ADJ
ghmj-1231	147	6	health	health	PROPN
ghmj-1231	147	7	management	management	NOUN
ghmj-1231	147	8	journal	journal	PROPN
ghmj-1231	147	9	)	)	PUNCT
ghmj-1231	147	10	2025	2025	NUM
ghmj-1231	147	11	,	,	PUNCT
ghmj-1231	147	12	vol	vol	NOUN
ghmj-1231	147	13	.	.	NOUN
ghmj-1231	147	14	8	8	NUM
ghmj-1231	147	15	,	,	PUNCT
ghmj-1231	147	16	no	no	INTJ
ghmj-1231	147	17	.	.	PUNCT
ghmj-1231	148	1	2s	2s	NOUN
ghmj-1231	148	2	291	291	NUM
ghmj-1231	148	3	5	5	NUM
ghmj-1231	148	4	.	.	PUNCT
ghmj-1231	149	1	conclusion	conclusion	NOUN
ghmj-1231	149	2	this	this	DET
ghmj-1231	149	3	study	study	NOUN
ghmj-1231	149	4	did	do	AUX
ghmj-1231	149	5	not	not	PART
ghmj-1231	149	6	find	find	VERB
ghmj-1231	149	7	an	an	DET
ghmj-1231	149	8	association	association	NOUN
ghmj-1231	149	9	between	between	ADP
ghmj-1231	149	10	ace2	ace2	PROPN
ghmj-1231	149	11	g8790a	g8790a	PROPN
ghmj-1231	149	12	and	and	CCONJ
ghmj-1231	149	13	essential	essential	ADJ
ghmj-1231	149	14	hypertension	hypertension	NOUN
ghmj-1231	149	15	in	in	ADP
ghmj-1231	149	16	our	our	PRON
ghmj-1231	149	17	sample	sample	NOUN
ghmj-1231	149	18	.	.	PUNCT
ghmj-1231	150	1	genetic	genetic	ADJ
ghmj-1231	150	2	screening	screening	NOUN
ghmj-1231	150	3	for	for	ADP
ghmj-1231	150	4	g8790a	g8790a	PROPN
ghmj-1231	150	5	is	be	AUX
ghmj-1231	150	6	not	not	PART
ghmj-1231	150	7	currently	currently	ADV
ghmj-1231	150	8	indicated	indicate	VERB
ghmj-1231	150	9	in	in	ADP
ghmj-1231	150	10	this	this	DET
ghmj-1231	150	11	population	population	NOUN
ghmj-1231	150	12	.	.	PUNCT
ghmj-1231	151	1	further	further	ADJ
ghmj-1231	151	2	research	research	NOUN
ghmj-1231	151	3	is	be	AUX
ghmj-1231	151	4	required	require	VERB
ghmj-1231	151	5	on	on	ADP
ghmj-1231	151	6	a	a	DET
ghmj-1231	151	7	larger	large	ADJ
ghmj-1231	151	8	scale	scale	NOUN
ghmj-1231	151	9	to	to	PART
ghmj-1231	151	10	investigate	investigate	VERB
ghmj-1231	151	11	the	the	DET
ghmj-1231	151	12	effects	effect	NOUN
ghmj-1231	151	13	of	of	ADP
ghmj-1231	151	14	gene	gene	NOUN
ghmj-1231	151	15	combinations	combination	NOUN
ghmj-1231	151	16	or	or	CCONJ
ghmj-1231	151	17	interactions	interaction	NOUN
ghmj-1231	151	18	with	with	ADP
ghmj-1231	151	19	other	other	ADJ
ghmj-1231	151	20	locus	locus	NOUN
ghmj-1231	151	21	genes	gene	NOUN
ghmj-1231	151	22	on	on	ADP
ghmj-1231	151	23	essential	essential	ADJ
ghmj-1231	151	24	hypertension	hypertension	NOUN
ghmj-1231	151	25	.	.	PUNCT
ghmj-1231	152	1	replication	replication	NOUN
ghmj-1231	152	2	that	that	PRON
ghmj-1231	152	3	includes	include	VERB
ghmj-1231	152	4	functional	functional	ADJ
ghmj-1231	152	5	assays	assay	NOUN
ghmj-1231	152	6	and	and	CCONJ
ghmj-1231	152	7	a	a	DET
ghmj-1231	152	8	comprehensive	comprehensive	ADJ
ghmj-1231	152	9	investigation	investigation	NOUN
ghmj-1231	152	10	of	of	ADP
ghmj-1231	152	11	ace2	ace2	NOUN
ghmj-1231	152	12	polymorphisms	polymorphism	NOUN
ghmj-1231	152	13	is	be	AUX
ghmj-1231	152	14	crucial	crucial	ADJ
ghmj-1231	152	15	to	to	PART
ghmj-1231	152	16	validate	validate	VERB
ghmj-1231	152	17	the	the	DET
ghmj-1231	152	18	biological	biological	ADJ
ghmj-1231	152	19	relevance	relevance	NOUN
ghmj-1231	152	20	of	of	ADP
ghmj-1231	152	21	these	these	DET
ghmj-1231	152	22	findings	finding	NOUN
ghmj-1231	152	23	.	.	PUNCT
ghmj-1231	153	1	this	this	DET
ghmj-1231	153	2	study	study	NOUN
ghmj-1231	153	3	has	have	VERB
ghmj-1231	153	4	several	several	ADJ
ghmj-1231	153	5	limitations	limitation	NOUN
ghmj-1231	153	6	,	,	PUNCT
ghmj-1231	153	7	such	such	ADJ
ghmj-1231	153	8	as	as	ADP
ghmj-1231	153	9	a	a	DET
ghmj-1231	153	10	limited	limited	ADJ
ghmj-1231	153	11	sample	sample	NOUN
ghmj-1231	153	12	size	size	NOUN
ghmj-1231	153	13	and	and	CCONJ
ghmj-1231	153	14	a	a	DET
ghmj-1231	153	15	single	single	ADJ
ghmj-1231	153	16	-	-	PUNCT
ghmj-1231	153	17	center	center	NOUN
ghmj-1231	153	18	design	design	NOUN
ghmj-1231	153	19	,	,	PUNCT
ghmj-1231	153	20	which	which	PRON
ghmj-1231	153	21	may	may	AUX
ghmj-1231	153	22	restrict	restrict	VERB
ghmj-1231	153	23	the	the	DET
ghmj-1231	153	24	generalizability	generalizability	NOUN
ghmj-1231	153	25	of	of	ADP
ghmj-1231	153	26	the	the	DET
ghmj-1231	153	27	results	result	NOUN
ghmj-1231	153	28	.	.	PUNCT
ghmj-1231	154	1	conflict	conflict	NOUN
ghmj-1231	154	2	of	of	ADP
ghmj-1231	154	3	interest	interest	NOUN
ghmj-1231	154	4	the	the	DET
ghmj-1231	154	5	authors	author	NOUN
ghmj-1231	154	6	declare	declare	VERB
ghmj-1231	154	7	no	no	DET
ghmj-1231	154	8	conflicts	conflict	NOUN
ghmj-1231	154	9	of	of	ADP
ghmj-1231	154	10	interest	interest	NOUN
ghmj-1231	154	11	for	for	ADP
ghmj-1231	154	12	the	the	DET
ghmj-1231	154	13	results	result	NOUN
ghmj-1231	154	14	.	.	PUNCT
ghmj-1231	155	1	references	reference	NOUN
ghmj-1231	155	2	ace2	ace2	PROPN
ghmj-1231	155	3	gene	gene	NOUN
ghmj-1231	155	4	.	.	PUNCT
ghmj-1231	156	1	(	(	PUNCT
ghmj-1231	156	2	2023	2023	NUM
ghmj-1231	156	3	)	)	PUNCT
ghmj-1231	156	4	.	.	PUNCT
ghmj-1231	157	1	retrieved	retrieve	VERB
ghmj-1231	157	2	from	from	ADP
ghmj-1231	157	3	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ace2	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ace2	NOUN
ghmj-1231	157	4	alwi	alwi	NOUN
ghmj-1231	157	5	,	,	PUNCT
ghmj-1231	157	6	i.	i.	NOUN
ghmj-1231	157	7	(	(	PUNCT
ghmj-1231	157	8	2014	2014	NUM
ghmj-1231	157	9	)	)	PUNCT
ghmj-1231	157	10	.	.	PUNCT
ghmj-1231	158	1	buku	buku	PROPN
ghmj-1231	158	2	ajar	ajar	PROPN
ghmj-1231	158	3	ilmu	ilmu	PROPN
ghmj-1231	158	4	penyakit	penyakit	PROPN
ghmj-1231	158	5	dalam	dalam	PROPN
ghmj-1231	158	6	jilid	jilid	PROPN
ghmj-1231	158	7	ii	ii	PROPN
ghmj-1231	158	8	edisi	edisi	VERB
ghmj-1231	158	9	vi	vi	PROPN
ghmj-1231	158	10	.	.	PROPN
ghmj-1231	158	11	interna	interna	PROPN
ghmj-1231	158	12	publishing	publishing	PROPN
ghmj-1231	158	13	.	.	PUNCT
ghmj-1231	159	1	benjafield	benjafield	PROPN
ghmj-1231	159	2	,	,	PUNCT
ghmj-1231	159	3	a.	a.	NOUN
ghmj-1231	159	4	v.	v.	PROPN
ghmj-1231	159	5	,	,	PUNCT
ghmj-1231	159	6	wang	wang	PROPN
ghmj-1231	159	7	,	,	PUNCT
ghmj-1231	159	8	w.	w.	PROPN
ghmj-1231	159	9	y.	y.	PROPN
ghmj-1231	159	10	s.	s.	PROPN
ghmj-1231	159	11	,	,	PUNCT
ghmj-1231	159	12	&	&	CCONJ
ghmj-1231	159	13	morris	morris	PROPN
ghmj-1231	159	14	,	,	PUNCT
ghmj-1231	159	15	b.	b.	PROPN
ghmj-1231	159	16	j.	j.	PROPN
ghmj-1231	159	17	(	(	PUNCT
ghmj-1231	159	18	2004	2004	NUM
ghmj-1231	159	19	)	)	PUNCT
ghmj-1231	159	20	.	.	PUNCT
ghmj-1231	160	1	no	no	DET
ghmj-1231	160	2	association	association	NOUN
ghmj-1231	160	3	of	of	ADP
ghmj-1231	160	4	angiotensin	angiotensin	NOUN
ghmj-1231	160	5	-	-	PUNCT
ghmj-1231	160	6	converting	convert	VERB
ghmj-1231	160	7	enzyme	enzyme	NOUN
ghmj-1231	160	8	2	2	NUM
ghmj-1231	160	9	gene	gene	NOUN
ghmj-1231	160	10	(	(	PUNCT
ghmj-1231	160	11	ace2	ace2	NOUN
ghmj-1231	160	12	)	)	PUNCT
ghmj-1231	160	13	polymorphisms	polymorphism	NOUN
ghmj-1231	160	14	with	with	ADP
ghmj-1231	160	15	essential	essential	ADJ
ghmj-1231	160	16	hypertension	hypertension	NOUN
ghmj-1231	160	17	.	.	PUNCT
ghmj-1231	161	1	american	american	ADJ
ghmj-1231	161	2	journal	journal	PROPN
ghmj-1231	161	3	of	of	ADP
ghmj-1231	161	4	hypertension	hypertension	NOUN
ghmj-1231	161	5	,	,	PUNCT
ghmj-1231	161	6	17(7	17(7	NUM
ghmj-1231	161	7	)	)	PUNCT
ghmj-1231	161	8	,	,	PUNCT
ghmj-1231	161	9	624–628	624–628	NUM
ghmj-1231	161	10	.	.	PUNCT
ghmj-1231	162	1	https://doi.org/10.1016/j.amjhyper.2004.02.022	https://doi.org/10.1016/j.amjhyper.2004.02.022	PROPN
ghmj-1231	162	2	burrell	burrell	PROPN
ghmj-1231	162	3	,	,	PUNCT
ghmj-1231	162	4	l.	l.	PROPN
ghmj-1231	162	5	m.	m.	PROPN
ghmj-1231	162	6	,	,	PUNCT
ghmj-1231	162	7	johnston	johnston	PROPN
ghmj-1231	162	8	,	,	PUNCT
ghmj-1231	162	9	c.	c.	PROPN
ghmj-1231	162	10	i.	i.	PROPN
ghmj-1231	162	11	,	,	PUNCT
ghmj-1231	162	12	tikellis	tikellis	PROPN
ghmj-1231	162	13	,	,	PUNCT
ghmj-1231	162	14	c.	c.	PROPN
ghmj-1231	162	15	,	,	PUNCT
ghmj-1231	162	16	&	&	CCONJ
ghmj-1231	162	17	cooper	cooper	PROPN
ghmj-1231	162	18	,	,	PUNCT
ghmj-1231	162	19	m.	m.	PROPN
ghmj-1231	162	20	e.	e.	PROPN
ghmj-1231	162	21	(	(	PUNCT
ghmj-1231	162	22	2004	2004	NUM
ghmj-1231	162	23	)	)	PUNCT
ghmj-1231	162	24	.	.	PUNCT
ghmj-1231	163	1	ace2	ace2	PROPN
ghmj-1231	163	2	,	,	PUNCT
ghmj-1231	163	3	a	a	DET
ghmj-1231	163	4	new	new	ADJ
ghmj-1231	163	5	regulator	regulator	NOUN
ghmj-1231	163	6	of	of	ADP
ghmj-1231	163	7	the	the	DET
ghmj-1231	163	8	renin	renin	ADJ
ghmj-1231	163	9	-	-	PUNCT
ghmj-1231	163	10	angiotensin	angiotensin	NOUN
ghmj-1231	163	11	system	system	NOUN
ghmj-1231	163	12	.	.	PUNCT
ghmj-1231	164	1	trends	trend	NOUN
ghmj-1231	164	2	in	in	ADP
ghmj-1231	164	3	endocrinology	endocrinology	NOUN
ghmj-1231	164	4	and	and	CCONJ
ghmj-1231	164	5	metabolism	metabolism	NOUN
ghmj-1231	164	6	,	,	PUNCT
ghmj-1231	164	7	15(4	15(4	NUM
ghmj-1231	164	8	)	)	PUNCT
ghmj-1231	164	9	,	,	PUNCT
ghmj-1231	164	10	166–169	166–169	NUM
ghmj-1231	164	11	.	.	PUNCT
ghmj-1231	165	1	https://doi.org/10.1016/j.tem.2004.03.001	https://doi.org/10.1016/j.tem.2004.03.001	PROPN
ghmj-1231	165	2	chappell	chappell	PROPN
ghmj-1231	165	3	,	,	PUNCT
ghmj-1231	165	4	m.	m.	PROPN
ghmj-1231	165	5	c.	c.	PROPN
ghmj-1231	165	6	,	,	PUNCT
ghmj-1231	165	7	marshall	marshall	PROPN
ghmj-1231	165	8	,	,	PUNCT
ghmj-1231	165	9	a.	a.	PROPN
ghmj-1231	165	10	c.	c.	PROPN
ghmj-1231	165	11	,	,	PUNCT
ghmj-1231	165	12	alzayadneh	alzayadneh	PROPN
ghmj-1231	165	13	,	,	PUNCT
ghmj-1231	165	14	e.	e.	PROPN
ghmj-1231	165	15	m.	m.	PROPN
ghmj-1231	165	16	,	,	PUNCT
ghmj-1231	165	17	shaltout	shaltout	PROPN
ghmj-1231	165	18	,	,	PUNCT
ghmj-1231	165	19	h.	h.	PROPN
ghmj-1231	165	20	a.	a.	PROPN
ghmj-1231	165	21	,	,	PUNCT
ghmj-1231	165	22	&	&	CCONJ
ghmj-1231	165	23	diz	diz	PROPN
ghmj-1231	165	24	,	,	PUNCT
ghmj-1231	165	25	d.	d.	PROPN
ghmj-1231	165	26	i.	i.	PROPN
ghmj-1231	165	27	(	(	PUNCT
ghmj-1231	165	28	2014	2014	NUM
ghmj-1231	165	29	)	)	PUNCT
ghmj-1231	165	30	.	.	PUNCT
ghmj-1231	166	1	update	update	NOUN
ghmj-1231	166	2	on	on	ADP
ghmj-1231	166	3	the	the	DET
ghmj-1231	166	4	angiotensin	angiotensin	NOUN
ghmj-1231	166	5	converting	convert	VERB
ghmj-1231	166	6	enzyme	enzyme	NOUN
ghmj-1231	166	7	2	2	NUM
ghmj-1231	166	8	-	-	PUNCT
ghmj-1231	166	9	angiotensin	angiotensin	NOUN
ghmj-1231	166	10	(	(	PUNCT
ghmj-1231	166	11	1	1	NUM
ghmj-1231	166	12	-	-	PUNCT
ghmj-1231	166	13	7)-mas	7)-mas	NUM
ghmj-1231	166	14	receptor	receptor	NOUN
ghmj-1231	166	15	axis	axis	NOUN
ghmj-1231	166	16	:	:	PUNCT
ghmj-1231	166	17	fetal	fetal	ADJ
ghmj-1231	166	18	programing	programing	NOUN
ghmj-1231	166	19	,	,	PUNCT
ghmj-1231	166	20	sex	sex	NOUN
ghmj-1231	166	21	differences	difference	NOUN
ghmj-1231	166	22	,	,	PUNCT
ghmj-1231	166	23	and	and	CCONJ
ghmj-1231	166	24	intracellular	intracellular	ADJ
ghmj-1231	166	25	pathways	pathway	NOUN
ghmj-1231	166	26	.	.	PUNCT
ghmj-1231	167	1	frontiers	frontier	NOUN
ghmj-1231	167	2	in	in	ADP
ghmj-1231	167	3	endocrinology	endocrinology	NOUN
ghmj-1231	167	4	,	,	PUNCT
ghmj-1231	167	5	5(jan	5(jan	NUM
ghmj-1231	167	6	)	)	PUNCT
ghmj-1231	167	7	,	,	PUNCT
ghmj-1231	167	8	1–13	1–13	NOUN
ghmj-1231	167	9	.	.	PUNCT
ghmj-1231	168	1	https://doi.org/10.3389/fendo.2013.00201	https://doi.org/10.3389/fendo.2013.00201	PROPN
ghmj-1231	168	2	fan	fan	PROPN
ghmj-1231	168	3	,	,	PUNCT
ghmj-1231	168	4	x.	x.	PROPN
ghmj-1231	168	5	h.	h.	PROPN
ghmj-1231	168	6	,	,	PUNCT
ghmj-1231	168	7	wang	wang	PROPN
ghmj-1231	168	8	,	,	PUNCT
ghmj-1231	168	9	y.	y.	PROPN
ghmj-1231	168	10	b.	b.	PROPN
ghmj-1231	168	11	,	,	PUNCT
ghmj-1231	168	12	wang	wang	PROPN
ghmj-1231	168	13	,	,	PUNCT
ghmj-1231	168	14	h.	h.	PROPN
ghmj-1231	168	15	,	,	PUNCT
ghmj-1231	168	16	sun	sun	PROPN
ghmj-1231	168	17	,	,	PUNCT
ghmj-1231	168	18	k.	k.	PROPN
ghmj-1231	168	19	,	,	PUNCT
ghmj-1231	168	20	zhang	zhang	PROPN
ghmj-1231	168	21	,	,	PUNCT
ghmj-1231	168	22	w.	w.	PROPN
ghmj-1231	168	23	l.	l.	PROPN
ghmj-1231	168	24	,	,	PUNCT
ghmj-1231	168	25	song	song	NOUN
ghmj-1231	168	26	,	,	PUNCT
ghmj-1231	168	27	x.	x.	PROPN
ghmj-1231	168	28	d.	d.	PROPN
ghmj-1231	168	29	,	,	PUNCT
ghmj-1231	168	30	…	…	PUNCT
ghmj-1231	168	31	hui	hui	PROPN
ghmj-1231	168	32	,	,	PUNCT
ghmj-1231	168	33	r.	r.	PROPN
ghmj-1231	168	34	t.	t.	PROPN
ghmj-1231	168	35	(	(	PUNCT
ghmj-1231	168	36	2009	2009	NUM
ghmj-1231	168	37	)	)	PUNCT
ghmj-1231	168	38	.	.	PUNCT
ghmj-1231	169	1	polymorphisms	polymorphism	NOUN
ghmj-1231	169	2	of	of	ADP
ghmj-1231	169	3	angiotensin	angiotensin	NOUN
ghmj-1231	169	4	-	-	PUNCT
ghmj-1231	169	5	converting	convert	VERB
ghmj-1231	169	6	enzyme	enzyme	NOUN
ghmj-1231	169	7	(	(	PUNCT
ghmj-1231	169	8	ace	ace	NOUN
ghmj-1231	169	9	)	)	PUNCT
ghmj-1231	169	10	and	and	CCONJ
ghmj-1231	169	11	ace2	ace2	NOUN
ghmj-1231	169	12	are	be	AUX
ghmj-1231	169	13	not	not	PART
ghmj-1231	169	14	associated	associate	VERB
ghmj-1231	169	15	with	with	ADP
ghmj-1231	169	16	orthostatic	orthostatic	ADJ
ghmj-1231	169	17	blood	blood	NOUN
ghmj-1231	169	18	pressure	pressure	NOUN
ghmj-1231	169	19	dysregulation	dysregulation	NOUN
ghmj-1231	169	20	in	in	ADP
ghmj-1231	169	21	hypertensive	hypertensive	ADJ
ghmj-1231	169	22	patients	patient	NOUN
ghmj-1231	169	23	.	.	PUNCT
ghmj-1231	170	1	acta	acta	PROPN
ghmj-1231	170	2	pharmacologica	pharmacologica	PROPN
ghmj-1231	170	3	sinica	sinica	PROPN
ghmj-1231	170	4	,	,	PUNCT
ghmj-1231	170	5	30(9	30(9	NOUN
ghmj-1231	170	6	)	)	PUNCT
ghmj-1231	170	7	,	,	PUNCT
ghmj-1231	170	8	1237–1244	1237–1244	NUM
ghmj-1231	170	9	.	.	PUNCT
ghmj-1231	171	1	https://doi.org/10.1038/aps.2009.110	https://doi.org/10.1038/aps.2009.110	PROPN
ghmj-1231	171	2	imai	imai	PROPN
ghmj-1231	171	3	,	,	PUNCT
ghmj-1231	171	4	y.	y.	PROPN
ghmj-1231	171	5	,	,	PUNCT
ghmj-1231	171	6	kuba	kuba	PROPN
ghmj-1231	171	7	,	,	PUNCT
ghmj-1231	171	8	k.	k.	PROPN
ghmj-1231	171	9	,	,	PUNCT
ghmj-1231	171	10	ohto	ohto	NOUN
ghmj-1231	171	11	-	-	PUNCT
ghmj-1231	171	12	nakanishi	nakanishi	ADJ
ghmj-1231	171	13	,	,	PUNCT
ghmj-1231	171	14	t.	t.	PROPN
ghmj-1231	171	15	,	,	PUNCT
ghmj-1231	171	16	&	&	CCONJ
ghmj-1231	171	17	penninger	penninger	PROPN
ghmj-1231	171	18	,	,	PUNCT
ghmj-1231	171	19	j.	j.	PROPN
ghmj-1231	171	20	m.	m.	PROPN
ghmj-1231	171	21	(	(	PUNCT
ghmj-1231	171	22	2010	2010	NUM
ghmj-1231	171	23	)	)	PUNCT
ghmj-1231	171	24	.	.	PUNCT
ghmj-1231	172	1	angiotensin	angiotensin	NOUN
ghmj-1231	172	2	-	-	PUNCT
ghmj-1231	172	3	converting	convert	VERB
ghmj-1231	172	4	enzyme	enzyme	NOUN
ghmj-1231	172	5	2	2	NUM
ghmj-1231	172	6	(	(	PUNCT
ghmj-1231	172	7	ace2	ace2	PROPN
ghmj-1231	172	8	)	)	PUNCT
ghmj-1231	172	9	in	in	ADP
ghmj-1231	172	10	disease	disease	NOUN
ghmj-1231	172	11	pathogenesis	pathogenesis	NOUN
ghmj-1231	172	12	.	.	PUNCT
ghmj-1231	173	1	circulation	circulation	NOUN
ghmj-1231	173	2	journal	journal	NOUN
ghmj-1231	173	3	,	,	PUNCT
ghmj-1231	173	4	74(3	74(3	NUM
ghmj-1231	173	5	)	)	PUNCT
ghmj-1231	173	6	,	,	PUNCT
ghmj-1231	173	7	405–410.https://doi.org/10.1253	405–410.https://doi.org/10.1253	NUM
ghmj-1231	173	8	/	/	SYM
ghmj-1231	173	9	circj.cj-10	circj.cj-10	NUM
ghmj-1231	173	10	-	-	PUNCT
ghmj-1231	173	11	0045	0045	NUM
ghmj-1231	173	12	kemenkes	kemenke	NOUN
ghmj-1231	173	13	.	.	PUNCT
ghmj-1231	174	1	(	(	PUNCT
ghmj-1231	174	2	2021	2021	NUM
ghmj-1231	174	3	)	)	PUNCT
ghmj-1231	174	4	.	.	PUNCT
ghmj-1231	175	1	pedoman	pedoman	PROPN
ghmj-1231	175	2	nasional	nasional	PROPN
ghmj-1231	175	3	pelayanan	pelayanan	PROPN
ghmj-1231	175	4	kedokteran	kedokteran	PROPN
ghmj-1231	175	5	tata	tata	PROPN
ghmj-1231	175	6	laksana	laksana	PROPN
ghmj-1231	175	7	hipertensi	hipertensi	PROPN
ghmj-1231	175	8	dewasa	dewasa	PROPN
ghmj-1231	175	9	.	.	PUNCT
ghmj-1231	176	1	kementerian	kementerian	PROPN
ghmj-1231	176	2	kesehatan	kesehatan	PROPN
ghmj-1231	176	3	ri	ri	PROPN
ghmj-1231	176	4	,	,	PUNCT
ghmj-1231	176	5	1–85	1–85	PROPN
ghmj-1231	176	6	.	.	PUNCT
ghmj-1231	177	1	kemenkes	kemenkes	PROPN
ghmj-1231	177	2	ri	ri	PROPN
ghmj-1231	177	3	.	.	PUNCT
ghmj-1231	178	1	(	(	PUNCT
ghmj-1231	178	2	2018	2018	NUM
ghmj-1231	178	3	)	)	PUNCT
ghmj-1231	178	4	.	.	PUNCT
ghmj-1231	179	1	hasil	hasil	PROPN
ghmj-1231	179	2	riset	riset	PROPN
ghmj-1231	179	3	kesehatan	kesehatan	PROPN
ghmj-1231	179	4	dasar	dasar	VERB
ghmj-1231	179	5	tahun	tahun	PROPN
ghmj-1231	179	6	2018	2018	NUM
ghmj-1231	179	7	.	.	PUNCT
ghmj-1231	180	1	kementrian	kementrian	PROPN
ghmj-1231	180	2	kesehatan	kesehatan	PROPN
ghmj-1231	180	3	ri	ri	PROPN
ghmj-1231	180	4	(	(	PUNCT
ghmj-1231	180	5	vol	vol	NOUN
ghmj-1231	180	6	.	.	PROPN
ghmj-1231	180	7	53	53	NUM
ghmj-1231	180	8	)	)	PUNCT
ghmj-1231	180	9	.	.	PUNCT
ghmj-1231	181	1	kuswara	kuswara	PROPN
ghmj-1231	181	2	,	,	PUNCT
ghmj-1231	181	3	h.	h.	PROPN
ghmj-1231	181	4	n.	n.	PROPN
ghmj-1231	181	5	,	,	PUNCT
ghmj-1231	181	6	nauphar	nauphar	PROPN
ghmj-1231	181	7	,	,	PUNCT
ghmj-1231	181	8	d.	d.	PROPN
ghmj-1231	181	9	,	,	PUNCT
ghmj-1231	181	10	&	&	CCONJ
ghmj-1231	181	11	sari	sari	NOUN
ghmj-1231	181	12	,	,	PUNCT
ghmj-1231	181	13	a.	a.	PROPN
ghmj-1231	181	14	i.	i.	PROPN
ghmj-1231	181	15	p.	p.	PROPN
ghmj-1231	181	16	(	(	PUNCT
ghmj-1231	181	17	2024	2024	NUM
ghmj-1231	181	18	)	)	PUNCT
ghmj-1231	181	19	.	.	PUNCT
ghmj-1231	182	1	angiotensin	angiotensin	NOUN
ghmj-1231	182	2	-	-	PUNCT
ghmj-1231	182	3	converting	convert	VERB
ghmj-1231	182	4	enzyme	enzyme	NOUN
ghmj-1231	182	5	insertion	insertion	NOUN
ghmj-1231	182	6	/	/	SYM
ghmj-1231	182	7	deletion	deletion	NOUN
ghmj-1231	182	8	(	(	PUNCT
ghmj-1231	182	9	ace	ace	VERB
ghmj-1231	182	10	i	i	PROPN
ghmj-1231	182	11	/	/	SYM
ghmj-1231	182	12	d	d	NOUN
ghmj-1231	182	13	)	)	PUNCT
ghmj-1231	182	14	gene	gene	NOUN
ghmj-1231	182	15	polymorphism	polymorphism	NOUN
ghmj-1231	182	16	as	as	ADP
ghmj-1231	182	17	a	a	DET
ghmj-1231	182	18	risk	risk	NOUN
ghmj-1231	182	19	factor	factor	NOUN
ghmj-1231	182	20	for	for	ADP
ghmj-1231	182	21	essential	essential	ADJ
ghmj-1231	182	22	hypertension	hypertension	NOUN
ghmj-1231	182	23	.	.	PUNCT
ghmj-1231	183	1	ghmj	ghmj	PROPN
ghmj-1231	183	2	(	(	PUNCT
ghmj-1231	183	3	global	global	ADJ
ghmj-1231	183	4	health	health	PROPN
ghmj-1231	183	5	management	management	NOUN
ghmj-1231	183	6	journal	journal	PROPN
ghmj-1231	183	7	)	)	PUNCT
ghmj-1231	183	8	,	,	PUNCT
ghmj-1231	183	9	7(4	7(4	NUM
ghmj-1231	183	10	)	)	PUNCT
ghmj-1231	183	11	,	,	PUNCT
ghmj-1231	183	12	180–190	180–190	NUM
ghmj-1231	183	13	.	.	PUNCT
ghmj-1231	184	1	https://doi.org/10.35898/ghmj-741044	https://doi.org/10.35898/ghmj-741044	PROPN
ghmj-1231	184	2	li	li	PROPN
ghmj-1231	184	3	,	,	PUNCT
ghmj-1231	184	4	y.	y.	PROPN
ghmj-1231	184	5	y.	y.	PROPN
ghmj-1231	184	6	(	(	PUNCT
ghmj-1231	184	7	2012	2012	NUM
ghmj-1231	184	8	)	)	PUNCT
ghmj-1231	184	9	.	.	PUNCT
ghmj-1231	185	1	lack	lack	NOUN
ghmj-1231	185	2	of	of	ADP
ghmj-1231	185	3	association	association	NOUN
ghmj-1231	185	4	of	of	ADP
ghmj-1231	185	5	ace2	ace2	PROPN
ghmj-1231	185	6	g8790a	g8790a	PROPN
ghmj-1231	185	7	gene	gene	NOUN
ghmj-1231	185	8	mutation	mutation	NOUN
ghmj-1231	185	9	with	with	ADP
ghmj-1231	185	10	essential	essential	ADJ
ghmj-1231	185	11	hypertension	hypertension	NOUN
ghmj-1231	185	12	in	in	ADP
ghmj-1231	185	13	the	the	DET
ghmj-1231	185	14	chinese	chinese	ADJ
ghmj-1231	185	15	population	population	NOUN
ghmj-1231	185	16	:	:	PUNCT
ghmj-1231	185	17	a	a	DET
ghmj-1231	185	18	metaanalysis	metaanalysis	NOUN
ghmj-1231	185	19	involving	involve	VERB
ghmj-1231	185	20	5260	5260	NUM
ghmj-1231	185	21	subjects	subject	NOUN
ghmj-1231	185	22	.	.	PUNCT
ghmj-1231	186	1	frontiers	frontier	NOUN
ghmj-1231	186	2	in	in	ADP
ghmj-1231	186	3	physiology	physiology	NOUN
ghmj-1231	186	4	,	,	PUNCT
ghmj-1231	186	5	3	3	NUM
ghmj-1231	186	6	sep(september	sep(september	NOUN
ghmj-1231	186	7	)	)	PUNCT
ghmj-1231	186	8	,	,	PUNCT
ghmj-1231	186	9	1–7.https://doi.org/10.3389	1–7.https://doi.org/10.3389	NUM
ghmj-1231	186	10	/	/	SYM
ghmj-1231	186	11	fphys.2012.00364	fphys.2012.00364	NUM
ghmj-1231	186	12	lu	lu	PROPN
ghmj-1231	186	13	,	,	PUNCT
ghmj-1231	186	14	n.	n.	PROPN
ghmj-1231	186	15	,	,	PUNCT
ghmj-1231	186	16	yang	yang	PROPN
ghmj-1231	186	17	,	,	PUNCT
ghmj-1231	186	18	y.	y.	PROPN
ghmj-1231	186	19	,	,	PUNCT
ghmj-1231	186	20	wang	wang	PROPN
ghmj-1231	186	21	,	,	PUNCT
ghmj-1231	186	22	y.	y.	PROPN
ghmj-1231	186	23	,	,	PUNCT
ghmj-1231	186	24	liu	liu	PROPN
ghmj-1231	186	25	,	,	PUNCT
ghmj-1231	186	26	y.	y.	PROPN
ghmj-1231	186	27	,	,	PUNCT
ghmj-1231	186	28	fu	fu	PROPN
ghmj-1231	186	29	,	,	PUNCT
ghmj-1231	186	30	g.	g.	PROPN
ghmj-1231	186	31	,	,	PUNCT
ghmj-1231	186	32	chen	chen	PROPN
ghmj-1231	186	33	,	,	PUNCT
ghmj-1231	186	34	d.	d.	PROPN
ghmj-1231	186	35	,	,	PUNCT
ghmj-1231	186	36	…	…	PUNCT
ghmj-1231	186	37	zheng	zheng	X
ghmj-1231	186	38	,	,	PUNCT
ghmj-1231	186	39	y.	y.	PROPN
ghmj-1231	186	40	(	(	PUNCT
ghmj-1231	186	41	2012	2012	NUM
ghmj-1231	186	42	)	)	PUNCT
ghmj-1231	186	43	.	.	PUNCT
ghmj-1231	187	1	ace2	ace2	PROPN
ghmj-1231	187	2	gene	gene	NOUN
ghmj-1231	187	3	polymorphism	polymorphism	NOUN
ghmj-1231	187	4	and	and	CCONJ
ghmj-1231	187	5	essential	essential	ADJ
ghmj-1231	187	6	hypertension	hypertension	NOUN
ghmj-1231	187	7	:	:	PUNCT
ghmj-1231	187	8	an	an	DET
ghmj-1231	187	9	updated	update	VERB
ghmj-1231	187	10	meta	meta	ADJ
ghmj-1231	187	11	-	-	PUNCT
ghmj-1231	187	12	analysis	analysis	NOUN
ghmj-1231	187	13	involving	involve	VERB
ghmj-1231	187	14	11,051	11,051	NUM
ghmj-1231	187	15	subjects	subject	NOUN
ghmj-1231	187	16	.	.	PUNCT
ghmj-1231	188	1	molecular	molecular	ADJ
ghmj-1231	188	2	biology	biology	NOUN
ghmj-1231	188	3	reports	report	NOUN
ghmj-1231	188	4	,	,	PUNCT
ghmj-1231	188	5	39(6	39(6	NUM
ghmj-1231	188	6	)	)	PUNCT
ghmj-1231	188	7	,	,	PUNCT
ghmj-1231	188	8	6581–6589	6581–6589	NUM
ghmj-1231	188	9	.	.	PUNCT
ghmj-1231	189	1	https://doi.org/10.1007/s11033-012-1487-1	https://doi.org/10.1007/s11033-012-1487-1	VERB
ghmj-1231	189	2	lupton	lupton	PROPN
ghmj-1231	189	3	,	,	PUNCT
ghmj-1231	189	4	s.	s.	PROPN
ghmj-1231	189	5	j.	j.	PROPN
ghmj-1231	189	6	,	,	PUNCT
ghmj-1231	189	7	chiu	chiu	PROPN
ghmj-1231	189	8	,	,	PUNCT
ghmj-1231	189	9	c.	c.	PROPN
ghmj-1231	189	10	l.	l.	PROPN
ghmj-1231	189	11	,	,	PUNCT
ghmj-1231	189	12	&	&	CCONJ
ghmj-1231	189	13	lind	lind	PROPN
ghmj-1231	189	14	,	,	PUNCT
ghmj-1231	189	15	j.	j.	PROPN
ghmj-1231	189	16	m.	m.	PROPN
ghmj-1231	189	17	(	(	PUNCT
ghmj-1231	189	18	2011	2011	NUM
ghmj-1231	189	19	)	)	PUNCT
ghmj-1231	189	20	.	.	PUNCT
ghmj-1231	190	1	a	a	DET
ghmj-1231	190	2	hypertension	hypertension	NOUN
ghmj-1231	190	3	gene	gene	NOUN
ghmj-1231	190	4	:	:	PUNCT
ghmj-1231	190	5	are	be	AUX
ghmj-1231	190	6	we	we	PRON
ghmj-1231	190	7	there	there	ADV
ghmj-1231	190	8	yet	yet	ADV
ghmj-1231	190	9	?	?	PUNCT
ghmj-1231	191	1	twin	twin	ADJ
ghmj-1231	191	2	research	research	NOUN
ghmj-1231	191	3	and	and	CCONJ
ghmj-1231	191	4	human	human	ADJ
ghmj-1231	191	5	genetics	genetic	NOUN
ghmj-1231	191	6	,	,	PUNCT
ghmj-1231	191	7	14(4	14(4	NUM
ghmj-1231	191	8	)	)	PUNCT
ghmj-1231	191	9	,	,	PUNCT
ghmj-1231	191	10	295–304	295–304	NUM
ghmj-1231	191	11	.	.	PUNCT
ghmj-1231	192	1	https://doi.org/10.1375/twin.14.4.295	https://doi.org/10.1375/twin.14.4.295	PROPN
ghmj-1231	192	2	olin	olin	PROPN
ghmj-1231	192	3	,	,	PUNCT
ghmj-1231	192	4	b.	b.	PROPN
ghmj-1231	192	5	r.	r.	PROPN
ghmj-1231	192	6	,	,	PUNCT
ghmj-1231	192	7	&	&	CCONJ
ghmj-1231	192	8	pharm	pharm	PROPN
ghmj-1231	192	9	,	,	PUNCT
ghmj-1231	192	10	d.	d.	PROPN
ghmj-1231	192	11	(	(	PUNCT
ghmj-1231	192	12	2018	2018	NUM
ghmj-1231	192	13	)	)	PUNCT
ghmj-1231	192	14	.	.	PUNCT
ghmj-1231	193	1	hypertension	hypertension	NOUN
ghmj-1231	193	2	 	 	SPACE
ghmj-1231	193	3	:	:	PUNCT
ghmj-1231	193	4	the	the	DET
ghmj-1231	193	5	silent	silent	ADJ
ghmj-1231	193	6	killer	killer	NOUN
ghmj-1231	193	7	 	 	SPACE
ghmj-1231	193	8	:	:	PUNCT
ghmj-1231	193	9	updated	update	VERB
ghmj-1231	193	10	jnc-8	jnc-8	VERB
ghmj-1231	193	11	guideline	guideline	NOUN
ghmj-1231	193	12	recommendations	recommendation	NOUN
ghmj-1231	193	13	.	.	PUNCT
ghmj-1231	194	1	p2ptm	p2ptm	PROPN
ghmj-1231	194	2	kemenkes	kemenkes	PROPN
ghmj-1231	194	3	ri	ri	PROPN
ghmj-1231	194	4	.	.	PUNCT
ghmj-1231	194	5	(	(	PUNCT
ghmj-1231	194	6	2024a	2024a	NUM
ghmj-1231	194	7	)	)	PUNCT
ghmj-1231	194	8	.	.	PUNCT
ghmj-1231	195	1	faktor	faktor	PROPN
ghmj-1231	195	2	risiko	risiko	PROPN
ghmj-1231	195	3	hipertensi	hipertensi	PROPN
ghmj-1231	195	4	yang	yang	PROPN
ghmj-1231	195	5	dapat	dapat	PROPN
ghmj-1231	195	6	diubah	diubah	PROPN
ghmj-1231	195	7	dan	dan	PROPN
ghmj-1231	195	8	tidak	tidak	PROPN
ghmj-1231	195	9	dapat	dapat	PROPN
ghmj-1231	195	10	diubah	diubah	PROPN
ghmj-1231	195	11	.	.	PUNCT
ghmj-1231	196	1	retrieved	retrieve	VERB
ghmj-1231	196	2	from	from	ADP
ghmj-1231	196	3	https://p2ptm.kemkes.go.id/infographic/faktor-risiko-hipertensi-yang-dapat-diubah-dan-tidak-dapat-diubah	https://p2ptm.kemkes.go.id/infographic/faktor-risiko-hipertensi-yang-dapat-diubah-dan-tidak-dapat-diubah	PROPN
ghmj-1231	196	4	p2ptm	p2ptm	PROPN
ghmj-1231	196	5	kemenkes	kemenkes	PROPN
ghmj-1231	196	6	ri	ri	PROPN
ghmj-1231	196	7	.	.	PUNCT
ghmj-1231	196	8	(	(	PUNCT
ghmj-1231	196	9	2024b	2024b	NUM
ghmj-1231	196	10	)	)	PUNCT
ghmj-1231	196	11	.	.	PUNCT
ghmj-1231	197	1	mengenal	mengenal	PROPN
ghmj-1231	197	2	penyakit	penyakit	PROPN
ghmj-1231	197	3	hipertensi	hipertensi	PROPN
ghmj-1231	197	4	.	.	PUNCT
ghmj-1231	198	1	pan	pan	PROPN
ghmj-1231	198	2	,	,	PUNCT
ghmj-1231	198	3	y.	y.	PROPN
ghmj-1231	198	4	(	(	PUNCT
ghmj-1231	198	5	2023	2023	NUM
ghmj-1231	198	6	)	)	PUNCT
ghmj-1231	198	7	.	.	PUNCT
ghmj-1231	199	1	angiotensin	angiotensin	NOUN
ghmj-1231	199	2	-	-	PUNCT
ghmj-1231	199	3	converting	convert	VERB
ghmj-1231	199	4	enzyme	enzyme	NOUN
ghmj-1231	199	5	2	2	NUM
ghmj-1231	199	6	g8790a	g8790a	NOUN
ghmj-1231	199	7	polymorphisms	polymorphism	NOUN
ghmj-1231	199	8	are	be	AUX
ghmj-1231	199	9	associated	associate	VERB
ghmj-1231	199	10	with	with	ADP
ghmj-1231	199	11	covid-19	covid-19	PROPN
ghmj-1231	199	12	severity	severity	NOUN
ghmj-1231	199	13	.	.	PUNCT
ghmj-1231	200	1	journal	journal	NOUN
ghmj-1231	200	2	of	of	ADP
ghmj-1231	200	3	infection	infection	NOUN
ghmj-1231	200	4	in	in	ADP
ghmj-1231	200	5	developing	develop	VERB
ghmj-1231	200	6	countries	country	NOUN
ghmj-1231	200	7	,	,	PUNCT
ghmj-1231	200	8	17(6	17(6	NUM
ghmj-1231	200	9	)	)	PUNCT
ghmj-1231	200	10	,	,	PUNCT
ghmj-1231	200	11	819–825	819–825	NUM
ghmj-1231	200	12	.	.	PUNCT
ghmj-1231	201	1	https://doi.org/10.3855/jidc.17762	https://doi.org/10.3855/jidc.17762	PROPN
ghmj-1231	201	2	pratamawati	pratamawati	PROPN
ghmj-1231	201	3	,	,	PUNCT
ghmj-1231	201	4	t.	t.	NOUN
ghmj-1231	201	5	m.	m.	NOUN
ghmj-1231	201	6	,	,	PUNCT
ghmj-1231	201	7	sadji	sadji	PROPN
ghmj-1231	201	8	,	,	PUNCT
ghmj-1231	201	9	a.	a.	PROPN
ghmj-1231	201	10	a.	a.	PROPN
ghmj-1231	201	11	e.	e.	PROPN
ghmj-1231	201	12	b.	b.	PROPN
ghmj-1231	201	13	,	,	PUNCT
ghmj-1231	201	14	brajadenta	brajadenta	PROPN
ghmj-1231	201	15	,	,	PUNCT
ghmj-1231	201	16	g.	g.	PROPN
ghmj-1231	201	17	s.	s.	PROPN
ghmj-1231	201	18	,	,	PUNCT
ghmj-1231	201	19	&	&	CCONJ
ghmj-1231	201	20	nauphar	nauphar	PROPN
ghmj-1231	201	21	,	,	PUNCT
ghmj-1231	201	22	d.	d.	PROPN
ghmj-1231	201	23	(	(	PUNCT
ghmj-1231	201	24	2024b	2024b	NUM
ghmj-1231	201	25	)	)	PUNCT
ghmj-1231	201	26	.	.	PUNCT
ghmj-1231	202	1	association	association	NOUN
ghmj-1231	202	2	of	of	ADP
ghmj-1231	202	3	rs9939609	rs9939609	PROPN
ghmj-1231	202	4	fto	fto	VERB
ghmj-1231	202	5	gene	gene	NOUN
ghmj-1231	202	6	polymorphism	polymorphism	NOUN
ghmj-1231	202	7	as	as	ADP
ghmj-1231	202	8	a	a	DET
ghmj-1231	202	9	risk	risk	NOUN
ghmj-1231	202	10	factor	factor	NOUN
ghmj-1231	202	11	of	of	ADP
ghmj-1231	202	12	obesity	obesity	NOUN
ghmj-1231	202	13	in	in	ADP
ghmj-1231	202	14	adults	adult	NOUN
ghmj-1231	202	15	.	.	PUNCT
ghmj-1231	203	1	ghmj	ghmj	PROPN
ghmj-1231	203	2	(	(	PUNCT
ghmj-1231	203	3	global	global	ADJ
ghmj-1231	203	4	health	health	PROPN
ghmj-1231	203	5	management	management	NOUN
ghmj-1231	203	6	journal	journal	PROPN
ghmj-1231	203	7	)	)	PUNCT
ghmj-1231	203	8	,	,	PUNCT
ghmj-1231	203	9	7(1	7(1	NUM
ghmj-1231	203	10	)	)	PUNCT
ghmj-1231	203	11	,	,	PUNCT
ghmj-1231	203	12	27–32	27–32	NUM
ghmj-1231	203	13	.	.	PUNCT
ghmj-1231	204	1	https://doi.org/10.35898/ghmj-71967	https://doi.org/10.35898/ghmj-71967	PROPN
ghmj-1231	204	2	sherwood	sherwood	PROPN
ghmj-1231	204	3	,	,	PUNCT
ghmj-1231	204	4	l.	l.	PROPN
ghmj-1231	204	5	(	(	PUNCT
ghmj-1231	204	6	2013	2013	NUM
ghmj-1231	204	7	)	)	PUNCT
ghmj-1231	204	8	.	.	PUNCT
ghmj-1231	205	1	introduction	introduction	NOUN
ghmj-1231	205	2	to	to	ADP
ghmj-1231	205	3	human	human	ADJ
ghmj-1231	205	4	physiology	physiology	NOUN
ghmj-1231	205	5	.	.	PUNCT
ghmj-1231	206	1	brooks	brooks	PROPN
ghmj-1231	206	2	/	/	SYM
ghmj-1231	206	3	cole	cole	PROPN
ghmj-1231	206	4	,	,	PUNCT
ghmj-1231	206	5	cengage	cengage	PROPN
ghmj-1231	206	6	learning	learning	PROPN
ghmj-1231	206	7	.	.	PUNCT
ghmj-1231	207	1	unger	unger	PROPN
ghmj-1231	207	2	,	,	PUNCT
ghmj-1231	207	3	t.	t.	PROPN
ghmj-1231	207	4	,	,	PUNCT
ghmj-1231	207	5	borghi	borghi	PROPN
ghmj-1231	207	6	,	,	PUNCT
ghmj-1231	207	7	c.	c.	PROPN
ghmj-1231	207	8	,	,	PUNCT
ghmj-1231	207	9	charchar	charchar	PROPN
ghmj-1231	207	10	,	,	PUNCT
ghmj-1231	207	11	f.	f.	PROPN
ghmj-1231	207	12	,	,	PUNCT
ghmj-1231	207	13	khan	khan	PROPN
ghmj-1231	207	14	,	,	PUNCT
ghmj-1231	207	15	n.	n.	PROPN
ghmj-1231	207	16	a.	a.	PROPN
ghmj-1231	207	17	,	,	PUNCT
ghmj-1231	207	18	poulter	poulter	NOUN
ghmj-1231	207	19	,	,	PUNCT
ghmj-1231	207	20	n.	n.	PROPN
ghmj-1231	207	21	r.	r.	PROPN
ghmj-1231	207	22	,	,	PUNCT
ghmj-1231	207	23	prabhakaran	prabhakaran	PROPN
ghmj-1231	207	24	,	,	PUNCT
ghmj-1231	207	25	d.	d.	PROPN
ghmj-1231	207	26	,	,	PUNCT
ghmj-1231	207	27	…	…	PUNCT
ghmj-1231	207	28	schutte	schutte	NOUN
ghmj-1231	207	29	,	,	PUNCT
ghmj-1231	207	30	a.	a.	PROPN
ghmj-1231	207	31	e.	e.	PROPN
ghmj-1231	207	32	(	(	PUNCT
ghmj-1231	207	33	2020	2020	NUM
ghmj-1231	207	34	)	)	PUNCT
ghmj-1231	207	35	.	.	PUNCT
ghmj-1231	208	1	2020	2020	NUM
ghmj-1231	208	2	international	international	ADJ
ghmj-1231	208	3	society	society	NOUN
ghmj-1231	208	4	of	of	ADP
ghmj-1231	208	5	hypertension	hypertension	NOUN
ghmj-1231	208	6	global	global	ADJ
ghmj-1231	208	7	hypertension	hypertension	NOUN
ghmj-1231	208	8	practice	practice	NOUN
ghmj-1231	208	9	guidelines	guideline	NOUN
ghmj-1231	208	10	.	.	PUNCT
ghmj-1231	209	1	hypertension	hypertension	NOUN
ghmj-1231	209	2	,	,	PUNCT
ghmj-1231	209	3	75(6	75(6	NUM
ghmj-1231	209	4	)	)	PUNCT
ghmj-1231	209	5	,	,	PUNCT
ghmj-1231	209	6	1334–1357	1334–1357	NUM
ghmj-1231	209	7	.	.	PUNCT
ghmj-1231	210	1	https://doi.org/10.1161/hypertensionaha.120.15026	https://doi.org/10.1161/hypertensionaha.120.15026	PROPN
ghmj-1231	210	2	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ace2	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ace2	NOUN
ghmj-1231	210	3	https://doi.org/10.1016/j.amjhyper.2004.02.022	https://doi.org/10.1016/j.amjhyper.2004.02.022	PROPN
ghmj-1231	210	4	https://doi.org/10.1016/j.amjhyper.2004.02.022	https://doi.org/10.1016/j.amjhyper.2004.02.022	PROPN
ghmj-1231	210	5	https://doi.org/10.1016/j.tem.2004.03.001	https://doi.org/10.1016/j.tem.2004.03.001	PROPN
ghmj-1231	211	1	https://doi.org/10.3389/fendo.2013.00201	https://doi.org/10.3389/fendo.2013.00201	PROPN
ghmj-1231	211	2	https://doi.org/10.1038/aps.2009.110	https://doi.org/10.1038/aps.2009.110	PROPN
ghmj-1231	211	3	https://doi.org/10.1253/circj.cj-10-0045	https://doi.org/10.1253/circj.cj-10-0045	PROPN
ghmj-1231	211	4	https://doi.org/10.35898/ghmj-741044	https://doi.org/10.35898/ghmj-741044	PROPN
ghmj-1231	211	5	https://doi.org/10.3389/fphys.2012.00364	https://doi.org/10.3389/fphys.2012.00364	PROPN
ghmj-1231	211	6	https://doi.org/10.1375/twin.14.4.295	https://doi.org/10.1375/twin.14.4.295	PROPN
ghmj-1231	211	7	https://p2ptm.kemkes.go.id/infographic/faktor-risiko-hipertensi-yang-dapat-diubah-dan-tidak-dapat-diubah	https://p2ptm.kemkes.go.id/infographic/faktor-risiko-hipertensi-yang-dapat-diubah-dan-tidak-dapat-diubah	NOUN
ghmj-1231	211	8	https://doi.org/10.3855/jidc.17762	https://doi.org/10.3855/jidc.17762	ADJ
ghmj-1231	211	9	https://doi.org/10.35898/ghmj-71967	https://doi.org/10.35898/ghmj-71967	PROPN
ghmj-1231	211	10	https://doi.org/10.1161/hypertensionaha.120.15026	https://doi.org/10.1161/hypertensionaha.120.15026	NUM
ghmj-1231	211	11	husna	husna	ADJ
ghmj-1231	211	12	,	,	PUNCT
ghmj-1231	211	13	et	et	PROPN
ghmj-1231	211	14	.	.	PUNCT
ghmj-1231	212	1	al	al	PROPN
ghmj-1231	212	2	ghmj	ghmj	PROPN
ghmj-1231	212	3	(	(	PUNCT
ghmj-1231	212	4	global	global	ADJ
ghmj-1231	212	5	health	health	PROPN
ghmj-1231	212	6	management	management	NOUN
ghmj-1231	212	7	journal	journal	PROPN
ghmj-1231	212	8	)	)	PUNCT
ghmj-1231	212	9	2025	2025	NUM
ghmj-1231	212	10	,	,	PUNCT
ghmj-1231	212	11	vol	vol	NOUN
ghmj-1231	212	12	.	.	NOUN
ghmj-1231	212	13	8	8	NUM
ghmj-1231	212	14	,	,	PUNCT
ghmj-1231	212	15	no	no	INTJ
ghmj-1231	212	16	.	.	PUNCT
ghmj-1231	213	1	2s	2s	NOUN
ghmj-1231	213	2	292	292	NUM
ghmj-1231	213	3	world	world	NOUN
ghmj-1231	213	4	health	health	NOUN
ghmj-1231	213	5	organization	organization	NOUN
ghmj-1231	213	6	.	.	PUNCT
ghmj-1231	214	1	(	(	PUNCT
ghmj-1231	214	2	2023	2023	NUM
ghmj-1231	214	3	)	)	PUNCT
ghmj-1231	214	4	.	.	PUNCT
ghmj-1231	215	1	global	global	ADJ
ghmj-1231	215	2	report	report	NOUN
ghmj-1231	215	3	on	on	ADP
ghmj-1231	215	4	hypertension	hypertension	NOUN
ghmj-1231	215	5	.	.	PUNCT
ghmj-1231	216	1	yan	yan	PROPN
ghmj-1231	216	2	,	,	PUNCT
ghmj-1231	216	3	q.	q.	PROPN
ghmj-1231	216	4	,	,	PUNCT
ghmj-1231	216	5	xu	xu	PROPN
ghmj-1231	216	6	,	,	PUNCT
ghmj-1231	216	7	c.	c.	PROPN
ghmj-1231	216	8	,	,	PUNCT
ghmj-1231	216	9	li	li	PROPN
ghmj-1231	216	10	,	,	PUNCT
ghmj-1231	216	11	z.	z.	PROPN
ghmj-1231	216	12	,	,	PUNCT
ghmj-1231	216	13	zhou	zhou	PROPN
ghmj-1231	216	14	,	,	PUNCT
ghmj-1231	216	15	p.	p.	NOUN
ghmj-1231	216	16	,	,	PUNCT
ghmj-1231	216	17	ye	ye	PROPN
ghmj-1231	216	18	,	,	PUNCT
ghmj-1231	216	19	r.	r.	PROPN
ghmj-1231	216	20	,	,	PUNCT
ghmj-1231	216	21	li	li	PROPN
ghmj-1231	216	22	,	,	PUNCT
ghmj-1231	216	23	m.	m.	NOUN
ghmj-1231	216	24	,	,	PUNCT
ghmj-1231	216	25	&	&	CCONJ
ghmj-1231	216	26	jiang	jiang	PROPN
ghmj-1231	216	27	,	,	PUNCT
ghmj-1231	216	28	c.	c.	PROPN
ghmj-1231	216	29	(	(	PUNCT
ghmj-1231	216	30	2008	2008	NUM
ghmj-1231	216	31	)	)	PUNCT
ghmj-1231	216	32	.	.	PUNCT
ghmj-1231	217	1	[	[	X
ghmj-1231	217	2	relationship	relationship	NOUN
ghmj-1231	217	3	of	of	ADP
ghmj-1231	217	4	angiotensin	angiotensin	NOUN
ghmj-1231	217	5	-	-	PUNCT
ghmj-1231	217	6	converting	convert	VERB
ghmj-1231	217	7	enzyme	enzyme	NOUN
ghmj-1231	217	8	2	2	NUM
ghmj-1231	217	9	gene	gene	NOUN
ghmj-1231	217	10	polymorphisms	polymorphism	NOUN
ghmj-1231	217	11	and	and	CCONJ
ghmj-1231	217	12	vulnerability	vulnerability	NOUN
ghmj-1231	217	13	to	to	ADP
ghmj-1231	217	14	coronary	coronary	ADJ
ghmj-1231	217	15	heart	heart	NOUN
ghmj-1231	217	16	disease	disease	NOUN
ghmj-1231	217	17	in	in	ADP
ghmj-1231	217	18	patients	patient	NOUN
ghmj-1231	217	19	with	with	ADP
ghmj-1231	217	20	type	type	NOUN
ghmj-1231	217	21	2	2	NUM
ghmj-1231	217	22	diabetes	diabetes	NOUN
ghmj-1231	217	23	mellitus	mellitus	NOUN
ghmj-1231	217	24	]	]	PUNCT
ghmj-1231	217	25	.	.	PUNCT
ghmj-1231	218	1	nan	nan	PROPN
ghmj-1231	218	2	fang	fang	PROPN
ghmj-1231	218	3	yi	yi	PROPN
ghmj-1231	218	4	ke	ke	PROPN
ghmj-1231	218	5	da	da	PROPN
ghmj-1231	218	6	xue	xue	PROPN
ghmj-1231	218	7	xue	xue	PROPN
ghmj-1231	218	8	bao	bao	PROPN
ghmj-1231	218	9	=	=	PUNCT
ghmj-1231	218	10	journal	journal	PROPN
ghmj-1231	218	11	of	of	ADP
ghmj-1231	218	12	southern	southern	PROPN
ghmj-1231	218	13	medical	medical	PROPN
ghmj-1231	218	14	university	university	PROPN
ghmj-1231	218	15	,	,	PUNCT
ghmj-1231	218	16	28(8	28(8	NUM
ghmj-1231	218	17	)	)	PUNCT
ghmj-1231	218	18	,	,	PUNCT
ghmj-1231	218	19	1365–1368	1365–1368	NUM
ghmj-1231	218	20	.	.	PUNCT
ghmj-1231	219	1	https://pubmed.ncbi.nlm.nih.gov/18753062/	https://pubmed.ncbi.nlm.nih.gov/18753062/	PROPN
ghmj-1231	219	2	yang	yang	PROPN
ghmj-1231	219	3	,	,	PUNCT
ghmj-1231	219	4	m.	m.	NOUN
ghmj-1231	219	5	,	,	PUNCT
ghmj-1231	219	6	zhao	zhao	PROPN
ghmj-1231	219	7	,	,	PUNCT
ghmj-1231	219	8	j.	j.	PROPN
ghmj-1231	219	9	,	,	PUNCT
ghmj-1231	219	10	xing	xing	PROPN
ghmj-1231	219	11	,	,	PUNCT
ghmj-1231	219	12	l.	l.	PROPN
ghmj-1231	219	13	,	,	PUNCT
ghmj-1231	219	14	&	&	CCONJ
ghmj-1231	219	15	shi	shi	PROPN
ghmj-1231	219	16	,	,	PUNCT
ghmj-1231	219	17	l.	l.	PROPN
ghmj-1231	219	18	(	(	PUNCT
ghmj-1231	219	19	2015	2015	NUM
ghmj-1231	219	20	)	)	PUNCT
ghmj-1231	219	21	.	.	PUNCT
ghmj-1231	220	1	the	the	DET
ghmj-1231	220	2	association	association	NOUN
ghmj-1231	220	3	between	between	ADP
ghmj-1231	220	4	angiotensinconverting	angiotensinconverte	VERB
ghmj-1231	220	5	enzyme	enzyme	NOUN
ghmj-1231	220	6	2	2	NUM
ghmj-1231	220	7	polymorphisms	polymorphism	NOUN
ghmj-1231	220	8	and	and	CCONJ
ghmj-1231	220	9	essential	essential	ADJ
ghmj-1231	220	10	hypertension	hypertension	NOUN
ghmj-1231	220	11	risk	risk	NOUN
ghmj-1231	220	12	:	:	PUNCT
ghmj-1231	220	13	a	a	DET
ghmj-1231	220	14	metaanalysis	metaanalysis	NOUN
ghmj-1231	220	15	involving	involve	VERB
ghmj-1231	220	16	14,122	14,122	NUM
ghmj-1231	220	17	patients	patient	NOUN
ghmj-1231	220	18	.	.	PUNCT
ghmj-1231	221	1	jraas	jraas	ADJ
ghmj-1231	221	2	journal	journal	NOUN
ghmj-1231	221	3	of	of	ADP
ghmj-1231	221	4	the	the	DET
ghmj-1231	221	5	renin	renin	ADJ
ghmj-1231	221	6	-	-	PUNCT
ghmj-1231	221	7	angiotensin	angiotensin	NOUN
ghmj-1231	221	8	-	-	PUNCT
ghmj-1231	221	9	aldosterone	aldosterone	NOUN
ghmj-1231	221	10	system	system	NOUN
ghmj-1231	221	11	,	,	PUNCT
ghmj-1231	221	12	16(4	16(4	NUM
ghmj-1231	221	13	)	)	PUNCT
ghmj-1231	221	14	,	,	PUNCT
ghmj-1231	221	15	1240–1244	1240–1244	NUM
ghmj-1231	221	16	.	.	PUNCT
ghmj-1231	222	1	https://doi.org/10.1177/1470320314549221	https://doi.org/10.1177/1470320314549221	PROPN
ghmj-1231	222	2	yang	yang	PROPN
ghmj-1231	222	3	,	,	PUNCT
ghmj-1231	222	4	y.	y.	PROPN
ghmj-1231	222	5	l.	l.	PROPN
ghmj-1231	222	6	,	,	PUNCT
ghmj-1231	222	7	mo	mo	PROPN
ghmj-1231	222	8	,	,	PUNCT
ghmj-1231	222	9	y.	y.	PROPN
ghmj-1231	222	10	p.	p.	PROPN
ghmj-1231	222	11	,	,	PUNCT
ghmj-1231	222	12	he	he	PRON
ghmj-1231	222	13	,	,	PUNCT
ghmj-1231	222	14	y.	y.	PROPN
ghmj-1231	222	15	s.	s.	PROPN
ghmj-1231	222	16	,	,	PUNCT
ghmj-1231	222	17	yang	yang	PROPN
ghmj-1231	222	18	,	,	PUNCT
ghmj-1231	222	19	f.	f.	PROPN
ghmj-1231	222	20	,	,	PUNCT
ghmj-1231	222	21	xu	xu	PROPN
ghmj-1231	222	22	,	,	PUNCT
ghmj-1231	222	23	y.	y.	PROPN
ghmj-1231	222	24	,	,	PUNCT
ghmj-1231	222	25	li	li	PROPN
ghmj-1231	222	26	,	,	PUNCT
ghmj-1231	222	27	c.	c.	PROPN
ghmj-1231	222	28	c.	c.	PROPN
ghmj-1231	222	29	,	,	PUNCT
ghmj-1231	222	30	…	…	PUNCT
ghmj-1231	222	31	long	long	ADV
ghmj-1231	222	32	,	,	PUNCT
ghmj-1231	222	33	l.	l.	PROPN
ghmj-1231	222	34	(	(	PUNCT
ghmj-1231	222	35	2015	2015	NUM
ghmj-1231	222	36	)	)	PUNCT
ghmj-1231	222	37	.	.	PUNCT
ghmj-1231	223	1	correlation	correlation	NOUN
ghmj-1231	223	2	between	between	ADP
ghmj-1231	223	3	renin	renin	ADJ
ghmj-1231	223	4	-	-	PUNCT
ghmj-1231	223	5	angiotensin	angiotensin	NOUN
ghmj-1231	223	6	system	system	NOUN
ghmj-1231	223	7	gene	gene	NOUN
ghmj-1231	223	8	polymorphisms	polymorphism	NOUN
ghmj-1231	223	9	and	and	CCONJ
ghmj-1231	223	10	essential	essential	ADJ
ghmj-1231	223	11	hypertension	hypertension	NOUN
ghmj-1231	223	12	in	in	ADP
ghmj-1231	223	13	the	the	DET
ghmj-1231	223	14	chinese	chinese	ADJ
ghmj-1231	223	15	yi	yi	PROPN
ghmj-1231	223	16	ethnic	ethnic	ADJ
ghmj-1231	223	17	group	group	NOUN
ghmj-1231	223	18	.	.	PUNCT
ghmj-1231	224	1	jraas	jraas	ADJ
ghmj-1231	224	2	journal	journal	NOUN
ghmj-1231	224	3	of	of	ADP
ghmj-1231	224	4	the	the	DET
ghmj-1231	224	5	renin	renin	ADJ
ghmj-1231	224	6	-	-	PUNCT
ghmj-1231	224	7	angiotensinaldosterone	angiotensinaldosterone	NOUN
ghmj-1231	224	8	system	system	NOUN
ghmj-1231	224	9	,	,	PUNCT
ghmj-1231	224	10	16(4	16(4	NUM
ghmj-1231	224	11	)	)	PUNCT
ghmj-1231	224	12	,	,	PUNCT
ghmj-1231	224	13	975–981	975–981	NUM
ghmj-1231	224	14	.	.	PUNCT
ghmj-1231	224	15	https://doi.org/10.1177/1470320315598697	https://doi.org/10.1177/1470320315598697	PROPN
ghmj-1231	224	16	yi	yi	PROPN
ghmj-1231	224	17	,	,	PUNCT
ghmj-1231	224	18	l.	l.	PROPN
ghmj-1231	224	19	,	,	PUNCT
ghmj-1231	224	20	gu	gu	PROPN
ghmj-1231	224	21	,	,	PUNCT
ghmj-1231	224	22	y.	y.	PROPN
ghmj-1231	224	23	h.	h.	PROPN
ghmj-1231	224	24	,	,	PUNCT
ghmj-1231	224	25	wang	wang	PROPN
ghmj-1231	224	26	,	,	PUNCT
ghmj-1231	224	27	x.	x.	PROPN
ghmj-1231	224	28	l.	l.	PROPN
ghmj-1231	224	29	,	,	PUNCT
ghmj-1231	224	30	an	an	PROPN
ghmj-1231	224	31	,	,	PUNCT
ghmj-1231	224	32	l.	l.	PROPN
ghmj-1231	224	33	z.	z.	PROPN
ghmj-1231	224	34	,	,	PUNCT
ghmj-1231	224	35	xie	xie	PROPN
ghmj-1231	224	36	,	,	PUNCT
ghmj-1231	224	37	x.	x.	PROPN
ghmj-1231	224	38	d.	d.	PROPN
ghmj-1231	224	39	,	,	PUNCT
ghmj-1231	224	40	shao	shao	PROPN
ghmj-1231	224	41	,	,	PUNCT
ghmj-1231	224	42	w.	w.	PROPN
ghmj-1231	224	43	,	,	PUNCT
ghmj-1231	224	44	…	…	PUNCT
ghmj-1231	224	45	zhang	zhang	PROPN
ghmj-1231	224	46	,	,	PUNCT
ghmj-1231	224	47	d.	d.	PROPN
ghmj-1231	224	48	l.	l.	PROPN
ghmj-1231	224	49	(	(	PUNCT
ghmj-1231	224	50	2006	2006	NUM
ghmj-1231	224	51	)	)	PUNCT
ghmj-1231	224	52	.	.	PUNCT
ghmj-1231	225	1	association	association	NOUN
ghmj-1231	225	2	of	of	ADP
ghmj-1231	225	3	ace	ace	PROPN
ghmj-1231	225	4	,	,	PUNCT
ghmj-1231	225	5	ace2	ace2	PROPN
ghmj-1231	225	6	and	and	CCONJ
ghmj-1231	225	7	uts2	uts2	PROPN
ghmj-1231	225	8	polymorphisms	polymorphism	NOUN
ghmj-1231	225	9	wih	wih	VERB
ghmj-1231	225	10	essential	essential	ADJ
ghmj-1231	225	11	hypertension	hypertension	NOUN
ghmj-1231	225	12	in	in	ADP
ghmj-1231	225	13	han	han	PROPN
ghmj-1231	225	14	and	and	CCONJ
ghmj-1231	225	15	dongxiang	dongxiang	PROPN
ghmj-1231	225	16	populations	population	NOUN
ghmj-1231	225	17	from	from	ADP
ghmj-1231	225	18	north	north	NOUN
ghmj-1231	225	19	-	-	PUNCT
ghmj-1231	225	20	western	western	ADJ
ghmj-1231	225	21	china	china	PROPN
ghmj-1231	225	22	.	.	PUNCT
ghmj-1231	226	1	journal	journal	PROPN
ghmj-1231	226	2	of	of	ADP
ghmj-1231	226	3	international	international	ADJ
ghmj-1231	226	4	medical	medical	ADJ
ghmj-1231	226	5	research	research	NOUN
ghmj-1231	226	6	,	,	PUNCT
ghmj-1231	226	7	34(3	34(3	NUM
ghmj-1231	226	8	)	)	PUNCT
ghmj-1231	226	9	,	,	PUNCT
ghmj-1231	226	10	272–283	272–283	NUM
ghmj-1231	226	11	.	.	PUNCT
ghmj-1231	227	1	https://doi.org/10.1177/147323000603400306	https://doi.org/10.1177/147323000603400306	NUM
ghmj-1231	227	2	younas	youna	NOUN
ghmj-1231	227	3	,	,	PUNCT
ghmj-1231	227	4	h.	h.	PROPN
ghmj-1231	227	5	,	,	PUNCT
ghmj-1231	227	6	ijaz	ijaz	PROPN
ghmj-1231	227	7	,	,	PUNCT
ghmj-1231	227	8	t.	t.	PROPN
ghmj-1231	227	9	,	,	PUNCT
ghmj-1231	227	10	&	&	CCONJ
ghmj-1231	227	11	choudhry	choudhry	PROPN
ghmj-1231	227	12	,	,	PUNCT
ghmj-1231	227	13	n.	n.	NOUN
ghmj-1231	227	14	(	(	PUNCT
ghmj-1231	227	15	2022	2022	NUM
ghmj-1231	227	16	)	)	PUNCT
ghmj-1231	227	17	.	.	PUNCT
ghmj-1231	228	1	investigation	investigation	NOUN
ghmj-1231	228	2	of	of	ADP
ghmj-1231	228	3	angiotensin-1	angiotensin-1	NUM
ghmj-1231	228	4	converting	convert	VERB
ghmj-1231	228	5	enzyme	enzyme	NOUN
ghmj-1231	228	6	2	2	NUM
ghmj-1231	228	7	gene	gene	NOUN
ghmj-1231	228	8	(	(	PUNCT
ghmj-1231	228	9	g8790a	g8790a	NOUN
ghmj-1231	228	10	)	)	PUNCT
ghmj-1231	228	11	polymorphism	polymorphism	NOUN
ghmj-1231	228	12	in	in	ADP
ghmj-1231	228	13	patients	patient	NOUN
ghmj-1231	228	14	of	of	ADP
ghmj-1231	228	15	type	type	NOUN
ghmj-1231	228	16	2	2	NUM
ghmj-1231	228	17	diabetes	diabetes	NOUN
ghmj-1231	228	18	mellitus	mellitus	NOUN
ghmj-1231	228	19	with	with	ADP
ghmj-1231	228	20	diabetic	diabetic	ADJ
ghmj-1231	228	21	nephropathy	nephropathy	NOUN
ghmj-1231	228	22	in	in	ADP
ghmj-1231	228	23	pakistani	pakistani	ADJ
ghmj-1231	228	24	population	population	NOUN
ghmj-1231	228	25	.	.	PUNCT
ghmj-1231	229	1	plos	plos	PROPN
ghmj-1231	229	2	one	one	NUM
ghmj-1231	229	3	,	,	PUNCT
ghmj-1231	229	4	17(2	17(2	NUM
ghmj-1231	229	5	february	february	PROPN
ghmj-1231	229	6	)	)	PUNCT
ghmj-1231	229	7	,	,	PUNCT
ghmj-1231	229	8	1–16	1–16	PROPN
ghmj-1231	229	9	.	.	PUNCT
ghmj-1231	230	1	https://doi.org/10.1371/journal.pone.0264038	https://doi.org/10.1371/journal.pone.0264038	PROPN
ghmj-1231	230	2	zhang	zhang	PROPN
ghmj-1231	230	3	,	,	PUNCT
ghmj-1231	230	4	x.	x.	PROPN
ghmj-1231	230	5	,	,	PUNCT
ghmj-1231	230	6	wang	wang	PROPN
ghmj-1231	230	7	,	,	PUNCT
ghmj-1231	230	8	y.	y.	PROPN
ghmj-1231	230	9	,	,	PUNCT
ghmj-1231	230	10	zheng	zheng	PROPN
ghmj-1231	230	11	,	,	PUNCT
ghmj-1231	230	12	y.	y.	PROPN
ghmj-1231	230	13	,	,	PUNCT
ghmj-1231	230	14	yuan	yuan	PROPN
ghmj-1231	230	15	,	,	PUNCT
ghmj-1231	230	16	j.	j.	PROPN
ghmj-1231	230	17	,	,	PUNCT
ghmj-1231	230	18	tong	tong	PROPN
ghmj-1231	230	19	,	,	PUNCT
ghmj-1231	230	20	j.	j.	PROPN
ghmj-1231	230	21	,	,	PUNCT
ghmj-1231	230	22	xu	xu	PROPN
ghmj-1231	230	23	,	,	PUNCT
ghmj-1231	230	24	j.	j.	PROPN
ghmj-1231	230	25	,	,	PUNCT
ghmj-1231	230	26	…	…	PUNCT
ghmj-1231	230	27	li	li	PROPN
ghmj-1231	230	28	,	,	PUNCT
ghmj-1231	230	29	x.	x.	NOUN
ghmj-1231	230	30	(	(	PUNCT
ghmj-1231	230	31	2022	2022	NUM
ghmj-1231	230	32	)	)	PUNCT
ghmj-1231	230	33	.	.	PUNCT
ghmj-1231	231	1	effect	effect	NOUN
ghmj-1231	231	2	of	of	ADP
ghmj-1231	231	3	ace	ace	NOUN
ghmj-1231	231	4	,	,	PUNCT
ghmj-1231	231	5	ace2	ace2	NOUN
ghmj-1231	231	6	and	and	CCONJ
ghmj-1231	231	7	cyp11b2	cyp11b2	NOUN
ghmj-1231	231	8	gene	gene	NOUN
ghmj-1231	231	9	polymorphisms	polymorphism	NOUN
ghmj-1231	231	10	and	and	CCONJ
ghmj-1231	231	11	noise	noise	NOUN
ghmj-1231	231	12	on	on	ADP
ghmj-1231	231	13	essential	essential	ADJ
ghmj-1231	231	14	hypertension	hypertension	NOUN
ghmj-1231	231	15	among	among	ADP
ghmj-1231	231	16	steelworkers	steelworker	NOUN
ghmj-1231	231	17	in	in	ADP
ghmj-1231	231	18	china	china	PROPN
ghmj-1231	231	19	:	:	PUNCT
ghmj-1231	231	20	a	a	DET
ghmj-1231	231	21	case	case	NOUN
ghmj-1231	231	22	–	–	PUNCT
ghmj-1231	231	23	control	control	NOUN
ghmj-1231	231	24	study	study	NOUN
ghmj-1231	231	25	.	.	PUNCT
ghmj-1231	232	1	bmc	bmc	PROPN
ghmj-1231	232	2	medical	medical	ADJ
ghmj-1231	232	3	genomics	genomic	NOUN
ghmj-1231	232	4	,	,	PUNCT
ghmj-1231	232	5	15(1	15(1	NUM
ghmj-1231	232	6	)	)	PUNCT
ghmj-1231	232	7	,	,	PUNCT
ghmj-1231	232	8	1–10	1–10	NOUN
ghmj-1231	232	9	.	.	PUNCT
ghmj-1231	233	1	https://doi.org/10.1186/s12920-022-01177-0	https://doi.org/10.1186/s12920-022-01177-0	NUM
ghmj-1231	234	1	zhou	zhou	PROPN
ghmj-1231	234	2	,	,	PUNCT
ghmj-1231	234	3	b.	b.	PROPN
ghmj-1231	234	4	,	,	PUNCT
ghmj-1231	234	5	carrillo	carrillo	PROPN
ghmj-1231	234	6	-	-	PUNCT
ghmj-1231	234	7	larco	larco	PROPN
ghmj-1231	234	8	,	,	PUNCT
ghmj-1231	234	9	r.	r.	PROPN
ghmj-1231	234	10	m.	m.	PROPN
ghmj-1231	234	11	,	,	PUNCT
ghmj-1231	234	12	danaei	danaei	PROPN
ghmj-1231	234	13	,	,	PUNCT
ghmj-1231	234	14	g.	g.	PROPN
ghmj-1231	234	15	,	,	PUNCT
ghmj-1231	234	16	riley	riley	PROPN
ghmj-1231	234	17	,	,	PUNCT
ghmj-1231	234	18	l.	l.	PROPN
ghmj-1231	234	19	m.	m.	PROPN
ghmj-1231	234	20	,	,	PUNCT
ghmj-1231	234	21	paciorek	paciorek	PROPN
ghmj-1231	234	22	,	,	PUNCT
ghmj-1231	234	23	c.	c.	PROPN
ghmj-1231	234	24	j.	j.	PROPN
ghmj-1231	234	25	,	,	PUNCT
ghmj-1231	234	26	stevens	stevens	PROPN
ghmj-1231	234	27	,	,	PUNCT
ghmj-1231	234	28	g.	g.	PROPN
ghmj-1231	234	29	a.	a.	PROPN
ghmj-1231	234	30	,	,	PUNCT
ghmj-1231	234	31	…	…	PUNCT
ghmj-1231	234	32	zuñiga	zuñiga	PROPN
ghmj-1231	234	33	cisneros	cisneros	PROPN
ghmj-1231	234	34	,	,	PUNCT
ghmj-1231	234	35	j.	j.	PROPN
ghmj-1231	234	36	(	(	PUNCT
ghmj-1231	234	37	2021	2021	NUM
ghmj-1231	234	38	)	)	PUNCT
ghmj-1231	234	39	.	.	PUNCT
ghmj-1231	235	1	worldwide	worldwide	ADJ
ghmj-1231	235	2	trends	trend	NOUN
ghmj-1231	235	3	in	in	ADP
ghmj-1231	235	4	hypertension	hypertension	NOUN
ghmj-1231	235	5	prevalence	prevalence	NOUN
ghmj-1231	235	6	and	and	CCONJ
ghmj-1231	235	7	progress	progress	NOUN
ghmj-1231	235	8	in	in	ADP
ghmj-1231	235	9	treatment	treatment	NOUN
ghmj-1231	235	10	and	and	CCONJ
ghmj-1231	235	11	control	control	NOUN
ghmj-1231	235	12	from	from	ADP
ghmj-1231	235	13	1990	1990	NUM
ghmj-1231	235	14	to	to	ADP
ghmj-1231	235	15	2019	2019	NUM
ghmj-1231	235	16	:	:	PUNCT
ghmj-1231	235	17	a	a	DET
ghmj-1231	235	18	pooled	pooled	ADJ
ghmj-1231	235	19	analysis	analysis	NOUN
ghmj-1231	235	20	of	of	ADP
ghmj-1231	235	21	1201	1201	NUM
ghmj-1231	235	22	population	population	NOUN
ghmj-1231	235	23	-	-	PUNCT
ghmj-1231	235	24	representative	representative	NOUN
ghmj-1231	235	25	studies	study	NOUN
ghmj-1231	235	26	with	with	ADP
ghmj-1231	235	27	104	104	NUM
ghmj-1231	235	28	million	million	NUM
ghmj-1231	235	29	participants	participant	NOUN
ghmj-1231	235	30	.	.	PUNCT
ghmj-1231	236	1	the	the	DET
ghmj-1231	236	2	lancet	lancet	PROPN
ghmj-1231	236	3	,	,	PUNCT
ghmj-1231	236	4	398(10304	398(10304	NUM
ghmj-1231	236	5	)	)	PUNCT
ghmj-1231	236	6	,	,	PUNCT
ghmj-1231	236	7	957–980	957–980	NUM
ghmj-1231	236	8	.	.	PUNCT
ghmj-1231	237	1	https://doi.org/10.1016/s0140-6736(21)01330-1	https://doi.org/10.1016/s0140-6736(21)01330-1	PROPN
ghmj-1231	237	2	cite	cite	VERB
ghmj-1231	237	3	this	this	DET
ghmj-1231	237	4	article	article	NOUN
ghmj-1231	237	5	as	as	ADP
ghmj-1231	237	6	:	:	PUNCT
ghmj-1231	237	7	husna	husna	ADJ
ghmj-1231	237	8	,	,	PUNCT
ghmj-1231	237	9	n.	n.	PROPN
ghmj-1231	237	10	,	,	PUNCT
ghmj-1231	237	11	nauphar	nauphar	PROPN
ghmj-1231	237	12	,	,	PUNCT
ghmj-1231	237	13	d.	d.	PROPN
ghmj-1231	237	14	,	,	PUNCT
ghmj-1231	237	15	&	&	CCONJ
ghmj-1231	237	16	pratamawati	pratamawati	PROPN
ghmj-1231	237	17	,	,	PUNCT
ghmj-1231	237	18	t.	t.	NOUN
ghmj-1231	237	19	m.	m.	NOUN
ghmj-1231	237	20	(	(	PUNCT
ghmj-1231	237	21	2025	2025	NUM
ghmj-1231	237	22	)	)	PUNCT
ghmj-1231	237	23	.	.	PUNCT
ghmj-1231	238	1	angiotensin	angiotensin	NOUN
ghmj-1231	238	2	converting	convert	VERB
ghmj-1231	238	3	enzyme	enzyme	NOUN
ghmj-1231	238	4	2	2	NUM
ghmj-1231	238	5	(	(	PUNCT
ghmj-1231	238	6	ace2	ace2	PROPN
ghmj-1231	238	7	)	)	PUNCT
ghmj-1231	238	8	g8790a	g8790a	PROPN
ghmj-1231	238	9	gene	gene	NOUN
ghmj-1231	238	10	polymorphism	polymorphism	NOUN
ghmj-1231	238	11	as	as	ADP
ghmj-1231	238	12	a	a	DET
ghmj-1231	238	13	risk	risk	NOUN
ghmj-1231	238	14	factor	factor	NOUN
ghmj-1231	238	15	for	for	ADP
ghmj-1231	238	16	essential	essential	ADJ
ghmj-1231	238	17	hypertension	hypertension	NOUN
ghmj-1231	238	18	.	.	PUNCT
ghmj-1231	239	1	ghmj	ghmj	PROPN
ghmj-1231	239	2	(	(	PUNCT
ghmj-1231	239	3	global	global	ADJ
ghmj-1231	239	4	health	health	PROPN
ghmj-1231	239	5	management	management	NOUN
ghmj-1231	239	6	journal	journal	PROPN
ghmj-1231	239	7	)	)	PUNCT
ghmj-1231	239	8	,	,	PUNCT
ghmj-1231	239	9	8(2s	8(2s	NUM
ghmj-1231	239	10	)	)	PUNCT
ghmj-1231	239	11	,	,	PUNCT
ghmj-1231	239	12	285–292	285–292	NUM
ghmj-1231	239	13	.	.	PUNCT
ghmj-1231	240	1	https://doi.org/10.35898/ghmj-82s1231	https://doi.org/10.35898/ghmj-82s1231	PROPN
ghmj-1231	240	2	https://pubmed.ncbi.nlm.nih.gov/18753062/	https://pubmed.ncbi.nlm.nih.gov/18753062/	PRON
ghmj-1231	240	3	https://doi.org/10.1177/1470320314549221	https://doi.org/10.1177/1470320314549221	VERB
ghmj-1231	240	4	https://doi.org/10.1177/1470320315598697	https://doi.org/10.1177/1470320315598697	ADJ
ghmj-1231	240	5	https://doi.org/10.1177/147323000603400306	https://doi.org/10.1177/147323000603400306	NOUN
ghmj-1231	240	6	https://doi.org/10.1371/journal.pone.0264038	https://doi.org/10.1371/journal.pone.0264038	NOUN
ghmj-1231	240	7	https://doi.org/10.1186/s12920-022-01177-0	https://doi.org/10.1186/s12920-022-01177-0	NUM
ghmj-1231	240	8	https://doi.org/10.1016/s0140-6736(21)01330-1	https://doi.org/10.1016/s0140-6736(21)01330-1	PROPN
ghmj-1231	240	9	https://doi.org/10.35898/ghmj-82s1231	https://doi.org/10.35898/ghmj-82s1231	PROPN